2025


  1. Moustakis C, Blanck O, Grohmann M, Albers D, Bartels D, Bathen B, Borzì GR, Broggi S, Bruschi A, Casale M, Delana A, Doolan P, Ebrahimi Tazehmahalleh F, Fabiani S, Falco MD, Fehr R, Friedlein M, Gutser S, Hamada AM, Hancock T, Köhn J, Kornhuber C, Krieger T, Lambrecht U, Lappi S, Moretti E, Mirus A, Muedder T, Plaude S, Polvika B, Ravaglia V, Righetto R, Rinaldin G, Schachner H, Scaggion A, Schilling P, Szeverinski P, Villaggi E, Walke M, Wilke L, Winkler P, Nicolay NH, Eich HT, Gkika E, Brunner (2025). Planning Benchmark Study for Stereotactic Body Radiation Therapy of Pancreas Carcinomas With Simultaneously Integrated Boost and Protection: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery. Int J Radiat Oncol Biol Phys, 121(2), 547-557.
     
  2. Moustakis C, Blanck O, Grohmann M, Albers D, Bartels D, Bathen B, Borzì GR, Broggi S, Bruschi A, Casale M, Delana A, Doolan P, Ebrahimi Tazehmahalleh F, Fabiani S, Falco MD, Fehr R, Friedlein M, Gutser S, Hamada AM, Hancock T, Köhn J, Kornhuber C, Krieger T, Lambrecht U, Lappi S, Moretti E, Mirus A, Muedder T, Plaude S, Polvika B, Ravaglia V, Righetto R, Rinaldin G, Schachner H, Scaggion A, Schilling P, Szeverinski P, Villaggi E, Walke M, Wilke L, Winkler P, Nicolay NH, Eich HT, Gkika E, Brunner (2025). Planning Benchmark Study for Stereotactic Body Radiation Therapy of Pancreas Carcinomas With Simultaneously Integrated Boost and Protection: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery. Int J Radiat Oncol Biol Phys, 121(2), 547-557.
     


    3. 2024


  3. Nicolay, NN, Seidel C (2024). Homozygous CDKN2A/B deletions in low- and high-grade glioma: a meta-analysis of individual patient data and predictive values of p16 immunohistochemistry testing. Acta Neuropathol Commun, 12(1), 180.
     
  4. Dietz A, Stöhr M, Zebralla V, Pirlich M, Wiegand S, Nicolay NH (2024). [Surgical Treatment of Hypopharyngeal Carcinoma, Neck Dissection and Adjuvant Postoperative Therapy of Oropharyngeal and Hypopharyngeal Cancer: Recommendations of the current S3 Guideline - Part II]. Laryngorhinootologie, 103(10), 734-753.
     
  5. Noack D, Wach J, Barrantes-Freer A, Nicolay NH, Güresir E, Seidel C (2024). Homozygous CDKN2A/B deletions in low- and high-grade glioma: a meta-analysis of individual patient data and predictive values of p16 immunohistochemistry testing. Acta Neuropathol Commun, 12(1), 180.
     
  6. Strack M, Kückelhaus J, Diebold M, Wuchter P, Huber PE, Schnell O, Sankowski R, Prinz M, Grosu AL, Heiland DH, Nicolay NH, Rühle A (2024). Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells. J Neurooncol, 169(2), 329-340.
     
  7. Gleim N, Rühle A, Heider S, Nägler F, Giordano FA, Combs SE, Becker J, Niyazi M, Grosu AL, Nicolay NH, Seidel C (2024). Neuroprotection in radiotherapy of brain metastases: A pattern-of-care analysis in Germany, Austria and Switzerland by the German Society for radiation Oncology - working group Neuro-Radio-Oncology (DEGRO AG-NRO). Clin Transl Radiat Oncol, 47(), 100783.
     
  8. Bitz HC, Sachpazidis I, Zou J, Schnell D, Baltas D, Grosu AL, Nicolay NH, Rühle A (2024). The role of the soft palate dose regarding normal tissue toxicities in older adults with head and neck cancer undergoing definitive radiotherapy. Radiat Oncol, 19(1), 53.
     
  9. Rühle A, Wieland L, Hinz A, Mehnert-Theuerkauf A, Nicolay NH, Seidel C (2024). Decision regret of cancer patients after radiotherapy: results from a cross-sectional observational study at a large tertiary cancer center in Germany. J Cancer Res Clin Oncol, 150(3), 167.
     
  10. Bostel T, Nikolaidou E, Wollschläger D, Mayer A, Kaufmann J, Hopprich A, Rühle A, Grosu AL, Debus J, Fottner C, Moehler M, Grimminger P, Schmidberger H, Nicolay NH (2024). Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction. Radiat Oncol, 19(1), 28.
     
  11. Rühle A, Nicolay NH (2024). [Hypoxia-based de-escalation of radiochemotherapy in patients with human papillomavirus-related oropharyngeal carcinoma]. Strahlenther Onkol, 200(5), 453-456.
     
  12. Seidel C, Nicolay NH (2024). [Vorasidenib for low-grade gliomas-new treatment option with unanswered questions regarding long-term outcomes]. Strahlenther Onkol, 200(2), 178-180.
     
  13. Schunn FA, El Shafie RA, Kronsteiner D, Sauer LD, Kudak A, Bougatf N, Oetzel D, Krämer A, Regnery S, Machmer T, Debus J, Nicolay NH (2024). Oncologic treatment support via a dedicated mobile app: a prospective feasibility evaluation (OPTIMISE-1). Strahlenther Onkol, 200(6), 475-486.
     
  14. Rühle A, Weymann M, Behrens M, Marschner S, Haderlein M, Fabian A, Senger C, Dickstein DR, Kraft J, von der Grün J, Chen E, Aquino-Michaels T, Domschikowski J, Bickel A, Altay-Langguth A, Kalinauskaite G, Lewitzki V, Bonomi M, Blakaj DM, Jhawar SR, Baliga S, Barve R, Ferentinos K, Zamboglou C, Schnellhardt S, Haehl E, Spohn SKB, Kuhnt T, Zöller D, Guckenberger M, Budach V, Belka C, Bakst R, Mayer A, Schmidberger H, Grosu AL, Balermpas P, Stromberger C, Nicolay NH (2024). A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation. Int J Radiat Oncol Biol Phys, 118(5), 1282-1293.
     
  15. Rühle A, Nicolay NH (2024). [Role of chemotherapy in radiotherapy-treated nasopharynx carcinoma: update of the MAC-NPC network meta-analysis]. Strahlenther Onkol, 200(1), 99-102.
     
  16. Rühle A, Kuhnt T (2024). [Neoadjuvant nivolumab plus chemotherapy followed by response-adaptive therapy for HPV-positive oropharyngeal cancer]. Strahlenther Onkol, 200(11), 1000-1004.
     
  17. Amrell L, Bär E, Glasow A, Kortmann RD, Seidel C, Patties I (2024). Enhanced anti-tumor effects by combination of tucatinib and radiation in HER2-overexpressing human cancer cell lines. Cancer Cell Int, 24(1), 277.
     
  18. Rühle A (2024). Stick Your Neck Out: Reirradiate or Not in a Head and Neck Cancer Patient With Extracapsular Extension After Salvage Neck Dissection. Int J Radiat Oncol Biol Phys, 120(5), 1205-1206.
     
  19. Rühle A, Weymann M, Behrens M, Olbrich J, Kut C, Marschner SN, Haderlein M, Fabian A, Senger C, Bakst BP, Kraft J, von der Grün J, Looman EL, Chen E, Domschikowski J, Altay-Langguth A, Kalinauskaite G, Lewitzki V, Bonomi M, Blakaj D, Jhawar SR, Baliga S, Elguindy AN, Ferentinos K, Zamboglou C, Müller JA, Leucht C, Dickstein DR, Schnellhardt S, Haehl E, Hambsch P, Kuhnt T, Seidel C, Belka C, Mayer A, Schmidberger H, Grosu AL, Balermpas P, Stromberger C, Binder H, Quon H, Nicolay NH (2024). Predicting cisplatin tolerability in older adults with head and neck cancer - Insights for improved chemoradiation outcomes. Radiother Oncol, 204(), 110697.
     
  20. Nunes B, Humphreys J, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, Moustsen-Helms IR, Sacco C, Fabiani M, Castilla J, Martínez-Baz I, Meijerink H, Machado A, Soares P, Ljung R, Pihlström N, Nardone A, Bacci S, Monge S (2024). Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study. Expert Rev Vaccines, 23(1), 1085-1090.
     
  21. Kafkaletos A, Sachpazidis I, Mix M, Carles M, Schäfer H, Rühle A, Nicolay NH, Lazzeroni M, Toma-Dasu I, Grosu AL, Baltas D (2024). Implications of the partial volume effect correction on the spatial quantification of hypoxia based on [(18)F]FMISO PET/CT data. Phys Med, 128(), 104853.
     
  22. Gkika E, Radicioni G, Eichhorst A, Kirste S, Sprave T, Nicolay NH, Fichtner-Feigl S, Thimme R, Wiehle R, Brunner TB, Grosu AL (2024). The role of ALBI score in patients treated with stereotactic body radiotherapy for locally advanced primary liver tumors: a pooled analysis of two prospective studies. Front Oncol, 14(), 1427332.
     
  23. Wichmann G, Wald T, Pirlich M, Napp J, Münter I, Asendorf T, Tostmann R, Vogt J, Vogel K, Meuret S, Stoehr M, Zebralla V, Nicolay NH, Kuhnt T, Hambsch P, Guntinas-Lichius O, Klußmann JP, Wiegand S, Dietz A (2024). The European Larynx Organ Preservation Study [MK-3475-C44]. Front Oncol, 14(), 1433238.
     
  24. Wegen S, Nestle U, Zamboglou C, Spohn SKB, Nicolay NH, Unterrainer LM, Koerber SA, La Fougère C, Fokas E, Kobe C, Eze C, Grosu AL, Fendler WP, Holzgreve A, Werner R, Schmidt-Hegemann NS (2024). Implementation of PET/CT in radiation oncology-a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology. Strahlenther Onkol, 200(11), 931-941.
     
  25. Wichmann G, Wald T, Pirlich M, Stoehr M, Zebralla V, Kuhnt T, Nicolay NH, Hambsch P, Krücken I, Hoffmann KT, Lordick F, Kluge R, Wiegand S, Dietz A (2024). Improved survival of locoregional-advanced larynx and hypopharynx cancer patients treated according to the DeLOS-II protocol. Front Oncol, 14(), 1394691.
     
  26. Kafkaletos A, Mix M, Sachpazidis I, Carles M, Rühle A, Ruf J, Grosu AL, Nicolay NH, Baltas D (2024). The significance of partial volume effect on the estimation of hypoxic tumour volume with [(18)F]FMISO PET/CT. EJNMMI Phys, 11(1), 43.
     
  27. Wurschi GW, Rühle A, Domschikowski J, Trommer M, Ferdinandus S, Becker JN, Boeke S, Sonnhoff M, Fink CA, Käsmann L, Schneider M, Bockelmann E, Krug D, Nicolay NH, Fabian A, Pietschmann K (2024). Patient-Relevant Costs for Organ Preservation versus Radical Resection in Locally Advanced Rectal Cancer. Cancers (Basel), 16(7), 1281.
     
  28. Ebert MP, Fischbach W, Hollerbach S, Höppner J, Lorenz D, Stahl M, Stuschke M, Pech O, Vanhoefer U, Porschen R (2024). S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus. Z Gastroenterol, 62(4), 535-642.
     
  29. Kaufmann J, Täubl AU, Nikolaidou E, Rühle A, Hopprich A, Wollschläger D, Mayer A, Nicolay NH, Schmidberger H, Bostel T (2024). Excellent long-term pain response and local control following postoperative radiotherapy in patients with multiple myeloma. Strahlenther Onkol, 200(7), 633-641.
     
  30. Fabian A, Rühle A, Domschikowski J, Trommer M, Wegen S, Becker JN, Wurschi G, Boeke S, Sonnhoff M, Fink CA, Käsmann L, Schneider M, Bockelmann E, Treppner M, Mehnert-Theuerkauf A, Nicolay NH, Krug D (2024). Satisfaction with radiotherapy care among cancer patients treated in Germany-secondary analysis of a large multicenter study. Strahlenther Onkol, 200(6), 487-496.
     
  31. Malmström A, Oppong FB, O Callaghan CJ, Wick W, Laperriere N, Gorlia T, Weller M, Henriksson R, Mason W, Platten M, Cantagallo E, Grønberg BH, Reifenberger G, Marosi C, Perry JR (2024). Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trial. Neurooncol Adv, 6(1), 211.
     
  32. Guckenberger M, Billiet C, Schnell D, Franzese C, Spa?ek M, Rogers S, Stelmes JJ, Aebersold DM, Hemmatazad H, Zimmermann F, Zimmer J, Zilli T, Bruni A, Baumert BG, Nägler F, Gut P, Förster R, Madani I (2024). Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial. Cancer, 130(15), 2713-2722.
     
  33. Horn LC, Brambs CE, Gilks B, Hoang L, Singh N, Hiller GGR, Hering K, McAlpine JN, Jamieson A, Alfaraidi M, Aktas B, Dornhöfer N, Höhn AK (2024). Molecular Subtypes of Vulvar Squamous Cell Carcinoma: The Significance of HPV-Independent/p53 Wild Type. Cancers (Basel), 16(24), 4216.
     
  34. Basaran AE, Vychopen M, Seidel C, Barrantes-Freer A, Arlt F, Güresir E, Wach J (2024). Postoperative Vision-Related Quality of Life After Sphenoid Wing Meningioma Surgery: Impact of Radiomic Shape Features and Age. J Clin Med, 14(1), 40.
     
  35. Oort Q, Reijneveld JC, Sikkes SAM, Koekkoek JAF, Boele F, Young T, Brannan C, Chalk T, Talacchi A, Mazzotta A, Narita Y, Sato H, Miyakita Y, Shamieh O, Alrjoob W, Pace A, Petranovic D, Ploh M, Capela A, Silva J, Hjermstad MJ, Purkart TU, Seidel C, Talhi N, Pichler J, Höllmüller I, Brown L, Hand M, Klein M, Aaronson NK, Uitdehaag BMJ, Taphoorn MJB, Dirven L (2024). Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire. Eur J Cancer, 212(), 114335.
     
  36. Glieme F, Haddad L, Arlt F, Vychopen M, Seidel C, Barrantes-Freer A, Güresir E, Wach J (2024). The Impact of Tumor Elongation on Facial Nerve Outcome after Surgery for Koos Grade 3 and 4 Vestibular Schwannomas in the Semi-Sitting Position via the Retrosigmoid Approach. J Clin Med, 13(17), 5319.
     
  37. Eekers DBP, Zegers CML, Ahmed KA, Amelio D, Gupta T, Harrabi SB, Kazda T, Scartoni D, Seidel C, Shih HA, Minniti G (2024). Controversies in neuro-oncology: Focal proton versus photon radiation therapy for adult brain tumors. Neurooncol Pract, 11(4), 369-382.
     
  38. Giordano FA, Layer JP, Leonardelli S, Friker LL, Turiello R, Corvino D, Zeyen T, Schaub C, Müller W, Sperk E, Schmeel LC, Sahm K, Oster C, Kebir S, Hambsch P, Pietsch T, Bisdas S, Platten M, Glas M, Seidel C, Herrlinger U, Hölzel M (2024). L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial. Nat Commun, 15(1), 4210.
     
  39. Maier SH, Schönecker S, Anagnostatou V, Garny S, Nitschmann A, Fleischmann DF, Büttner M, Kaul D, Imhoff D, Fokas E, Seidel C, Hau P, Kölbl O, Popp I, Grosu AL, Haussmann J, Budach W, Celik E, Kahl KH, Hoffmann E, Tabatabai G, Paulsen F, Holzgreve A, Albert NL, Mansmann U, Corradini S, Belka C, Niyazi M, Bodensohn R (2024). Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06). Clin Transl Radiat Oncol, 47(), 100790.
     
  40. Nussbaumer G, Benesch M, Grabovska Y, Mackay A, Castel D, Grill J, Alonso MM, Antonelli M, Bailey S, Baugh JN, Biassoni V, Blattner-Johnson M, Broniscer A, Carai A, Colafati GS, Colditz N, Corbacioglu S, Crampsie S, Entz-Werle N, Eyrich M, Friker LL, Frühwald MC, Garrè ML, Gerber NU, Giangaspero F, Gil-da-Costa MJ, Graf N, Hargrave D, Hauser P, Herrlinger U, Hoffmann M, Hulleman E, Izquierdo E, Jacobs S, Karremann M, Kattamis A, Kebudi R, Kortmann RD, Kwiecien R, Massimino M, Mastronuzzi A, Miel (2024). Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile. Neuro Oncol, 26(9), 1723-1737.
     
  41. Arlt F, Basaran AE, Vogel M, Vychopen M, Seidel C, Barrantes-Freer A, Güresir E, Wach J (2024). The safety and use of perioperative dexamethasone in the perioperative management of primary sporadic supratentorial meningiomas. Front Oncol, 14(), 1379692.
     
  42. Lawson McLean AC, Lawson McLean A, Ernst T, Forster MT, Freyschlag C, Gempt J, Goldbrunner R, Grau S, Jungk C, van Oorschot B, Rosahl SK, Wedding U, Senft C, Kamp MA (2024). Benchmarking palliative care practices in neurooncology: a german perspective. J Neurooncol, 168(2), 333-343.
     
  43. Roth P, Gorlia T, Reijneveld JC, de Vos F, Idbaih A, Frenel JS, Le Rhun E, Sepulveda JM, Perry J, Masucci GL, Freres P, Hirte H, Seidel C, Walenkamp A, Lukacova S, Meijnders P, Blais A, Ducray F, Verschaeve V, Nicholas G, Balana C, Bota DA, Preusser M, Nuyens S, Dhermain F, van den Bent M, O'Callaghan CJ, Vanlancker M, Mason W, Weller M (2024). Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial. Neuro Oncol, 26(9), 1670-1682.
     
  44. Adolph JE, Fleischhack G, Tschirner S, Rink L, Dittes C, Mikasch R, Dammann P, Mynarek M, Obrecht-Sturm D, Rutkowski S, Bison B, Warmuth-Metz M, Pietsch T, Pfister SM, Pajtler KW, Milde T, Kortmann RD, Dietzsch S, Timmermann B, Tippelt S (2024). Radiotherapy for Recurrent Medulloblastoma in Children and Adolescents: Survival after Re-Irradiation and First-Time Irradiation. Cancers (Basel), 16(11), 1955.
     
  45. Weissmann T, Deloch L, Grohmann M, Trommer M, Fabian A, Ehret F, Stefanowicz S, Rühle A, Lettmaier S, Putz F, Shariff M, Wegen S, Matschke J, Sperk E, Schröder A (2024). German radiation oncology's next generation: a web-based survey of young biologists, medical physicists, and physicians-from problems to solutions. Strahlenther Onkol, 200(12), 1005-1024.
     
  46. Brunner TB, Boda-Heggemann J, Bürgy D, Corradini S, Dieckmann UK, Gawish A, Gerum S, Gkika E, Grohmann M, Hörner-Rieber J, Kirste S, Klement RJ, Moustakis C, Nestle U, Niyazi M, Rühle A, Lang ST, Winkler P, Zurl B, Wittig-Sauerwein A, Blanck O (2024). Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery. Strahlenther Onkol, 200(9), 737-750.
     
  47. Morgenthaler J, Rühle A, Kirste S, Trommer M (2024). [SBRT for primary kidney cancer: Data from the multicentre prospective FASTRACK II study]. Strahlenther Onkol, 200(8), 733-735.
     
  48. Lazzeroni M, Ureba A, Rosenberg V, Schäfer H, Rühle A, Baltas D, Toma-Dasu I, Grosu AL (2024). Evaluating the impact of a rigid and a deformable registration method of pre-treatment images for hypoxia-based dose painting. Phys Med, 122(), 103376.
     
  49. Löser A, Fabian A, Rühle A, Thieme A, Baehr A, Käsmann L, Zwaan I, Kahle B, Soror T, Kunte A, Seyedi N, Kebenko M, Seidel C, Dierks F, Krause L, Bruchhage KL, Rades D (2024). Multidisciplinary survey on use of feeding tubes in head and neck cancer patients undergoing chemoradiotherapy in Germany-the SUFEETUBE project. Strahlenther Onkol, 200(7), 583-594.
     
  50. Baehr A, Schäfer S, Jäckel M, Becker SA, Ghandili S, Grohmann M, Eich HT, Oertel M (2024). Minimizing Long-Term Toxicities for Patients with Primary Mediastinal B-Cell Lymphoma Undergoing Modern Radiotherapy: Results from a Monocentric Biophysical Risk Evaluation. Cancers (Basel), 16(24), 4265.
     
  51. Falke I, Elsayad K, Channaoui M, Kandler C, Moustakis C, Theodor Eich H (2024). Physical and clinical results of a radiation bra in patients treated with total skin electron beam therapy. Phys Imaging Radiat Oncol, 31(), 100628.
     
  52. Reinhold A, Glasow A, Nürnberger S, Weimann A, Telemann L, Stolzenburg JU, Neuhaus J, Berndt-Paetz M (2024). Ionizing radiation and photodynamic therapy lead to multimodal tumor cell death, synergistic cytotoxicity and immune cell invasion in human bladder cancer organoids. Photodiagnosis Photodyn Ther, 51(), 104459.
     
  53. Bach C, Glasow A, Baran-Schmidt R, Oppermann H, Bach C, Meixensberger J, Güresir E, Gaunitz F (2024). Rapid and reproducible generation of glioblastoma spheroids for high-throughput drug screening. Front Bioeng Biotechnol, 12(), 1471012.
     
  54. Seidel C, Nicolay NH, Trepel M, Jordan F, Barantes-Freer A, Güresir E (2024). ZNS-Tumoren In: Hocker, Claßen, Preiß, Dornoff, Taschenbuch Hämatologie und Onkologie Interdisziplinäre Empfehlungen zur Therapie 2024/25 (S. 262-68), München: Zuckschwerdt-Verlag .
     


    55. 2023


  55. Sprave T, Pfaffenlehner M, Stoian R, Christofi E, Rühle A, Zöller D, Fabian A, Fahrner H, Binder H, Schäfer H, Gkika E, Grosu AL, Heinemann F, Nicolay NH (2023). App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled Trial. J Med Internet Res, 25(), e46189.
     
  56. Jeong S, Poudyal S, Klagges S, Kuhnt T, Papsdorf K, Hambsch P, Wach J, Güresir E, Nägler F, Rühle A, Nicolay NH, Seidel C (2023). Diabetes Mellitus Is a Strong Independent Negative Prognostic Factor in Patients with Brain Metastases Treated with Radiotherapy. Cancers (Basel), 15(19), 4845.
     
  57. Fabian A, Rühle A, Domschikowski J, Trommer M, Wegen S, Becker JN, Wurschi G, Boeke S, Sonnhoff M, Fink CA, Käsmann L, Schneider M, Bockelmann E, Treppner M, Mehnert-Theuerkauf A, Krug D, Nicolay NH (2023). Psychosocial distress in cancer patients undergoing radiotherapy: a prospective national cohort of 1042 patients in Germany. J Cancer Res Clin Oncol, 149(11), 9017-9024.
     
  58. Seidel C, Nicolay NH (2023). [Re-irradiation and Bevacizumab - active combination for treatment of recurrent glioblastoma]. Strahlenther Onkol, 199(6), 604-606.
     
  59. Rühle A, Zou J, Popp I, Nicolay NH (2023). Authors' response to the letter to the editor by Busra Yilmaz and Ugur Selek regarding our study "The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation". Eur Arch Otorhinolaryngol, 280(6), 3039-3040.
     
  60. Rühle A, Zou J, Popp I, Nicolay NH (2023). Authors' response to the Letter to the Editor by Efsun Somay and Erkan Topkan regarding our study "The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation". Eur Arch Otorhinolaryngol, 280(6), 3043-3044.
     
  61. Bostel T, Akbaba S, Wollschläger D, Mayer A, Nikolaidou E, Murnik M, Kirste S, Rühle A, Grosu AL, Debus J, Fottner C, Moehler M, Grimminger P, Schmidberger H, Nicolay NH (2023). Chemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: Multi-center analysis on the value of standard treatment in the elderly. Front Oncol, 13(), 1063670.
     
  62. Fabian A, Rühle A, Domschikowski J, Trommer M, Wegen S, Becker JN, Wurschi G, Boeke S, Sonnhoff M, Fink CA, Käsmann L, Schneider M, Bockelmann E, Treppner M, Krug D, Nicolay NH (2023). Financial toxicity in cancer patients undergoing radiotherapy in a universal health care system - A prospective multicenter study of 1075 patients. Radiother Oncol, 183(), 109604.
     
  63. Rühle A, Marschner S, Haderlein M, Fabian A, Weymann M, Behrens M, Senger C, Dickstein DR, Kraft J, von der Grün J, Chen E, Aquino-Michaels T, Domschikowski J, Bickel A, Altay-Langguth A, Kalinauskaite G, Lewitzki V, Ferentinos K, Zamboglou C, Schnellhardt S, Haehl E, Spohn SKB, Gkika E, Zöller D, Guckenberger M, Budach V, Belka C, Bakst R, Mayer A, Schmidberger H, Grosu AL, Balermpas P, Stromberger C, Nicolay NH (2023). Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy. JAMA Netw Open, 6(2), e230090.
     
  64. Rühle A, Marschner S, Haderlein M, Fabian A, Weymann M, Behrens M, Senger C, Dickstein DR, Kraft J, von der Grün J, Chen E, Aquino-Michaels T, Domschikowski J, Bickel A, Altay-Langguth A, Kalinauskaite G, Lewitzki V, Ferentinos K, Zamboglou C, Schnellhardt S, Haehl E, Spohn SKB, Gkika E, Zöller D, Guckenberger M, Budach V, Belka C, Bakst R, Mayer A, Schmidberger H, Grosu AL, Balermpas P, Stromberger C, Nicolay NH (2023). The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation. JAMA Netw Open, 6(2), e230090.
     
  65. Pfau LC, Glasow A, Seidel C, Patties I (2023). Imidazolyl Ethanamide Pentandioic Acid (IEPA) as Potential Radical Scavenger during Tumor Therapy in Human Hematopoietic Stem Cells. Molecules, 28(5), 1-22.
     
  66. Weller J, Schäfer N, Schaub C, Tzaridis T, Zeyen T, Schneider M, Potthoff AL, Giordano FA, Steinbach JP, Zeiner PS, Kowalski T, Sabel M, Hau P, Krex D, Grauer O, Goldbrunner R, Schnell O, Tabatabai G, Ringel F, Schmidt-Graf F, Brehmer S, Tonn JC, Bullinger L, Vajkoczy P, Glas M, Vatter H, Herrlinger U, Seidel C (2023). Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial. J Neurooncol, 161(1), 147-153.
     
  67. Rühle A, Kirste S (2023). [SBRT for primary renal cell carcinoma-long-term results from the IROCK database]. Strahlenther Onkol, 199(3), 330-332.
     
  68. Prasse G, Glaas A, Meyer HJ, Zebralla V, Dietz A, Hering K, Kuhnt T, Denecke T (2023). A Radiomics-Based Machine Learning Perspective on the Parotid Gland as a Potential Surrogate Marker for HPV in Oropharyngeal Cancer. Cancers (Basel), 15(22), 1-13.
     
  69. Timmermann B, Kortmann RD (2023). [Meningioma risk following treatment for childhood cancer. A pooled analysis]. Strahlenther Onkol, 199(1), 106-109.
     
  70. Hügel M, Stöhr J, Kuhnt T, Nägler F, Papsdorf K, Klagges S, Hambsch P, Güresir E, Nicolay NH, Seidel C (2023). Long-term survival in patients with brain metastases-clinical characterization of a rare scenario. Strahlenther Onkol, (), 1-11.
     
  71. Rühle A, Zou J, Glaser M, Halle L, Gkika E, Schäfer H, Knopf A, Becker C, Grosu AL, Popp I, Nicolay NH (2023). The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation. Eur Arch Otorhinolaryngol, 280(5), 2605-2616.
     
  72. Duda D, Gkika E, Firat E, Adebahr S, Graf E, Eichhorst A, Radicioni G, Lo S, Spohn S, Nestle U, Nicolay N, Niedermann G, Grosu AL (2023). A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatment. Res Sq, (), 1-20.
     
  73. Roesch J, Rühle A, Nicolay NH, Hecht M (2023). Reply to the comment on "Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis'' by Kahvecioglu et al. Radiother Oncol, 188(), 109866.
     
  74. Wurschi GW, Güllmar D, Gaßler N, Clement J, Kesselmeier M, Müller-Wurschi JJ, Settmacher U, Mothes H, Helfritzsch H, Liebe Y, Franiel T, Mäurer MA, Ernst T, Nicolay NH, Wittig A (2023). Planning adaptive treatment by longitudinal response assessment implementing MR imaging, liquid biopsy and analysis of microenvironment during neoadjuvant treatment of rectal cancer (PRIMO). Medicine (Baltimore), 102(17), 1-7.
     
  75. Gkika E, Firat E, Adebahr S, Graf E, Popp I, Radicioni G, Lo SS, Nestle U, Nicolay NH, Niedermann G, Duda DG, Grosu AL (2023). Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer. NPJ Precis Oncol, 7(1), 24.
     
  76. Janssen S, El Shafie RA, Ruder AM, Buergy D, Scafa D, Giordano FA, Nicolay NH, Vogel MME, Combs SE, Fahlbusch FB, Rades D, Käsmann L (2023). Mobile applications in radiation oncology-current choices and future potentials. Strahlenther Onkol, 199(4), 337-349.
     
  77. Roesch J, Oertel M, Wegen S, Trommer M, Schleifenbaum J, Hering D, Mäurer M, Knippen S, Dobiasch S, Waltenberger M, von der Grün J, Medenwald D, Süß C, Hoeck M, Käsmann L, Fleischmann DF, Rühle A, Nicolay NH, Fabian A, Löser A, Heß S, Tamaskovics B, Vinsensia M, Hecht M (2023). Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis. Radiother Oncol, 181(), 109380.
     
  78. Wolf J, Stoller S, Lübke J, Rothe T, Serpa M, Scholber J, Zamboglou C, Gkika E, Baltas D, Juhasz-Böss I, Verma V, Krug D, Grosu AL, Nicolay NH, Sprave T (2023). Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses. Strahlenther Onkol, 199(4), 379-388.
     
  79. Weller J, Zeyen T, Schäfer N, Schaub C, Potthoff AL, Steinbach JP, Hau P, Seidel C, Goldbrunner R, Tabatabai G, Vatter H, Tzaridis T, Schneider M, Herrlinger U (2023). The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial. J Neurooncol, 164(3), 749-755.
     
  80. Zeyen T, Paech D, Weller J, Schäfer N, Tzaridis T, Duffy C, Nitsch L, Schneider M, Potthoff AL, Steinbach JP, Hau P, Schlegel U, Seidel C, Krex D, Grauer O, Goldbrunner R, Zeiner PS, Tabatabai G, Galldiks N, Stummer W, Hattingen E, Glas M, Radbruch A, Herrlinger U, Schaub C (2023). Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses. J Neurooncol, 164(3), 607-616.
     
  81. Pertz M, Schlömer S, Seidel C, Hentschel B, Löffler M, Schackert G, Krex D, Juratli T, Tonn JC, Schnell O, Vatter H, Simon M, Westphal M, Martens T, Sabel M, Bendszus M, Dörner N, Wick A, Fliessbach K, Hoppe C, Klingner M, Felsberg J, Reifenberger G, Gramatzki D, Weller M, Schlegel U (2023). Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up. J Neurooncol, 164(2), 353-366.
     
  82. Zeyen T, Paech D, Weller J, Schäfer N, Tzaridis T, Duffy C, Nitsch L, Schneider M, Potthoff AL, Steinbach JP, Hau P, Schlegel U, Seidel C, Krex D, Grauer O, Goldbrunner R, Zeiner PS, Tabatabai G, Galldiks N, Stummer W, Hattingen E, Glas M, Radbruch A, Herrlinger U, Schaub C (2023). Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses. J Neurooncol, 165(2), 387.
     
  83. Wach J, Basaran AE, Arlt F, Vychopen M, Seidel C, Barrantes-Freer A, Müller W, Gaunitz F, Güresir E (2023). CDKN2A/B deletions are strongly associated with meningioma progression: a meta-analysis of individual patient data. Acta Neuropathol Commun, 11(1), 189.
     
  84. Wach J, Naegeli J, Vychopen M, Seidel C, Barrantes-Freer A, Grunert R, Güresir E, Arlt F (2023). Impact of Shape Irregularity in Medial Sphenoid Wing Meningiomas on Postoperative Cranial Nerve Functioning, Proliferation, and Progression-Free Survival. Cancers (Basel), 15(12), 1-21.
     
  85. Helbig D, Dippel E, Erdmann M, Frisman A, Kage P, Leiter U, Mentzel T, Seidel C, Weishaupt C, Ziemer M, Ugurel S (2023). S1-Leitlinie dermales und subkutanes Leiomyosarkom. J Dtsch Dermatol Ges, 21(5), 555-564.
     
  86. Helbig D, Dippel E, Erdmann M, Frisman A, Kage P, Leiter U, Mentzel T, Seidel C, Weishaupt C, Ziemer M, Ugurel S (2023). S1-guideline cutaneous and subcutaneous leiomyosarcoma. J Dtsch Dermatol Ges, 21(5), 555-564.
     
  87. Wach J, Vychopen M, Kühnapfel A, Seidel C, Güresir E (2023). A Systematic Review and Meta-Analysis of Supramarginal Resection versus Gross Total Resection in Glioblastoma: Can We Enhance Progression-Free Survival Time and Preserve Postoperative Safety? Cancers (Basel), 15(6), 1-17.
     
  88. Tzaridis T, Weller J, Bachurski D, Shakeri F, Schaub C, Hau P, Buness A, Schlegel U, Steinbach JP, Seidel C, Goldbrunner R, Schäfer N, Wechsler-Reya RJ, Hallek M, Scheffler B, Glas M, Haeberle L, Herrlinger U, Coch C, Reiners KS, Hartmann G (2023). A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression. Int J Cancer, 152(2), 308-319.
     
  89. Lassman AB, Pugh SL, Wang TJC, Aldape K, Gan HK, Preusser M, Vogelbaum MA, Sulman EP, Won M, Zhang P, Moazami G, Macsai MS, Gilbert MR, Bain EE, Blot V, Ansell PJ, Samanta S, Kundu MG, Armstrong TS, Wefel JS, Seidel C, de Vos FY, Hsu S, Cardona AF, Lombardi G, Bentsion D, Peterson RA, Gedye C, Bourg V, Wick A, Curran WJ, Mehta MP (2023). Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial. Neuro Oncol, 25(2), 339-350.
     
  90. Spohn SKB, Schmidt-Hegemann NS, Ruf J, Mix M, Benndorf M, Bamberg F, Makowski MR, Kirste S, Rühle A, Nouvel J, Sprave T, Vogel MME, Galitsnaya P, Gschwend JE, Gratzke C, Stief C, Löck S, Zwanenburg A, Trapp C, Bernhardt D, Nekolla SG, Li M, Belka C, Combs SE, Eiber M, Unterrainer L, Unterrainer M, Bartenstein P, Grosu AL, Zamboglou C, Peeken JC (2023). Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy. Eur J Nucl Med Mol Imaging, 50(8), 2537-2547.
     
  91. Prasse G, Glaas A, Meyer HJ, Zebralla V, Dietz A, Hering K, Kuhnt T, Denecke T (2023). A Radiomics-Based Machine Learning Perspective on the Parotid Gland as a Potential Surrogate Marker for HPV in Oropharyngeal Cancer. Cancers (Basel), 15(22), 1-13.
     
  92. Strnad V, Polgár C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, ?yczek J, Guinot JL, Gutierrez Miguelez C, Slampa P, Allgäuer M, Lössl K, Polat B, Fietkau R, Schlamann A, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Dunst J, Gall C, Uter W (2023). Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial. Lancet Oncol, 24(3), 262-272.
     
  93. Wiegand S, Wichmann G, Vogt J, Vogel K, Franke A, Kuhnt T, Lordick F, Scheuble AM, Hambsch P, Brossart P, Bauernfeind FG, Kaftan H, Maschmeyer G, Paland M, Münter M, Lewitzki V, Rotter N, Stromberger C, Beck M, Dommerich S, Gauler TC, Hapke G, Guntinas-Lichius O, Schröder U, Görner M, Hautmann MG, Steger F, Tamaskovics B, Schmiedeknecht A, Dietz A (2023). Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial. Front Oncol, 13(), 1128176.
     
  94. Diefenhardt M, Fleischmann M, Martin D, Hofheinz RD, Piso P, Germer CT, Hambsch P, Grützmann R, Kirste S, Schlenska-Lange A, Ghadimi M, Rödel C, Fokas E (2023). Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trials. Radiother Oncol, 179(), 109455.
     
  95. Osterhoff G, Kreinest M, Kuhnt T, Pohlenz C, Müller-Broich J, Röllig C, Teipel R, Scheyerer MJ, Schnake KJ, Spiegl UJA, Disch AC (2023). Management of Pathological Thoracolumbar Vertebral Fractures in Patients With Multiple Myeloma: Multidisciplinary Recommendations. Global Spine J, 13, 1-9.
     
  96. Kroese TE, van Laarhoven HWM, Schoppman SF, Deseyne PRAJ, van Cutsem E, Haustermans K, Nafteux P, Thomas M, Obermannova R, Mortensen HR, Nordsmark M, Pfeiffer P, Elme A, Adenis A, Piessen G, Bruns CJ, Lordick F, Gockel I, Moehler M, Gani C, Liakakos T, Reynolds J, Morganti AG, Rosati R, Castoro C, Cellini F, D'Ugo D, Roviello F, Bencivenga M, de Manzoni G, van Berge Henegouwen MI, Hulshof MCCM, van Dieren J, Vollebergh M, van Sandick JW, Jeene P, Muijs CT, Slingerland M, Voncken FEM, Hartgrink H (2023). Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe. Eur J Cancer, 185(), 28-39.
     
  97. Roers J, Rolf D, Baehr A, Pöttgen C, Stickan-Verfürth M, Siats J, Hering DA, Moustakis C, Grohmann M, Oertel M, Haverkamp U, Stuschke M, Timmermann B, Eich HT, Reinartz G (2023). Impact of Modern Low Dose Involved Site Radiation Therapy on Normal Tissue Toxicity in Cervicothoracic Non-Hodgkin Lymphomas: A Biophysical Study. Cancers (Basel), 15(24), 1-13.
     
  98. Gkika E, Kostyszyn D, Fechter T, Moustakis C, Ernst F, Boda-Heggemann J, Sarria G, Dieckmann K, Dobiasch S, Duma MN, Eberle F, Kroeger K, Häussler B, Izaguirre V, Jazmati D, Lautenschläger S, Lohaus F, Mantel F, Menzel J, Pachmann S, Pavic M, Radlanski K, Riesterer O, Gerum S, Röder F, Willner J, Barczyk S, Imhoff D, Blanck O, Wittig A, Guckenberger M, Grosu AL, Brunner TB (2023). Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities. Strahlenther Onkol, 199(11), 973-981.
     
  99. Elsayad K, Weishaupt C, Moustakis C, Danzer MF, Müller EC, Rolf D, Stranzenbach R, Livingstone E, Booken N, Stadler R, Eich HT (2023). Ultrahypofractionated Low-Dose Total Skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sézary Syndrome. Int J Radiat Oncol Biol Phys, 117(1), 164-170.
     
  100. Vychopen M, Arlt F, Wilhelmy F, Seidel C, Barrantes-Freer A, Güresir E, Wach J (2023). Association of quantitative radiomic shape features with functional outcome after surgery for primary sporadic dorsal spinal meningiomas Frontiers in Surgery, (), 1-9.
     
  101. Ng CH, Obrecht D, Wells O, Zapotocky M, Sumerauer D, Coltin H, Khuong-Quang DA, Eisenstat DD, Kinross KM, White CL, Algar EM, Luck A, Witt H, Schüller U, Mynarek M, Pietsch T, Gerber NU, Benesch M, Warmuth-Metz M, Kortmann R, Bison B, Taylor MD, Rutkowski S, Pfister SM, Jones DT, Gottardo NG, von Hoff K, Pajtler KW, Ramaswamy V, Hansford JR (2023). A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial ZFTA-fused ependymoma. Neurooncol Adv, 5(1), 1-8.
     
  102. Büttner M, Melton P, Fietkau R, Petersen C, Krause M, Borgmann K, Wolf U, Niyazi M, Christiansen H, Höller U, Schmitt D, Käsmann L, Linde P, Fleischmann DF, Ziegler S, Bresch A, Mäurer M (2023). Successful implementation of online educational lectures of the German Society for Radiation Oncology (DEGRO). Strahlenther Onkol, (), 1-8.
     
  103. Jazmati D, Brualla L, Littooij AS, Webber B, Dieckmann K, Janssens GO, Simon T, Gaze MN, Merta J, Serrano A, Dietzsch S, Kramer PH, Wulff J, Boterberg T, Timmermann B (2023). Overcoming inter-observer planning variability in target volume contouring and dose planning for high-risk neuroblastoma - a European multicenter effort of the SIOPEN radiotherapy committee. Radiother Oncol, 181(), 1-8.
     
  104. Seidel C, Nicolay NH, Trepel M, Jordan F, Meixensberger J (2023). ZNS-Tumoren In: Honecker F, Claßen J, Preiß J, Dornoff W, Taschenbuch Hämatologie und Onkologie Interdisziplinäre Empfehlungen zur Therapie (S. 252-258), München: Zuckschwerdt-Verlag.
     
  105. Rühle A, Nicolay NN (2023). Head and Neck Cancer In: Grosu AL, Nieder C, Nicolay NN, Target Volume Definition in Radiation Oncology (S. 24), Cham: Springer Nature.
     


    106. 2022


  106. Rühle A, Todorovic J, Spohn SSK, Gkika E, Becker C, Knopf A, Zamboglou C, Sprave T, Werner M, Grosu AL, Kayser G, Nicolay NH (2022). Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy. Radiat Oncol, 17(1), 181.
     
  107. Haehl E, Alvino L, Rühle A, Zou J, Fabian A, Grosu AL, Nicolay NH (2022). Sarcopenia as a Prognostic Marker in Elderly Head and Neck Squamous Cell Carcinoma Patients Undergoing (Chemo-)Radiation. Cancers (Basel), 14(22), 1-14.
     
  108. Rühle A, Nicolay NH (2022). [Weekly versus three-weekly cisplatin for the postoperative chemoradiation of locally advanced head-and-neck squamous cell carcinoma: results of the JCOG1008 trial]. Strahlenther Onkol, 198(10), 966-969.
     
  109. Rühle A, Nicolay NH (2022). [Weekly versus three-weekly cisplatin for the postoperative chemoradiation of locally advanced head-and-neck squamous cell carcinoma: results of the JCOG1008 trial]. Strahlenther Onkol, 198(10), 966-969.
     
  110. Sprave T, Verma V, Fabian A, Rühle A, Baltas D, Grosu AL, Nicolay NH (2022). Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients. Strahlenther Onkol, 198(11), 1008-1015.
     
  111. Rühle A, Lies M, Strack M, Perez RL, Bieber B, Thomsen AR, Bronsert P, Huber PE, Hess J, Knopf A, Wuchter P, Grosu AL, Nicolay NH (2022). Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell Carcinoma. Int J Mol Sci, 23(14), 1-17.
     
  112. Rühle A, Nicolay NH (2022). [De-escalation of adjuvant radiotherapy after transoral surgery of HPV-associated oropharyngeal cancer: results of the E3311 trial]. Strahlenther Onkol, 198(4), 400-403.
     
  113. Rühle A, Wiedenmann N, Fennell JT, Mix M, Ruf J, Stoian R, Thomsen AR, Vaupel P, Baltas D, Grosu AL, Nicolay NH (2022). Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation-results from a prospective pilot trial. Eur J Nucl Med Mol Imaging, 49(5), 1650-1660.
     
  114. Rühle A, Grosu AL, Wiedenmann N, Ruf J, Bieber B, Stoian R, Thomsen AR, Gkika E, Vaupel P, Baltas D, Weber WA, Mix M, Nicolay NH (2022). The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation. Clin Transl Radiat Oncol, 33(), 120-127.
     
  115. Rühle A, Ping D, Lopez Perez R, Strack M, Brons S, Yijia Q, Debus J, Wuchter P, Grosu AL, Huber PE, Nicolay NH (2022). Human mesenchymal stromal cells maintain their stem cell traits after high-LET particle irradiation - Potential implications for particle radiotherapy and manned space missions. Cancer Lett, 524(), 172-181.
     
  116. Hoppe J, Kalckreuth T, Metelmann M, Rumpf JJ, Klagges S, Dietzsch S, Scherlach C, Kuhnt T, Kortmann RD, Seidel C (2022). [Skull base metastases with cranial nerve deficits : Clinical profile of a severe disease]. Nervenarzt, 93(8), 812-818.
     
  117. Rothe F, Patties I, Kortmann RD, Glasow A (2022). Immunomodulatory Effects by Photodynamic Treatment of Glioblastoma Cells In Vitro. Molecules, 27(11), 1-20.
     
  118. Gringmuth M, Walther J, Greiser S, Toussaint M, Schwalm B, Kool M, Kortmann RD, Glasow A, Patties I (2022). Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir. Int J Mol Sci, 23(7), 1-28.
     
  119. Dietzsch S, Braesigk A, Seidel C, Remmele J, Kitzing R, Schlender T, Mynarek M, Geismar D, Jablonska K, Schwarz R, Pazos M, Weber DC, Frick S, Gurtner K, Matuschek C, Harrabi SB, Glück A, Lewitzki V, Dieckmann K, Benesch M, Gerber NU, Obrecht D, Rutkowski S, Timmermann B, Kortmann RD (2022). Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial. Strahlenther Onkol, 198(3), 282-290.
     
  120. Fabian A, Domschikowski J, Greiner W, Bockelmann G, Karsten E, Rühle A, Nicolay NH, Grosu AL, Dunst J, Krug D (2022). Financial toxicity in cancer patients treated with radiotherapy in Germany-a cross-sectional study. Strahlenther Onkol, 198(12), 1053-1061.
     
  121. Fabian A, Nicolay NH, Krug D (2022). [ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy]. Strahlenther Onkol, 198(11), 1045-1048.
     
  122. Sprave T, Verma V, Fabian A, Rühle A, Baltas D, Grosu AL, Nicolay NH (2022). Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients. Strahlenther Onkol, 198(11), 1008-1015.
     
  123. Rühle A, Nya Yompang VA, Spohn SKB, Stoian R, Zamboglou C, Gkika E, Grosu AL, Nicolay NH, Sprave T (2022). Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients. Radiat Oncol, 17(1), 153.
     
  124. Marinescu IM, Spohn SKB, Kiefer S, Bronsert P, Ceci L, Holzschuh J, Sigle A, Jilg CA, Rühle A, Sprave T, Nicolay NH, Winzer R, Rehm J, Kotzerke J, Hölscher T, Grosu AL, Ruf J, Benndorf M, Zamboglou C (2022). Intraindividual Comparison Between [(18)F] PSMA-1007 PET/CT and Multiparametric MRI for Radiotherapy Planning in Primary Prostate Cancer Patients. Front Oncol, 12(), 880042.
     
  125. Wolf J, Kurz S, Rothe T, Serpa M, Scholber J, Erbes T, Gkika E, Baltas D, Verma V, Krug D, Juhasz-Böss I, Grosu AL, Nicolay NH, Sprave T (2022). Incidental irradiation of the regional lymph nodes during deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a dosimetric analysis. BMC Cancer, 22(1), 682.
     
  126. Spohn SKB, Birkenmaier V, Ruf J, Mix M, Sigle A, Haehl E, Adebahr S, Sprave T, Gkika E, Rühle A, Nicolay NH, Kirste S, Grosu AL, Zamboglou C (2022). Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With De Novo Lymph Node-Positive Prostate Cancer. Front Oncol, 12(), 898774.
     
  127. Spohn SKB, Adebahr S, Huber M, Jenkner C, Wiehle R, Nagavci B, Schmucker C, Carl EG, Chen RC, Weber WA, Mix M, Rühle A, Sprave T, Nicolay NH, Gratzke C, Benndorf M, Wiegel T, Weis J, Baltas D, Grosu AL, Zamboglou C (2022). Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients. BMC Cancer, 22(1), 337.
     
  128. Dapper H, Belka C, Bock F, Budach V, Budach W, Christiansen H, Debus J, Distel L, Dunst J, Eckert F, Eich H, Eicheler W, Engenhart-Cabillic R, Fietkau R, Fleischmann DF, Frerker B, Giordano FA, Grosu AL, Herfarth K, Hildebrandt G, Kaul D, Kölbl O, Krause M, Krug D, Martin D, Matuschek C, Medenwald D, Nicolay NH, Niewald M, Oertel M, Petersen C, Pohl F, Raabe A, Rödel C, Rübe C, Schmalz C, Schmeel LC, Steinmann D, Stüben G, Thamm R, Vordermark D, Vorwerk H, Wiegel T, Zips D, Combs SE (2022). Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO). Strahlenther Onkol, 198(1), 1-11.
     
  129. Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC (2022). Correction to: Value of PET imaging for radiation therapy. Strahlenther Onkol, 198(1), 80-82.
     
  130. Weller J, Schäfer N, Schaub C, Potthoff AL, Steinbach JP, Schlegel U, Sabel M, Hau P, Seidel C, Krex D, Goldbrunner R, Pietsch T, Tzaridis T, Zeyen T, Borger V, Güresir E, Vatter H, Herrlinger U, Schneider M (2022). Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS. J Neurooncol, 159(1), 95-101.
     
  131. Zeyen T, Potthoff AL, Nemeth R, Heiland DH, Burger MC, Steinbach JP, Hau P, Tabatabai G, Glas M, Schlegel U, Grauer O, Krex D, Schnell O, Goldbrunner R, Sabel M, Thon N, Delev D, Clusmann H, Seidel C, Güresir E, Schmid M, Schuss P, Giordano FA, Radbruch A, Becker A, Weller J, Schaub C, Vatter H, Schilling J, Winkler F, Herrlinger U, Schneider M (2022). Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial. Trials, 23(1), 57.
     
  132. Chavaz L, Janssens GO, Bolle S, Mandeville H, Ramos-Albiac M, Van Beek K, Benghiat H, Hoeben B, Morales La Madrid A, Seidel C, Kortmann RD, Hargrave D, Gandola L, Pecori E, van Vuurden DG, Biassoni V, Massimino M, Kramm CM, von Bueren AO (2022). Neurological Symptom Improvement After Re-Irradiation in Patients With Diffuse Intrinsic Pontine Glioma: A Retrospective Analysis of the SIOP-E-HGG/DIPG Project. Front Oncol, 12(), 1-8.
     
  133. Lassman AB, Pugh SL, Wang TJC, Aldape K, Gan HK, Preusser M, Vogelbaum MA, Sulman EP, Won M, Zhang P, Moazami G, Macsai MS, Gilbert MR, Bain EE, Blot V, Ansell PJ, Samanta S, Kundu MG, Armstrong TS, Wefel JS, Seidel C, de Vos FY, Hsu S, Cardona AF, Lombardi G, Bentsion D, Peterson RA, Gedye C, Bourg V, Wick A, Curran WJ, Mehta MP (2022). Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial. Neuro Oncol, (), 1-12.
     
  134. Tzaridis T, Weller J, Bachurski D, Shakeri F, Schaub C, Hau P, Buness A, Schlegel U, Steinbach JP, Seidel C, Goldbrunner R, Schäfer N, Wechsler-Reya RJ, Hallek M, Scheffler B, Glas M, Haeberle L, Herrlinger U, Coch C, Reiners KS, Hartmann G (2022). A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression. Int J Cancer, 152(2), 308-319.
     
  135. Franceschi E, Giannini C, Furtner J, Pajtler KW, Asioli S, Guzman R, Seidel C, Gatto L, Hau P (2022). Adult Medulloblastoma: Updates on Current Management and Future Perspectives. Cancers (Basel), 14(15), 1-21.
     
  136. Kasper J, Frydrychowicz C, Jähne K, Wende T, Wilhelmy F, Arlt F, Seidel C, Hoffmann KT, Meixensberger J (2022). The Role of Delayed Radiotherapy Initiation in Patients with Newly Diagnosed Glioblastoma with Residual Tumor Mass. J Neurol Surg A Cent Eur Neurosurg, 83(3), 252-258.
     
  137. Goschzik T, Mynarek M, Doerner E, Schenk A, Spier I, Warmuth-Metz M, Bison B, Obrecht D, Struve N, Kortmann RD, Schmid M, Aretz S, Rutkowski S, Pietsch T (2022). Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas. Acta Neuropathol, 144(6), 1143-1156.
     
  138. Thomale UW, Gnekow AK, Kandels D, Bison B, Hernáiz Driever P, Witt O, Pietsch T, Koch A, Capper D, Kortmann RD, Timmermann B, Harrabi S, Simon M, El Damaty A, Krauss J, Schuhmann MU, Aigner A (2022). Long-term follow-up of surgical intervention pattern in pediatric low-grade gliomas: report from the German SIOP-LGG 2004 cohort. J Neurosurg Pediatr, (), 1-14.
     
  139. Obrecht D, Mynarek M, Hagel C, Kwiecien R, Spohn M, Bockmayr M, Bison B, Pfister SM, Jones DTW, Sturm D, von Deimling A, Sahm F, von Hoff K, Juhnke BO, Benesch M, Gerber NU, Friedrich C, von Bueren AO, Kortmann RD, Schwarz R, Pietsch T, Fleischhack G, Schüller U, Rutkowski S (2022). Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies. J Neurooncol, 157(1), 37-48.
     
  140. Gaab C, Adolph JE, Tippelt S, Mikasch R, Obrecht D, Mynarek M, Rutkowski S, Pfister SM, Milde T, Witt O, Bison B, Warmuth-Metz M, Kortmann RD, Dietzsch S, Pietsch T, Timmermann B, Sträter R, Bode U, Faldum A, Kwiecien R, Fleischhack G (2022). Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 Study. Cancers (Basel), 14(3), 1-24.
     
  141. Peters S, Merta J, Schmidt L, Jazmati D, Kramer PH, Blase C, Tippelt S, Fleischhack G, Stock A, Bison B, Rutkowski S, Pietsch T, Kortmann RD, Timmermann B (2022). Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg Study. Neuro Oncol, 24(7), 1193-1202.
     
  142. Stock A, Hancken CV, Kandels D, Kortmann RD, Dietzsch S, Timmermann B, Pietsch T, Bison B, Schmidt R, Pham M, Gnekow AK, Warmuth-Metz M (2022). Pseudoprogression Is Frequent After Front-Line Radiation Therapy in Pediatric Low-Grade Glioma: Results From the German Low-Grade Glioma Cohort. Int J Radiat Oncol Biol Phys, 112(5), 1190-1202.
     
  143. Frappaz D, Dhall G, Murray MJ, Goldman S, Faure Conter C, Allen J, Kortmann RD, Haas-Kogen D, Morana G, Finlay J, Nicholson JC, Bartels U, Souweidane M, Schönberger S, Vasiljevic A, Robertson P, Albanese A, Alapetite C, Czech T, Lau CC, Wen P, Schiff D, Shaw D, Calaminus G, Bouffet E (2022). EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults. Neuro Oncol, 24(4), 516-527.
     
  144. Juhnke BO, Gessi M, Gerber NU, Friedrich C, Mynarek M, von Bueren AO, Haberler C, Schüller U, Kortmann RD, Timmermann B, Bison B, Warmuth-Metz M, Kwiecien R, Pfister SM, Spix C, Pietsch T, Kool M, Rutkowski S, von Hoff K (2022). Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial. Neuro Oncol, 24(1), 127-137.
     
  145. Lazaridis L, Bumes E, Cäcilia Spille D, Schulz T, Heider S, Agkatsev S, Schmidt T, Blau T, Oster C, Feldheim J, Stummer W, Kessler AF, Seidel C, Grauer O, Hau P, Sure U, Keyvani K, Herrlinger U, Kleinschnitz C, Stuschke M, Herrmann K, Deuschl C, Breuer S, Hattingen E, Scheffler B, Kebir S, Glas M (2022). First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma. Neurooncol Adv, 4(1), 1-10.
     
  146. Schweyen R, Reich W, Jevnikar P, Kuhnt T, Wienke A, Hey J (2022). Factors Influencing the Survival Rate of Teeth and Implants in Patients after Tumor Therapy to the Head and Neck Region-Part 2: Implant Survival. J Clin Med, 11(21), 1-11.
     
  147. Schweyen R, Reich W, Vordermark D, Kuhnt T, Wienke A, Hey J (2022). Factors Influencing the Survival Rate of Teeth and Implants in Patients after Tumor Therapy to the Head and Neck Region-Part 1: Tooth Survival. J Clin Med, 11(20), 1-15.
     
  148. Diefenhardt M, Schlenska-Lange A, Kuhnt T, Kirste S, Piso P, Bechstein WO, Hildebrandt G, Ghadimi M, Hofheinz RD, Rödel C, Fokas E (2022). Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial: Early Surrogate Endpoints Revisited. Cancers (Basel), 14(15), 1-12.
     
  149. Kroese TE, van Hillegersberg R, Schoppmann S, Deseyne PRAJ, Nafteux P, Obermannova R, Nordsmark M, Pfeiffer P, Hawkins MA, Smyth E, Markar S, Hanna GB, Cheong E, Chaudry A, Elme A, Adenis A, Piessen G, Gani C, Bruns CJ, Moehler M, Liakakos T, Reynolds J, Morganti A, Rosati R, Castoro C, D'Ugo D, Roviello F, Bencivenga M, de Manzoni G, Jeene P, van Sandick JW, Muijs C, Slingerland M, Nieuwenhuijzen G, Wijnhoven B, Beerepoot LV, Kolodziejczyk P, Polkowski WP, Alsina M, Pera M, Kanonnikoff TF, Nils (2022). Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe. Eur J Cancer, 164(), 18-29.
     
  150. Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, Kirste S, Jacobasch L, Allgäuer M, Flentje M, Germer CT, Grützmann R, Hildebrandt G, Schwarzbach M, Bechstein WO, Sülberg H, Friede T, Gaedcke J, Ghadimi M, Hofheinz RD, Rödel C (2022). Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial. JAMA Oncol, 8(1), 1-11.
     
  151. Roick J, Danker H, Kersting A, Dietrich A, Dietz A, Papsdorf K, Meixensberger J, Stolzenburg JU, Wirtz H, Singer S (2022). Predictors of psychiatric comorbidity in cancer patients at the time of their discharge from the hospital. Soc Psychiatry Psychiatr Epidemiol, 57(3), 553-561.
     
  152. Kebir S, Lazaridis L, Wick W, Platten M, Tabatabai G, Combs SE, Schmidt T, Agkatsev S, Blau T, Mäurer I, Kahlert U, Sagerer A, Berberich A, Heider S, Müther M, Bodensohn R, Behling F (2022). Gender disparity regarding work-life balance satisfaction among German neuro-oncologists: a YoungNOA survey. Neuro Oncol, 24(9), 1609-1611.
     
  153. Moustakis C, Blanck O, Chan MKH, Boda-Heggemann J, Andratschke N, Duma MN, Albers D, Bäumer C, Fehr R, Körber SA, Schmidhalter D, Alraun M, Baus WW, Beckers E, Dierl M, Droege S, Ebrahimi Tazehmahalleh F, Fleckenstein J, Guckenberger M, Heinz C, Henkenberens C, Hennig A, Köhn J, Kornhuber C, Krieger T, Loutfi-Krauss B, Mayr M, Oechsner M, Pfeiler T, Pollul G, Schöffler J, Tümmler H, Ullm C, Walke M, Weigel R, Wertman M, Wiehle R, Wiezorek T, Wilke L, Wolf U, Eich HT, Schmitt D (2022). Planning Benchmark Study for Stereotactic Body Radiation Therapy of Liver Metastases: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery. Int J Radiat Oncol Biol Phys, 113(1), 214-227.
     
  154. Weidner J, Horn J, Kabat CN, Stathakis S, Geissler P, Wolf U, Poppinga D (2022). Artificial intelligence based deconvolving on megavoltage photon beam profiles for radiotherapy applications. Phys Med Biol, 67(6), 1-19.
     
  155. Diefenhardt M, Fleischmann M, Martin D, Hofheinz RD, Piso P, Germer CT, Hambsch P, Grützmann R, Kirste S, Schlenska-Lange A, Ghadimi M, Rödel C, Fokas E (2022). Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trials. Radiother Oncol, 179(), 109455.
     
  156. Thomsen AR, Saalmann MR, Nicolay NH, Grosu AL, Vaupel P (2022). Improved Oxygenation of Human Skin, Subcutis and Superficial Cancers Upon Mild Hyperthermia Delivered by WIRA-Irradiation. Adv Exp Med Biol, 1395(), 255-261.
     
  157. Seidel C, Kortmann RD, Trepel M, Jordan F, Meixensberger J (2022). ZNS-Tumoren In: Honecker F, Claßen J, Preiß J, Dornoff W, Taschenbuch Hämatologie und Onkologie Interdisziplinäre Empfehlungen zur Therapie (S. 252-258), München: Zuckschwerdt-Verlag.
     
  158. Illerhaus G, Kortmann RD (2022). Lymphome des ZNS In: Honecker F, Claßen J, Preiß J, Dornoff W, Taschenbuch Hämatologie und Onkologie Interdisziplinäre Empfehlungen zur Therapie (S. 44-46), München: Zuckschwerdt-Verlag.
     


    159. 2021


  159. Seidel C, Heider S, Hau P, Glasow A, Dietzsch S, Kortmann RD (2021). Radiotherapy in Medulloblastoma-Evolution of Treatment, Current Concepts and Future Perspectives. Cancers (Basel), 13(23), 5945.
     
  160. Seidel C, Viehweger C, Kortmann RD (2021). Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma? Cancers (Basel), 13(11), 2580.
     
  161. Dietzsch S, Braesigk A, Seidel C, Remmele J, Kitzing R, Schlender T, Mynarek M, Geismar D, Jablonska K, Schwarz R, Pazos M, Walser M, Frick S, Gurtner K, Matuschek C, Harrabi SB, Glück A, Lewitzki V, Dieckmann K, Benesch M, Gerber NU, Rutkowski S, Timmermann B, Kortmann RD (2021). Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial. Strahlenther Onkol, 197(8), 674-682.
     
  162. Glasow A, Patties I, Priest ND, Mitchel REJ, Hildebrandt G, Manda K (2021). Dose and Dose Rate-Dependent Effects of Low-Dose Irradiation on Inflammatory Parameters in ApoE-Deficient and Wild Type Mice. Cells, 10(11), 3251.
     
  163. Haehl E, Rühle A, Spohn S, Sprave T, Gkika E, Zamboglou C, Grosu AL, Nicolay NH (2021). Patterns-of-Care Analysis for Radiotherapy of Elderly Head-and-Neck Cancer Patients: A Trinational Survey in Germany, Austria and Switzerland. Front Oncol, 11(), 723716.
     
  164. Bostel T, Akbaba S, Wollschläger D, Klodt T, Oebel L, Mayer A, Drabke S, Sprave T, Debus J, Förster R, Rief H, Rühle A, Grosu AL, Schmidberger H, Nicolay NH (2021). Comparative Analyses of Two Established Scores to Assess the Stability of Spinal Bone Metastases Before and After Palliative Radiotherapy. Front Oncol, 11(), 753768.
     
  165. Rühle A, Tkotsch E, Mravlag R, Haehl E, Spohn SKB, Zamboglou C, Huber PE, Debus J, Grosu AL, Sprave T, Nicolay NH (2021). Low-dose radiotherapy for painful osteoarthritis of the elderly: A multicenter analysis of 970 patients with 1185 treated sites. Strahlenther Onkol, 197(10), 895-902.
     
  166. Rühle A, Nicolay NH (2021). [Moderate dose de-escalation of cisplatin-based chemoradiation for HPV-associated oropharyngeal carcinoma : Results of the NRG-HN002 trial]. Strahlenther Onkol, 197(10), 950-952.
     
  167. Carles M, Fechter T, Grosu AL, Sörensen A, Thomann B, Stoian RG, Wiedenmann N, Rühle A, Zamboglou C, Ruf J, Martí-Bonmatí L, Baltas D, Mix M, Nicolay NH (2021). (18)F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy. Cancers (Basel), 13(14), 1-16.
     
  168. Rühle A, Rothhaar S, Haehl E, Kalckreuth T, Sprave T, Stoian R, Zamboglou C, Gkika E, Knopf A, Grosu AL, Nicolay NH (2021). Radiation-induced toxicities and outcomes after radiotherapy are independent of patient age in elderly salivary gland cancer patients: results from a matched-pair analysis of a rare disease. Eur Arch Otorhinolaryngol, 278(7), 2537-2548.
     
  169. Haehl E, Rühle A, Klink R, Kalckreuth T, Sprave T, Gkika E, Zamboglou C, Meiß F, Grosu AL, Nicolay NH (2021). The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly. Radiat Oncol, 16(1), 105.
     
  170. Rühle A, Nicolay NH (2021). [Aggressive radiotherapy de-escalation for HPV-associated oropharyngeal carcinoma based on hypoxia dynamics]. Strahlenther Onkol, 197(6), 570-573.
     
  171. Rühle A, Grosu AL, Wiedenmann N, Stoian R, Haehl E, Zamboglou C, Baltas D, Werner M, Kayser G, Nicolay NH (2021). Immunohistochemistry-based hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing chemoradiation - Post-hoc analysis from a prospective imaging trial. Radiother Oncol, 159(), 75-81.
     
  172. Rühle A, Grosu AL, Nicolay NH (2021). De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers-HPV and Beyond. Cancers (Basel), 13(9), 1-17.
     
  173. Rühle A, Grosu AL, Nicolay NH (2021). The Particle Radiobiology of Multipotent Mesenchymal Stromal Cells: A Key to Mitigating Radiation-Induced Tissue Toxicities in Cancer Treatment and Beyond? Front Oncol, 11(), 616831.
     
  174. Rühle A, Nicolay NH (2021). [De-escalation concepts for chemoradiotherapy of HPV-positive oropharyngeal carcinomas: pros and cons]. HNO, 69(4), 278-284.
     
  175. Nicolay NH, Rühle A, Wiedenmann N, Niedermann G, Mix M, Weber WA, Baltas D, Werner M, Kayser G, Grosu AL (2021). Lymphocyte Infiltration Determines the Hypoxia-Dependent Response to Definitive Chemoradiation in Head-and-Neck Cancer: Results from a Prospective Imaging Trial. J Nucl Med, 62(4), 471-478.
     
  176. Rühle A, Haehl E, Kalckreuth T, Stoian R, Spohn SKB, Sprave T, Zamboglou C, Gkika E, Knopf A, Grosu AL, Nicolay NH (2021). Surviving Elderly Patients with Head-and-Neck Squamous Cell Carcinoma-What Is the Long-Term Quality of Life after Curative Radiotherapy? Cancers (Basel), 13(6), 1-14.
     
  177. Akbaba S, Rühle A, Rothhaar S, Zamboglou C, Gkika E, Foerster R, Oebel L, Klodt T, Schmidberger H, Grosu AL, Debus J, Bostel T, Nicolay NH (2021). Treatment outcomes of elderly salivary gland cancer patients undergoing radiotherapy - Results from a large multicenter analysis. Radiother Oncol, 156(), 266-274.
     
  178. Rühle A, Stromberger C, Haehl E, Senger C, David H, Stoian R, Zamboglou C, Knopf A, Budach V, Grosu AL, Nicolay NH (2021). Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation. Radiother Oncol, 154(), 276-282.
     
  179. Haehl E, Rühle A, Spohn S, Sprave T, Gkika E, Zamboglou C, Grosu AL, Nicolay NH (2021). Patterns-of-Care Analysis for Radiotherapy of Elderly Head-and-Neck Cancer Patients: A Trinational Survey in Germany, Austria and Switzerland. Front Oncol, 11(), 723716.
     
  180. Haehl E, Rühle A, Spohn S, Sprave T, Gkika E, Zamboglou C, Grosu AL, Nicolay NH (2021). Patterns-of-Care Analysis for Radiotherapy of Elderly Head-and-Neck Cancer Patients: A Trinational Survey in Germany, Austria and Switzerland. Front Oncol, 11(), 723716.
     
  181. Haehl E, Rühle A, Spohn S, Sprave T, Gkika E, Zamboglou C, Grosu AL, Nicolay NH (2021). Patterns-of-Care Analysis for Radiotherapy of Elderly Head-and-Neck Cancer Patients: A Trinational Survey in Germany, Austria and Switzerland. Front Oncol, 11(), 1-11.
     
  182. Haehl E, Rühle A, Spohn S, Sprave T, Gkika E, Zamboglou C, Grosu AL, Nicolay NH (2021). Patterns-of-Care Analysis for Radiotherapy of Elderly Head-and-Neck Cancer Patients: A Trinational Survey in Germany, Austria and Switzerland. Front Oncol, 11, 723716.
     
  183. Bostel T, Akbaba S, Wollschläger D, Klodt T, Oebel L, Mayer A, Drabke S, Sprave T, Debus J, Förster R, Rief H, Rühle A, Grosu AL, Schmidberger H, Nicolay NH (2021). Comparative Analyses of Two Established Scores to Assess the Stability of Spinal Bone Metastases Before and After Palliative Radiotherapy. Front Oncol, 11(), 753768.
     
  184. Adolph JE, Fleischhack G, Gaab C, Mikasch R, Mynarek M, Rutkowski S, Schüller U, Pfister SM, Pajtler KW, Milde T, Witt O, Bison B, Warmuth-Metz M, Kortmann RD, Dietzsch S, Pietsch T, Timmermann B, Tippelt S (2021). Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies. J Neurooncol, 155(2), 193-202.
     
  185. Hau P, Frappaz D, Hovey E, McCabe MG, Pajtler KW, Wiestler B, Seidel C, Combs SE, Dirven L, Klein M, Anazodo A, Hattingen E, Hofer S, Pfister SM, Zimmer C, Kortmann RD, Sunyach MP, Tanguy R, Effeney R, von Deimling A, Sahm F, Rutkowski S, Berghoff AS, Franceschi E, Pineda E, Beier D, Peeters E, Gorlia T, Vanlancker M, Bromberg JEC, Gautier J, Ziegler DS, Preusser M, Wick W, Weller M (2021). Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23. Cancers (Basel), 13(14), 3451.
     
  186. Albrecht F, Wolters H, Ziert Y, Timmermann B, Kortmann RD, Matuschek C, Rübe C, Martini C, Christiansen H, Eich HT, Willich N, Steinmann D (2021). Evaluation of treatment-associated eye toxicity after irradiation in childhood and adolescence-results from the Registry of the Evaluation of Side Effects after Radiotherapy in Childhood and Adolescence (RiSK). Strahlenther Onkol, 197(8), 700-710.
     
  187. Gnekow AK, Kandels D, Pietsch T, Bison B, Warmuth-Metz M, Thomale UW, Kortmann RD, Timmermann B, Driever PH, Witt O, Schmidt R, Spix C (2021). Doubling Recruitment of Pediatric Low-grade Glioma within Two Decades does not change Outcome - Report from the German LGG Studies. Klin Padiatr, 233(3), 107-122.
     
  188. Perwein T, Benesch M, Kandels D, Pietsch T, Schmidt R, Quehenberger F, Bison B, Warmuth-Metz M, Timmermann B, Krauss J, Thomale UW, Kortmann RD, Driever PH, Gnekow AK (2021). High frequency of disease progression in pediatric spinal cord low-grade glioma (LGG): management strategies and results from the German LGG study group. Neuro Oncol, 23(7), 1148-1162.
     
  189. Adolph JE, Fleischhack G, Mikasch R, Zeller J, Warmuth-Metz M, Bison B, Mynarek M, Rutkowski S, Schüller U, von Hoff K, Obrecht D, Pietsch T, Pfister SM, Pajtler KW, Witt O, Witt H, Kortmann RD, Timmermann B, Krauß J, Frühwald MC, Faldum A, Kwiecien R, Bode U, Tippelt S (2021). Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 study. Neuro Oncol, 23(6), 1012-1023.
     
  190. Wichmann G, Pavlychenko M, Willner M, Halama D, Kuhnt T, Kluge R, Gradistanac T, Fest S, Wald T, Lethaus B, Dietz A, Wiegand S, Zebralla V (2021). Standardized Diagnostic Workup and Patient-Centered Decision Making for Surgery and Neck Dissection Followed by Risk-Factor Adapted Adjuvant Therapy Improve Loco-Regional Control in Local Advanced Oral Squamous Cell Carcinoma. Front Oncol, 11(), 737080.
     
  191. Wichmann G, Willner M, Kuhnt T, Kluge R, Gradistanac T, Wald T, Fest S, Lordick F, Dietz A, Wiegand S, Zebralla V (2021). Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of Neck Squamous Cell Carcinoma of Unknown Primary Patients. Front Oncol, 11(), 682088.
     
  192. Bartella AK, Kamal M, Kuhnt T, Hering K, Halama D, Pausch NC, Lethaus B (2021). Mixed reality in oral and maxillofacial surgery: a symbiosis of virtual and augmented reality or a pointless technological gadget? Int J Comput Dent, 24(1), 65-76.
     
  193. Franceschi E, Seidel C, Sahm F, Pajtler KW, Hau P (2021). Erratum to 'How we treat medulloblastoma in adults': [ESMO Open Volume 6, Issue 4, August 2021, 100173]. ESMO Open, 6(6), 100327.
     
  194. Krug D, Hecht M, Ebert N, Mäurer M, Fleischmann DF, Fokas E, Straube C, Nicolay NH, Hörner-Rieber J, Schmitt D, von Neubeck C, Zamboglou C, Sperk E, Kaul D, Hess J, Corradini S, Seidel C, Gani C, Baues C, Frey B, Blanck O, Gauer T, Niyazi M (2021). Correction to: Innovative radiation oncology Together-Precise, Personalized, Human. Strahlenther Onkol, 197(12), 1049-1050.
     
  195. Krug D, Hecht M, Ebert N, Mäurer M, Fleischmann DF, Fokas E, Straube C, Nicolay NH, Hörner-Rieber J, Schmitt D, von Neubeck C, Zamboglou C, Sperk E, Kaul D, Hess J, Corradini S, Seidel C, Gani C, Baues C, Frey B, Blanck O, Gauer T, Niyazi M (2021). Innovative radiation oncology Together - Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in Germany. Strahlenther Onkol, 197(12), 1043-1048.
     
  196. Franceschi E, Seidel C, Sahm F, Pajtler KW, Hau P (2021). How we treat medulloblastoma in adults. ESMO Open, 6(4), 100173.
     
  197. Tzaridis T, Schäfer N, Weller J, Steinbach JP, Schlegel U, Seidel S, Sabel M, Hau P, Seidel C, Krex D, Goldbrunner R, Tonn JC, Grauer O, Kebir S, Schneider M, Schaub C, Vatter H, Coch C, Glas M, Fimmers R, Pietsch T, Reifenberger G, Herrlinger U, Felsberg J (2021). MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial. Int J Cancer, 148(7), 1695-1707.
     
  198. Bartella AK, Kamal M, Kuhnt T, Hering K, Halama D, Pausch NC, Lethaus B (2021). Mixed reality in oral and maxillofacial surgery: a symbiosis of virtual and augmented reality or a pointless technological gadget? Int J Comput Dent, 24(1), 65-76.
     
  199. Nemes K, Bens S, Kachanov D, Teleshova M, Hauser P, Simon T, Tippelt S, Woessmann W, Beck O, Flotho C, Grigull L, Driever PH, Schlegel PG, Khurana C, Hering K, Kolb R, Leipold A, Abbink F, Gil-Da-Costa MJ, Benesch M, Kerl K, Lowis S, Marques CH, Graf N, Nysom K, Vokuhl C, Melchior P, Kröncke T, Schneppenheim R, Kordes U, Gerss J, Siebert R, Furtwängler R, Frühwald MC (2021). Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK). Eur J Cancer, 142(), 112-122.
     
  200. Schenk H, Simon D, Waldenmeier L, Evers C, Janka R, Welsch GH, Pachowsky ML (2021). Regions at Risk in the Knee Joint of Young Professional Soccer Players: Longitudinal Evaluation of Early Cartilage Degeneration by Quantitative T2 Mapping in 3 T MRI. Cartilage, 13, 595-603.
     
  201. Tsurkan D, Simon P, Schimpf C, Motylenko M, Rafaja D, Roth F, Inosov DS, Makarova AA, Stepniak I, Petrenko I, Springer A, Langer E, Kulbakov AA, Avdeev M, Stefankiewicz AR, Heimler K, Kononchuk O, Hippmann S, Kaiser D, Viehweger C, Rogoll A, Voronkina A, Kovalchuk V, Bazhenov VV, Galli R, Rahimi-Nasrabadi M, Molodtsov SL, Rahimi P, Falahi S, Joseph Y, Vogt C, Vyalikh DV, Bertau M, Ehrlich H (2021). Extreme Biomimetics: Designing of the First Nanostructured 3D Spongin-Atacamite Composite and its Application. Adv Mater, 33(30), 2101682.
     
  202. Stockinger M, Karle H, Rennau H, Sebb S, Wolf U, Remmele J, Bührdel S, Bartkowiak D, Blettner M, Schmidberger H, Wollschläger D (2021). Heart atlas for retrospective cardiac dosimetry: a multi-institutional study on interobserver contouring variations and their dosimetric impact. Radiat Oncol, 16(1), 241.
     
  203. Fiebich M, Block A, Borowski M, Geworski L, Happel C, Kamp A, Lenzen H, Mahnken AH, Müller WU, Östreicher G, Rudolf F, Stamm G, Starck P, Steiniger B, Wicke JH, Wolf U, Wucherer M, Zankl M, Zink K, Zweig C (2021). Prenatal radiation exposure in diagnostic and interventional radiology. Rofo, 193(7), 778-786.
     
  204. Zhang X, Bobeica M, Unger M, Bednarz A, Gerold B, Patties I, Melzer A, Landgraf L (2021). Focused ultrasound radiosensitizes human cancer cells by enhancement of DNA damage. Strahlenther Onkol, 197(8), 730-743.
     
  205. Krug D, Hecht M, Ebert N, Mäurer M, Fleischmann DF, Fokas E, Straube C, Nicolay NH, Hörner-Rieber J, Schmitt D, von Neubeck C, Zamboglou C, Sperk E, Kaul D, Hess J, Corradini S, Seidel C, Gani C, Baues C, Frey B, Blanck O, Gauer T, Niyazi M (2021). Correction to: Innovative radiation oncology Together-Precise, Personalized, Human. Strahlenther Onkol, 197(12), 1049-1050.
     
  206. Krug D, Hecht M, Ebert N, Mäurer M, Fleischmann DF, Fokas E, Straube C, Nicolay NH, Hörner-Rieber J, Schmitt D, von Neubeck C, Zamboglou C, Sperk E, Kaul D, Hess J, Corradini S, Seidel C, Gani C, Baues C, Frey B, Blanck O, Gauer T, Niyazi M (2021). Innovative radiation oncology Together - Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in Germany. Strahlenther Onkol, 197(12), 1043-1048.
     
  207. Gkika E, Adebahr S, Brenner A, Schimek-Jasch T, Radicioni G, Exner JP, Rühle A, Spohn SKB, Popp I, Zamboglou C, Sprave T, Firat E, Niedermann G, Nicolay NH, Nestle U, Grosu AL, Duda DG (2021). Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies. Cancers (Basel), 13(22), 1-14.
     
  208. Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC (2021). Value of PET imaging for radiation therapy. Nuklearmedizin, 60(5), 326-343.
     
  209. Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC (2021). Value of PET imaging for radiation therapy. Strahlenther Onkol, 197(9), 1-23.
     
  210. Stoian R, Erbes T, Zamboglou C, Scholber J, Gainey M, Sachpazidis I, Haehl E, Spohn SKB, Verma V, Krug D, Rühle A, Juhasz-Böss I, Grosu AL, Nicolay NH, Sprave T (2021). Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis. Strahlenther Onkol, 197(9), 812-819.
     
  211. Spohn SKB, Bettermann AS, Bamberg F, Benndorf M, Mix M, Nicolay NH, Fechter T, Hölscher T, Grosu R, Chiti A, Grosu AL, Zamboglou C (2021). Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies. Theranostics, 11(16), 8027-8042.
     
  212. Kostyszyn D, Fechter T, Bartl N, Grosu AL, Gratzke C, Sigle A, Mix M, Ruf J, Fassbender TF, Kiefer S, Bettermann AS, Nicolay NH, Spohn S, Kramer MU, Bronsert P, Guo H, Qiu X, Wang F, Henkenberens C, Werner RA, Baltas D, Meyer PT, Derlin T, Chen M, Zamboglou C (2021). Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network. J Nucl Med, 62(6), 823-828.
     
  213. Spohn SKB, Sachpazidis I, Wiehle R, Thomann B, Sigle A, Bronsert P, Ruf J, Benndorf M, Nicolay NH, Sprave T, Grosu AL, Baltas D, Zamboglou C (2021). Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology Reference. Front Oncol, 11(), 652678.
     
  214. Niebuhr NI, Splinter M, Bostel T, Seco J, Hentschke CM, Floca RO, Hörner-Rieber J, Alber M, Huber P, Nicolay NH, Pfaffenberger A (2021). Biologically consistent dose accumulation using daily patient imaging. Radiat Oncol, 16(1), 65.
     
  215. Brunner TB, Bettinger D, Schultheiss M, Maruschke L, Sturm L, Bartl N, Koundurdjieva I, Kirste S, Neeff HP, Goetz C, Nicolay NH, Ihorst G, Bamberg F, Thimme R, Grosu AL, Gkika E (2021). Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study). Front Oncol, 11(), 653141.
     
  216. Zamboglou C, Kramer M, Kiefer S, Bronsert P, Ceci L, Sigle A, Schultze-Seemann W, Jilg CA, Sprave T, Fassbender TF, Nicolay NH, Ruf J, Benndorf M, Grosu AL, Spohn SKB (2021). The impact of the co-registration technique and analysis methodology in comparison studies between advanced imaging modalities and whole-mount-histology reference in primary prostate cancer. Sci Rep, 11(1), 5836.
     
  217. Deutschbein T, Jaursch-Hancke C, Knappe UJ, Saeger W, Flitsch J, Bojunga J, Buchfelder M, Ditzen B, Gerlach R, Gertzen E, Honegger J, Horstmann GA, Koch A, Kreitschmann-Andermahr I, Kunz M, Lagrèze WA, Nicolay NH, Paulus W, Reincke M, Schmidt MA, Weber MM, Wilhelm H, Fassnacht M (2021). First German Guideline on Diagnostics and Therapy of Clinically Non-Functioning Pituitary Tumors. Exp Clin Endocrinol Diabetes, 129(3), 250-264.
     
  218. Carles M, Fechter T, Radicioni G, Schimek-Jasch T, Adebahr S, Zamboglou C, Nicolay NH, Martí-Bonmatí L, Nestle U, Grosu AL, Baltas D, Mix M, Gkika E (2021). FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy. Cancers (Basel), 13(4), 1-16.
     
  219. Lazzeroni M, Ureba A, Wiedenmann N, Nicolay NH, Mix M, Thomann B, Baltas D, Toma-Dasu I, Grosu AL (2021). Evolution of the hypoxic compartment on sequential oxygen partial pressure maps during radiochemotherapy in advanced head and neck cancer. Phys Imaging Radiat Oncol, 17(), 100-105.
     
  220. Stockinger M, Karle H, Rennau H, Sebb S, Wolf U, Remmele J, Bührdel S, Bartkowiak D, Blettner M, Schmidberger H, Wollschläger D (2021). Heart atlas for retrospective cardiac dosimetry: a multi-institutional study on interobserver contouring variations and their dosimetric impact. Radiat Oncol, 16(1), 1-11.
     
  221. Rutkowski S, Kortmann RD (2021). Hirntumoren In: Schmoll HJ, Kompendium Internistische Onkologie (S. 1-9), Berlin, Heidelberg: Springer.
     
  222. Hau P, Schackert G, Seidel C, Wick W, Weller W (2021). Kindliche Hirntumoren bei Erwachsenen: Medulloblastom In: Schmoll HJ, Kompendium Internistische Onkologie (S. 1-8), Berlin, Heidelberg: Springer.
     
  223. Hau P, Schackert G, Seidel C, Wick W, Weller W (2021). Kindliche Hirntumoren bei Erwachsenen: Pinealistumoren In: Schmoll HJ, Kompendium Internistische Onkologie (S. 1-8), Berlin, Heidelberg: Springer.
     


    224. 2020


  224. Dietzsch S, Placzek F, Pietschmann K, von Bueren AO, Matuschek C, Glück A, Guckenberger M, Budach V, Welzel J, Pöttgen C, Schmidberger H, Heinzelmann F, Paulsen F, Escudero MP, Schwarz R, Hornung D, Martini C, Grosu AL, Stueben G, Jablonska K, Dunst J, Stranzl-Lawatsch H, Dieckmann K, Timmermann B, Pietsch T, Warmuth-Metz M, Bison B, Kwiecien R, Benesch M, Gerber NU, Grotzer MA, Pfister SM, Clifford SC, von Hoff K, Klagges S, Rutkowski S, Kortmann RD, Mynarek M (2020). Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma - A Report From the HIT 2000 Trial. Adv Radiat Oncol, 5(6), 1158-1169.
     
  225. Dietzsch S, Placzek F, Pietschmann K, von Bueren AO, Matuschek C, Glück A, Guckenberger M, Budach V, Welzel J, Pöttgen C, Schmidberger H, Heinzelmann F, Paulsen F, Escudero MP, Schwarz R, Hornung D, Martini C, Grosu AL, Stueben G, Jablonska K, Dunst J, Stranzl-Lawatsch H, Dieckmann K, Timmermann B, Pietsch T, Warmuth-Metz M, Bison B, Kwiecien R, Benesch M, Gerber NU, Grotzer MA, Pfister SM, Clifford SC, von Hoff K, Klagges S, Rutkowski S, Kortmann RD, Mynarek M (2020). Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma - A Report From the HIT 2000 Trial. Adv Radiat Oncol, 5(6), 1158-1169.
     
  226. Evers C, Ostheimer C, Sieker F, Vordermark D, Medenwald D (2020). Benefit from surgery with additional radiotherapy in N1 head and neck cancer at the time of IMRT: A population-based study on recent developments. PLoS One, 15(2), 1-14.
     
  227. Giralt J, Tao Y, Kortmann RD, Zasadny X, Contreras-Martinez J, Ceruse P, Arias de la Vega F, Lalla RV, Ozsahin EM, Pajkos G, Mazar A, Attali P, Bossi P, Vasseur B, Sonis S, Henke M, Bensadoun RJ (2020). Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer. Int J Radiat Oncol Biol Phys, 106(2), 320-328.
     
  228. Matuschek C, Nestle-Kraemling C, Kühn T, Fehm T, Bölke E, Corradini S, Fastner G, Maas K, Seidel C, Budach W (2020). Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited. Breast Care (Basel), 15(2), 112-117.
     
  229. Dirven L, Luerding R, Beier D, Bumes E, Reinert C, Seidel C, Bonsanto MM, Bremer M, Rieken S, Combs SE, Herrlinger U, Seliger C, Kuntze H, Mayer-Steinacker R, Dieing A, Bartels C, Schnell O, Weyerbrock A, Seidel S, Grauer O, Nadji-Ohl M, Paulsen F, Weller M, Wick W, Hau P (2020). Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study. J Neurooncol, 148(1), 117-130.
     
  230. Rades D, Bartscht T, Hunold P, Schmidberger H, König L, Debus J, Belka C, Homann N, Spillner P, Petersen C, Kuhnt T, Fietkau R, Ridwelski K, Karcher-Kilian K, Kranich A, Männikkö S, Schild SE, Maderer A, Moehler M (2020). Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2). Strahlenther Onkol, 196(9), 795-804.
     
  231. Bacher H, Schweyen R, Kuhnt T, Leplow B, Hey J (2020). Use of a Patient Information Leaflet on Oro-Dental Care During Radiotherapy. Patient Prefer Adherence, 14(), 1751-1759.
     
  232. Dietz A, Wichmann G, Kuhnt T, Wiegand S (2020). [Organ preservation in advanced laryngeal/hypopharyngeal carcinoma: lessons from the DeLOS-II trial]. HNO, 68(9), 648-656.
     
  233. Martin D, Balermpas P, Gollrad J, Weiß C, Valentini C, Stuschke M, Schäfer H, Henckenberens C, Debus J, Krug D, Kuhnt T, Brunner T, Bostel T, Engenhart-Cabillic R, Nestle U, Combs S, Belka C, Hautmann M, Hildebrandt G, Gani C, Polat B, Rödel C, Fokas E (2020). RADIANCE - Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial. Clin Transl Radiat Oncol, 23(), 43-49.
     
  234. Grün A, Kuhnt T, Schlomm T, Olze H, Budach V, Stromberger C (2020). Repeat Radiation for Local Recurrence of Head and Neck Tumors and in Prostate Cancer. Dtsch Arztebl Int, 117(10), 167-174.
     
  235. Freitag J, Wald T, Kuhnt T, Gradistanac T, Kolb M, Dietz A, Wiegand S, Wichmann G (2020). Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma. Cancer, 126(9), 1856-1872.
     
  236. Wick A, Kessler T, Platten M, Meisner C, Bamberg M, Herrlinger U, Felsberg J, Weyerbrock A, Papsdorf K, Steinbach JP, Sabel M, Vesper J, Debus J, Meixensberger J, Ketter R, Hertler C, Mayer-Steinacker R, Weisang S, Bölting H, Reuss D, Reifenberger G, Sahm F, von Deimling A, Weller M, Wick W (2020). Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma. Neuro Oncol, 22(8), 1162-1172.
     
  237. Roick J, Danker H, Dietz A, Papsdorf K, Singer S (2020). Predictors of changes in quality of life in head and neck cancer patients: a prospective study over a 6-month period. Eur Arch Otorhinolaryngol, 277(2), 559-567.
     
  238. Teichmann T, Salz H, Schwedas M, Schilz J, Wolf U, Walke M, Kornhuber C, Berger R, Schröder D, Hourle M, Peil T, Tümmler H, Wiezorek T, Wittig A (2020). A multi-institutional initiative on patient-related quality assurance: Independent computational dose verification of fluence-modulated treatment techniques. Z Med Phys, 30(2), 155-165.
     
  239. Kandels D, Pietsch T, Bison B, Warmuth-Metz M, Thomale UW, Kortmann RD, Timmermann B, Hernáiz Driever P, Witt O, Schmidt R, Gnekow AK (2020). Loss of efficacy of subsequent nonsurgical therapy after primary treatment failure in pediatric low-grade glioma patients-Report from the German SIOP-LGG 2004 cohort. Int J Cancer, 147(12), 3471-3489.
     
  240. Jünger ST, Andreiuolo F, Mynarek M, Wohlers I, Rahmann S, Klein-Hitpass L, Dörner E, Zur Mühlen A, Velez-Char N, von Hoff K, Warmuth-Metz M, Kortmann RD, Timmermann B, von Bueren A, Rutkowski S, Pietsch T (2020). CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort. Acta Neuropathol, 140(3), 405-407.
     
  241. Mynarek M, von Hoff K, Pietsch T, Ottensmeier H, Warmuth-Metz M, Bison B, Pfister S, Korshunov A, Sharma T, Jaeger N, Ryzhova M, Zheludkova O, Golanov A, Rushing EJ, Hasselblatt M, Koch A, Schüller U, von Deimling A, Sahm F, Sill M, Riemenschneider MJ, Dohmen H, Monoranu CM, Sommer C, Staszewski O, Mawrin C, Schittenhelm J, Brück W, Filipski K, Hartmann C, Meinhardt M, Pietschmann K, Haberler C, Slavc I, Gerber NU, Grotzer M, Benesch M, Schlegel PG, Deinlein F, von Bueren AO, Friedrich C, Juhnke (2020). Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort. J Clin Oncol, 38(18), 2028-2040.
     
  242. Falkenstein F, Gessi M, Kandels D, Ng HK, Schmidt R, Warmuth-Metz M, Bison B, Krauss J, Kortmann RD, Timmermann B, Thomale UW, Albert MH, Pekrun A, Maaß E, Gnekow AK, Pietsch T (2020). Prognostic impact of distinct genetic entities in pediatric diffuse glioma WHO-grade II-Report from the German/Swiss SIOP-LGG 2004 cohort. Int J Cancer, 147(8), 2159-2175.
     
  243. Frühwald MC, Hasselblatt M, Nemes K, Bens S, Steinbügl M, Johann PD, Kerl K, Hauser P, Quiroga E, Solano-Paez P, Biassoni V, Gil-da-Costa MJ, Perek-Polnik M, van de Wetering M, Sumerauer D, Pears J, Stabell N, Holm S, Hengartner H, Gerber NU, Grotzer M, Boos J, Ebinger M, Tippelt S, Paulus W, Furtwängler R, Hernáiz-Driever P, Reinhard H, Rutkowski S, Schlegel PG, Schmid I, Kortmann RD, Timmermann B, Warmuth-Metz M, Kordes U, Gerss J, Nysom K, Schneppenheim R, Siebert R, Kool M, Graf N (2020). Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors. Neuro Oncol, 22(7), 1006-1017.
     
  244. Holzapfel J, Kandels D, Schmidt R, Pietsch T, Warmuth-Metz M, Bison B, Krauss J, Kortmann RD, Timmermann B, Thomale UW, Albert MH, Hernáiz Driever P, Witt O, Gnekow AK (2020). Favorable prognosis in pediatric brainstem low-grade glioma: Report from the German SIOP-LGG 2004 cohort. Int J Cancer, 146(12), 3385-3396.
     
  245. Oing C, Hentrich M, Lorch A, Gläser D, Rumpold H, Ochsenreither S, Richter S, Dieing A, Zschäbitz S, Pereira RR, Bokemeyer C, Seidel C (2020). Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case series. J Cancer Res Clin Oncol, 146(2), 449-455.
     
  246. Tran B, Ruiz-Morales JM, Gonzalez-Billalabeitia E, Patrikidou A, Amir E, Seidel C, Bokemeyer C, Fankhauser C, Hermanns T, Rumyantsev A, Tryakin A, Brito M, Fléchon A, Kwan EM, Cheng T, Castellano D, Garcia Del Muro X, Hamid AA, Ottaviano M, Palmieri G, Kitson R, Reid A, Heng DYC, Bedard PL (2020). Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3). Cancer Med, 9(1), 116-124.
     
  247. Hu S, Zhang X, Unger M, Patties I, Melzer A, Landgraf L (2020). Focused Ultrasound-Induced Cavitation Sensitizes Cancer Cells to Radiation Therapy and Hyperthermia. Cells, 9(12), 1-18.
     
  248. Traunwieser T, Kandels D, Pauls F, Pietsch T, Warmuth-Metz M, Bison B, Krauss J, Kortmann RD, Timmermann B, Thomale UW, Luettich P, Neumann-Holbeck A, Tischler T, Hernáiz Driever P, Witt O, Gnekow AK (2020). Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions-report from the German LGG studies. Neurooncol Adv, 2(1), 1-18.
     
  249. Ottensmeier H, Schlegel PG, Eyrich M, Wolff JE, Juhnke BO, von Hoff K, Frahsek S, Schmidt R, Faldum A, Fleischhack G, von Bueren A, Friedrich C, Resch A, Warmuth-Metz M, Krauss J, Kortmann RD, Bode U, Kühl J, Rutkowski S (2020). Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment. PLoS One, 15(1), 1-14.
     
  250. Illerhaus G, Kortmann RD (2020). Lymphome des ZNS In: Hocker F, Claßen J, Preiß J, Dornoff W , Taschenbuch Onkologie (S. 42-44), München: W. Zuckschwerdt Verlga.
     
  251. Seidel C, Kortmann RD, Trepel M, Jordan F, Meixensberger J (2020). ZNS-Tumoren In: Hocker F, Claßen J, Preiß J, Dornoff W , Taschenbuch Onkologie - Interdisziplinäre Empfehlungen zur Therapie 2020/21 (S. 237-243), München: W. Zuckschwerdt Verlag.
     
  252. Seidel C, Dietzsch S, Kortmann RD, Schackert G, Hau P (2020). Radiation Therapy in Ependymal Tumors In: Wenz et al., Radiation Oncology (S. 1-13), Cham: Springer.
     


    253. 2019


  253. Patties I, Kallendrusch S, Bohme L, Kendzia E, Oppermann H, Gaunitz F, Kortmann RD, Glasow A (2019). The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment. J Exp Clin Cancer Res, 38(1), 420-420.
     
  254. Dirven L, Reijneveld JC, Taphoorn MJB, Coens C, El-Badawy SA, Tzuk-Shina T, Bravo-Marques J, Back M, Stalpers LJA, Stupp R, Baumert BG, Seidel C (2019). Impact of Radiation Target Volume on Health-Related Quality of Life in Patients With Low-Grade Glioma in the 2-Year Period Post Treatment: A Secondary Analysis of the EORTC 22033-26033. Int J Radiat Oncol Biol Phys, 104(1), 90-100.
     
  255. Seidel C, Kortmann RD (2019). [Lomustine and temozolomide in combination with radiotherapy : New treatment option for patients with MGMT promoter methylated Glioblastoma]. Strahlenther Onkol, 195(9), 855-856.
     
  256. Berk BA, Hering K, Kortmann RD, Hoffmann KT, Ziemer M, Seidel C (2019). Vascular white matter lesions negatively correlate with brain metastases in malignant melanoma-Results from a retrospective comparative analysis. Clin Neurol Neurosurg, 180, 117-121.
     
  257. Ajithkumar T, Kortmann RD (2019). "Indeed, Cure is Not Enough" - A Reflection on Paediatric Radiation Oncology. Clin Oncol (R Coll Radiol), 31(3), 135-138.
     
  258. Ajithkumar T, Taylor R, Kortmann RD (2019). Radiotherapy in the Management of Paediatric Low-Grade Gliomas. Clin Oncol (R Coll Radiol), 31(3), 151-161.
     
  259. Franceschi E, Hofer S, Brandes AA, Frappaz D, Kortmann RD, Bromberg J, Dangouloff-Ros V, Boddaert N, Hattingen E, Wiestler B, Clifford SC, Figarella-Branger D, Giangaspero F, Haberler C, Pietsch T, Pajtler KW, Pfister SM, Guzman R, Stummer W, Combs SE, Seidel C, Beier D, McCabe MG, Grotzer M, Laigle-Donadey F, Stucklin ASG, Idbaih A, Preusser M, van den Bent M, Weller M, Hau P (2019). EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. Lancet Oncol, 20(12), 715-728.
     
  260. Hamerla G, Meyer HJ, Hambsch P, Wolf U, Kuhnt T, Hoffmann KT, Surov A (2019). Radiomics Model Based on Non-Contrast CT Shows No Predictive Power for Complete Pathological Response in Locally Advanced Rectal Cancer. Cancers (Basel), 11(11), 1-9.
     
  261. Knoop N, Seidel C, Frydrychowicz C, Meixensberger J (2019). Combined Microsurgery and Radiotherapy for Multiple Spinal Cord Hemangioblastomas with Holocord Syrinx in von Hippel-Lindau Disease: A Case Report. J Neurol Surg Rep, 80(4), 46-50.
     
  262. Dietterle J, Oppermann H, Glasow A, Neumann K, Meixensberger J, Gaunitz F (2019). Carnosine increases efficiency of temozolomide and irradiation treatment of isocitrate dehydrogenase-wildtype glioblastoma cells in culture. Future Oncol, 15(32), 3683-3691.
     
  263. Oppermann H, Matusova M, Glasow A, Dietterle J, Baran-Schmidt R, Neumann K, Meixensberger J, Gaunitz F (2019). D,L-Methadone does not improve radio- and chemotherapy in glioblastoma in vitro. Cancer Chemother Pharmacol, 83(6), 1017-1024.
     
  264. Berndt-Paetz M, Schulze P, Stenglein PC, Weimann A, Wang Q, Horn LC, Riyad YM, Griebel J, Hermann R, Glasow A, Stolzenburg JU, Neuhaus J (2019). Reduction of Muscle-Invasive Tumors by Photodynamic Therapy with Tetrahydroporphyrin-Tetratosylat in an Orthotopic Rat Bladder Cancer Model. Mol Cancer Ther, 18(4), 743-750.
     
  265. Weller J, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Hau P, Krex D, Grauer O, Goldbrunner R, Bahr O, Uhl M, Seidel C, Tabatabai G, Brehmer S, Bullinger L, Galldiks N, Schaub C, Kebir S, Stummer W, Simon M, Fimmers R, Coch C, Glas M, Herrlinger U, Schafer N (2019). Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol, 20(10), 1444-1453.
     
  266. Kebir S, Schaub C, Junold N, Hattingen E, Schafer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Galldiks N, Weller J, Mack F, Tzaridis T, Bahr O, Seidel C, Schlegel U, Schmidt-Graf F, Rohde V, Borchers C, Tabatabai G, Hanel M, Sabel M, Gerlach R, Krex D, Belka C, Vatter H, Proescholdt M, Glas M, Herrlinger U (2019). Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial. J Neurooncol, 144(3), 501-509.
     
  267. Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bahr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schafer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Co (2019). Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial. Lancet, 393(10172), 678-688.
     
  268. Junger ST, Mynarek M, Wohlers I, Dorner E, Muhlen AZ, Velez-Char N, von Hoff K, Rutkowski S, Warmuth-Metz M, Kortmann RD, Timmermann B, Rahmann S, Klein-Hitpass L, von Bueren AO, Pietsch T (2019). Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohort. Acta Neuropathol Commun, 7(1), 181-.
     
  269. Singer S, Danker H, Meixensberger J, Briest S, Dietz A, Kortmann RD, Stolzenburg JU, Kersting A, Roick J (2019). Structured multi-disciplinary psychosocial care for cancer patients and the perceived quality of care from the patient perspective: a cluster-randomized trial. J Cancer Res Clin Oncol, 145(11), 2845-2854.
     
  270. Ugurel S, Kortmann RD, Mohr P, Mentzel T, Garbe C, Breuninger H, Bauer S, Grabbe S (2019). S1-Leitlinie Dermatofibrosarcoma protuberans (DFSP) - Update 2018. J Dtsch Dermatol Ges, 17(6), 663-668.
     
  271. Eveslage M, Calaminus G, Warmuth-Metz M, Kortmann RD, Pohl F, Timmermann B, Schuhmann MU, Flitsch J, Faldum A, Muller HL (2019). The Postopera tive Quality of Life in Children and Adolescents with Craniopharyngioma. Dtsch Arztebl Int, 116(18), 321-328.
     
  272. Ludmir EB, Mahajan A, Ahern V, Ajithkumar T, Alapetite C, Bernier-Chastagner V, Bindra RS, Bishop AJ, Bolle S, Brown PD, Carrie C, Chalmers AJ, Chang EL, Chung C, Dieckmann K, Esiashvili N, Gandola L, Ghia AJ, Gondi V, Grosshans DR, Harrabi SB, Horan G, Indelicato DJ, Jalali R, Janssens GO, Krause M, Laack NN, Laperriere N, Laprie A, Li J, Marcus KJ, McGovern SL, Merchant TE, Merrell KW, Padovani L, Parkes J, Paulino AC, Schwarz R, Shih HA, Souhami L, Sulman EP, Taylor RE, Thorp N, Timmermann B, (2019). Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Nat Rev Clin Oncol, 16(8), 521-522.
     
  273. Gnekow AK, Kandels D, van Tilburg C, Azizi AA, Opocher E, Stokland T, Driever PH, Meeteren AYNSV, Thomale UW, Schuhmann MU, Czech T, Goodden JR, Warmuth-Metz M, Bison B, Avula S, Kortmann RD, Timmermann B, Pietsch T, Witt O (2019). SIOP-E-BTG and GPOH Guidelines for Diagnosis and Treatment of Children and Adolescents with Low Grade Glioma. Klin Padiatr, 231(3), 107-135.
     
  274. de Rojas T, Clementel E, Giralt J, Cruz O, Boterberg T, Kortmann RD, Gaze MN, Moreno L, Janssens GO (2019). Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives: Current situation, international survey and future perspectives. Eur J Cancer, 114, 36-46.
     
  275. Berk BA, Hering K, Kortmann RD, Hoffmann KT, Ziemer M, Seidel C (2019). Vascular white matter lesions negatively correlate with brain metastases in malignant melanoma-Results from a retrospective comparative analysis. Clin Neurol Neurosurg, 180, 117-121.
     
  276. Benesch M, Mynarek M, Witt H, Warmuth-Metz M, Pietsch T, Bison B, Pfister SM, Pajtler KW, Kool M, Schuller U, Pietschmann K, Juhnke BO, Tippelt S, Fleischhack G, Schmid I, Kramm CM, Vorwerk P, Beilken A, Classen CF, Hernaiz Driever P, Kropshofer G, Imschweiler T, Lemmer A, Kortmann RD, Rutkowski S, von Hoff K (2019). Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series. Oncologist, 24(9), 921-929.
     
  277. Hoeben BA, Carrie C, Timmermann B, Mandeville HC, Gandola L, Dieckmann K, Ramos Albiac M, Magelssen H, Lassen-Ramshad Y, Ondrova B, Ajithkumar T, Alapetite C, Balgobind BV, Bolle S, Cameron AL, Davila Fajardo R, Dietzsch S, Dumont Lecomte D, van den Heuvel-Eibrink MM, Kortmann RD, Laprie A, Melchior P, Padovani L, Rombi B, Scarzello G, Schwarz R, Seiersen K, Seravalli E, Thorp N, Whitfield GA, Boterberg T, Janssens GO (2019). Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group. Lancet Oncol, 20(3), 155-166.
     
  278. Kundrat P, Remmele J, Rennau H, Sebb S, Simonetto C, Eidemuller M, Wolf U, Hildebrandt G (2019). INTER-PATIENT VARIABILITY IN DOSES TO NEARBY ORGANS IN BREAST-CANCER RADIOTHERAPY: INFERENCE FROM ANATOMIC FEATURES. Radiat Prot Dosimetry, 183, 255-258.
     
  279. Eidemuller M, Simonetto C, Kundrat P, Ulanowski A, Shemiakina E, Guthlin D, Rennau H, Remmele J, Hildebrandt G, Wolf U (2019). LONG-TERM HEALTH RISK AFTER BREAST-CANCER RADIOTHERAPY: OVERVIEW OF PASSOS METHODOLOGY AND SOFTWARE. Radiat Prot Dosimetry, 183, 259-263.
     
  280. Simonetto C, Rennau H, Remmele J, Sebb S, Kundrat P, Eidemuller M, Wolf U, Hildebrandt G (2019). Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy. Strahlenther Onkol, 195, 32-42.
     
  281. Dietz A, Wiegand S, Kuhnt T, Wichmann G (2019). Laryngeal Preservation Approaches: Considerations for New Selection Criteria Based on the DeLOS-II Trial. Front Oncol, 9, 1-7.
     
  282. Fokas E, Allgauer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, Schmiegel W, Jacobasch L, Weitz J, Folprecht G, Schlenska-Lange A, Flentje M, Germer CT, Grutzmann R, Schwarzbach M, Paolucci V, Bechstein WO, Friede T, Ghadimi M, Hofheinz RD, Rodel C (2019). Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12. J Clin Oncol, 37(34), 3212-3222.
     
  283. Fokas E, Allgauer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, Schmiegel W, Jacobasch L, Weitz J, Folprecht G, Schlenska-Lange A, Flentje M, Germer CT, Grutzmann R, Schwarzbach M, Paolucci V, Bechstein WO, Friede T, Ghadimi M, Hofheinz RD, Rodel C (2019). Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12. J Clin Oncol, 37(34), 3212-3222.
     
  284. Kotzerke D, Moritz F, Mantovani L, Hambsch P, Hering K, Kuhnt T, Yahiaoui-Doktor M, Forstmeyer D, Lordick F, Knodler M (2019). The performance of three oncogeriatric screening tools - G8, optimised G8 and CARG - in predicting chemotherapy-related toxicity in older patients with cancer. A prospective clinical study. J Geriatr Oncol, 10(6), 937-943.
     
  285. Kundrat P, Remmele J, Rennau H, Sebb S, Simonetto C, Eidemuller M, Wolf U, Hildebrandt G (2019). Minimum breast distance largely explains individual variability in doses to contralateral breast from breast-cancer radiotherapy. Radiother Oncol, 131, 186-191.
     
  286. Berndt-Paetz M, Schulze P, Stenglein PC, Weimann A, Wang Q, Horn LC, Riyad YM, Griebel J, Hermann R, Glasow A, Stolzenburg JU, Neuhaus J (2019). Reduction of Muscle-Invasive Tumors by Photodynamic Therapy with Tetrahydroporphyrin-Tetratosylat in an Orthotopic Rat Bladder Cancer Model. Mol Cancer Ther, 18, 743-750.
     
  287. Ludmir EB, Mahajan A, Ahern V, Ajithkumar T, Alapetite C, Bernier-Chastagner V, Bindra RS, Bishop AJ, Bolle S, Brown PD, Carrie C, Chalmers AJ, Chang EL, Chung C, Dieckmann K, Esiashvili N, Gandola L, Ghia AJ, Gondi V, Grosshans DR, Harrabi SB, Horan G, Indelicato DJ, Jalali R, Janssens GO, Krause M, Laack NN, Laperriere N, Laprie A, Li J, Marcus KJ, McGovern SL, Merchant TE, Merrell KW, Padovani L, Parkes J, Paulino AC, Schwarz R, Shih HA, Souhami L, Sulman EP, Taylor RE, Thorp N, Timmermann B, (2019). Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Nat Rev Clin Oncol, 16, 521-522.
     
  288. Fleischhack G, Massimino M, Warmuth-Metz M, Khuhlaeva E, Janssen G, Graf N, Rutkowski S, Beilken A, Schmid I, Biassoni V, Gorelishev SK, Kramm C, Reinhard H, Schlegel PG, Kortmann RD, Reuter D, Bach F, Iznaga-Escobar NE, Bode U (2019). Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study. J Neurooncol, 143, 107-113.
     
  289. Roick J, Danker H, Kersting A, Dietrich A, Dietz A, Papsdorf K, Meixensberger J, Stolzenburg JU, Wirtz H, Singer S (2019). The association of socioeconomic status with quality of life in cancer patients over a 6-month period using individual growth models. Support Care Cancer, 27, 3347-3355.
     
  290. Knoop N, Seidel C, Frydrychowicz C, Meixensberger J (2019). Combined Microsurgery and Radiotherapy for Multiple Spinal Cord Hemangioblastomas with Holocord Syrinx in von Hippel-Lindau Disease: A Case Report. J Neurol Surg Rep, 80(4), 46-50.
     
  291. Ostheimer C, Evers C, Palm F, Mikolajczyk R, Vordermark D, Medenwald D (2019). Mortality after radiotherapy or surgery in the treatment of early stage non-small-cell lung cancer: a population-based study on recent developments. J Cancer Res Clin Oncol, 145(11), 2813-2822.
     


    292. 2018


  292. Patties I, Kendzia E, Böhme L, Gaunitz F, Kortmann RD, Glasow A (2018). Der Chk1-Inhibitor SAR-020106 vermindert die Reparatur von DNA-Schäden und reduziert so synergistisch das klonogene Überleben humaner Glioblastomzellen nach Bestrahlung und 5-Aza-2'desoxycytidin-Behandlung. Strahlenther Onkol, 194, 13.
     
  293. Prager I, Patties I, Himmelbach K, Kendzia E, Glasow A (2018). Einfluss von ionisierender Strahlung und Resveratrol auf das Überleben neuraler Stammzellen am murinen Hippokampus-Gewebekulturmodell. Strahlenther Onkol, 194, 208.
     
  294. Patties I, Thöle L, Gaunitz F, Kortmann RD, Glasow A (2018). Treatment of human glioblastoma cells with the Chk1 Inhibitor SAR-020106 and Irradiation and/or 5-aza-2'deoxycytidine synergistically reduces clonogenic survival Klinische Pädiatrie, 06, 340.
     
  295. Seidel C, von Bueren AO, Bojko S, Hoffmann M, Pietsch T, Gielen GH, Warmuth-Metz M, Bison B, Kortmann RD, Kramm CM (2018). Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients. Strahlenther Onkol, 194(3), 215-224.
     
  296. Nagel S, Berk BA, Kortmann RD, Hoffmann KT, Seidel C (2018). Can vascular risk factors influence number and size of cerebral metastases? A 3D-MRI study in patients with different tumor entities. Clin Neurol Neurosurg, 165, 55-59.
     
  297. Fiebich M, Wolf U (2018). Die neue deutsche Strahlenschutzverordnung Z Med Phys, 28(4), 259-263.
     
  298. Kortmann RD, Seidel C, Muller K, Hirsch FW (2018). Irradiation of Intracranial Gliomas in Children. Prog Neurol Surg, 31, 87-101.
     
  299. Dietzsch S, Remmele J, Kitzing `R, Timmermann B, Jablonska K, Vlad J, Schwarz R, Matuschek C, Grannaß A, Lewitzki V, Valentini C, Rutkowski S, Kortmann RD (2018). Abweichungen der Risikoorgankonturierung und deren Einfluss auf die dokumentierten Organdosen bei kraniospinaler Bestrahlung mit Tumorbett-Boost-Pilotstudie aus dem SIOPE-PNET-5-MB-Protokoll Strahlenther Onkol, 194, 34-34.
     
  300. Seidel C, Nagel S, Kortmann RD, Berk BA (2018). Ist der Nachweis vaskulärer Hirnschädigung bei der Wahl der Strahlentherapie für Hirnmetastasen relevant? Ein literaturbasierter Review Strahlenther Onkol, 194, 46-46.
     
  301. Seidel C, Hering K, Kortmann RD, Papsdorf K, Kuhnt T, Schuchert J, Friedrich F (2018). Ist die prophylaktische Gabe von Dexamethason bei stereotaktischer Einzeitbestrahlung von kleinen Hirnmetastasen notwendig? Strahlenther Onkol, 194, 74-74.
     
  302. Wiezorek T, Brachwitz T, Georg D, Knäusl B, Lechner W, Weibert K, Wittig A, Wolf U (2018). Ein multizentrischer Planungsvergleich moderner photonen- und protonenbasierter intensitätsmodulierter Strahlentherapietechniken beim Pankreaskarzinom - Erste Ergebnisse Strahlenther Onkol, 194, 108-108.
     
  303. Seidel C, Kortmann RD, Papsdorf K, Kuhnt T, Oberstandt M, Hering K (2018). Schädelbasismetastasen mit Hirnnervenausfällen - Präsentation, Therapie und Verlauf einer seltenen onkologischen Komplekation Strahlenther Onkol, 194, 112-112.
     
  304. Hering K, Büttner R, Zebralla V, Kortmann RD, Seehofer D, Kuhnt T (2018). Lokal fortgeschrittenes HNSCC: definitive Radioimunotherapie nach Lebertransplantation Strahlenther Onkol, 194, 128-128.
     
  305. Kortmann RD (2018). Grußwort des Tagungspräsidenten Strahlenther Onkol, 194, 3-3.
     
  306. Seidel C, Dirven L, Rejneveld C, Coens C, Taphoorn JB, Gorlia T, Tzuk-Shina T, Back M, Stupp R, Baumert B (2018). Does Radiation target volume affect health-related Quality of life in patients with low grade glioma on the short-term? - a secondary Analysis of the EORTC 22033-26033 trial Neuro Oncol, 20, 223-224.
     
  307. Warren KE, Vezina G, Poussaint TY, Warmuth-Metz M, Chamberlain MC, Packer RJ, Brandes AA, Reiss M, Goldman S, Fisher MJ, Pollack IF, Prados MD, Wen PY, Chang SM, Dufour C, Zurakowski D, Kortmann RD, K (2018). Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee. Neuro Oncol, 20(1), 13-23.
     
  308. Dietz A, Wichmann G, Kuhnt T, Pfreundner L, Hagen R, Scheich M, Kolbl O, Hautmann MG, Strutz J, Schreiber F, Bockmuhl U, Schilling V, Feyer P, de Wit M, Maschmeyer G, Jungehulsing M, Schroeder U, Woll (2018). Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II. Ann Oncol, 29(10), 2105-2114.
     
  309. Kaufmann A, Gerber NU, Kandels D, Azizi AA, Schmidt R, Warmuth-Metz M, Pietsch T, Kortmann RD, Gnekow AK, Grotzer MA (2018). Management of Primary Tectal Plate Low-Grade Glioma in Pediatric Patients: Results of the Multicenter Treatment Study SIOP-LGG 2004. Neuropediatrics, 49(5), 314-323.
     
  310. Schaub C, Kebir S, Junold N, Hattingen E, Schafer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Niessen M, Mack F, Stuplich M, Tzaridis T, Bahr O, Kortmann RD, Schlegel U, Schmidt-Graf F, Rohde (2018). Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial. J Cancer Res Clin Oncol, 144(8), 1581-1589.
     
  311. Ajithkumar T, Horan G, Padovani L, Thorp N, Timmermann B, Alapetite C, Gandola L, Ramos M, Van Beek K, Christiaens M, Lassen-Ramshad Y, Magelssen H, Nilsson K, Saran F, Rombi B, Kortmann R, Janssens G (2018). SIOPE - Brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy. Radiother Oncol, 128(2), 192-197.
     
  312. Seravalli E, Bosman M, Lassen-Ramshad Y, Vestergaard A, Oldenburger F, Visser J, Koutsouveli E, Paraskevopoulou C, Horan G, Ajithkumar T, Timmermann B, Fuentes CS, Whitfield G, Marchant T, Padovani L, (2018). Dosimetric comparison of five different techniques for craniospinal irradiation across 15 European centers: analysis on behalf of the SIOP-E-BTG (radiotherapy working group). Acta Oncol, 57(9), 1240-1249.
     
  313. Singer S, Roick J, Danker H, Kortmann RD, Papsdorf K, Taubenheim S, Renovanz M, Jahne K, Meixensberger J (2018). Psychiatric co-morbidity, distress, and use of psycho-social services in adult glioma patients-a prospective study. Acta Neurochir (Wien), 160(6), 1187-1194.
     
  314. Bowzyk Al-Naeeb A, Murray M, Horan G, Harris F, Kortmann RD, Nicholson J, Ajithkumar T (2018). Current Management of Intracranial Germ Cell Tumours. Clin Oncol (R Coll Radiol), 30(4), 204-214.
     
  315. Kortmann RD, Seidel C, Muller K, Hirsch FW (2018). Irradiation of Intracranial Gliomas in Children. Prog Neurol Surg, 31, 87-101.
     
  316. Nemes K, Clement N, Kachanov D, Bens S, Hasselblatt M, Timmermann B, Schneppenheim R, Gerss J, Siebert R, Furtwangler R, Bourdeaut F, Fruhwald MC (2018). The extraordinary challenge of treating patients with congenital rhabdoid tumors-a collaborative European effort. Pediatr Blood Cancer, 65(6), 1-9.
     
  317. Gnekow AK, Walker DA, Kandels D, Picton S, Giorgio Perilongo, Grill J, Stokland T, Sandstrom PE, Warmuth-Metz M, Pietsch T, Giangaspero F, Schmidt R, Faldum A, Kilmartin D, De Paoli A, De Salvo GL (2018). Corrigendum to "A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (?16 years) low grade glioma - A final report" [Eur J of Canc (2017) 206-225]. Eur J Cancer, 90, 156-157.
     
  318. Beier D, Proescholdt M, Reinert C, Pietsch T, Jones DTW, Pfister SM, Hattingen E, Seidel C, Dirven L, Luerding R, Reijneveld J, Warmuth-Metz M, Bonsanto M, Bremer M, Combs SE, Rieken S, Herrlinger U, (2018). Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07). Neuro Oncol, 20(3), 400-410.
     
  319. Schafer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgauer M, Lossl K, Kovacs G, Fischedick AR, (2018). Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial. Lancet Oncol, 19(6), 834-844.
     
  320. Menzel F, Kaiser N, Haehnel S, Rapp F, Patties I, Schoneberg N, Haimon Z, Immig K, Bechmann I (2018). Impact of X-irradiation on microglia. Glia, 66(1), 15-33.
     
  321. Patties I, Thöle L, Gaunitz F, Kortmann RD, Glasow A (2018). Treatment of human glioblastoma cells with the Chk1 Inhibitor SAR-020106 and Irradiation and/or 5-aza-2'deoxycytidine synergistically reduces clonogenic survival Klinische Pädiatrie, 06, 340.
     
  322. Prager I, Patties I, Himmelbach K, Kendzia E, Glasow A, Kortmann RD (2018). Einfluss von ionisierender Strahlung und Resveratrol auf das Überleben neuraler Stammzellen am murinen Hippokampus-Gewerbekulturmodell Strahlenther Onkol, 194, 208.
     
  323. Patties I, Kendzia E, Böhme L, Gaunitz F, Kortmann RD, Glasow A (2018). Der Chk1-Inhibitor SAR-020106 vermindert die Reparatur von DNA-Schäden und reduziert so synergistisch das klonogene Überleben humaner Glioblastomzellen nach Bestrahlung und 5-Aza-2'desoxycytidin-Behandlung. Strahlenther Onkol, 194, 13.
     
  324. Moustakis C, Blanck =, Andratschke N, Boda-Heggemann J, Wilke L, Tanadini-Lang S, Albers D, Alraun M, Bäumer C, Beckers E, Blaschek M, Brunner T, Chan MKH, Dierl M, Droege S, Duma MN, Ebrahimi F, Eich (2018). Referenz Planvergleichsstudie für Leber-SBRT - Ergebnisse DEGRO AG/DGMP AK Stereotaxie Strahlenther Onkol, 194, 18-19.
     
  325. Kotzerke D, Knödler M, Hering K, Kuhnt T, Lordick F (2018). Is prediction of chemotherapy related toxicity in elderly cancer patients possible? Correlation of three onco-eriatric scores: G8, optimized G8 and CARG. A clinical, oligocentric prospective observational study Strahlenther Onkol, 194, 24-24.
     
  326. Simonetto C, Rennau H, Remmele J, Sebb S, Kunrat P, Eidemüller M, Wolf U, Hildebrandt G (2018). Dosen in entfernt liegenden Organen und Zweittumor-Risiken bei der Brustkrebs-Strahlentherapie mit 3D-CRT und IMRT Strahlenther Onkol, 194, 191-191.
     
  327. Dunst J, Hildebrandt G, Becker-Schiebe M, Kuhnt T, Weykamp F, Martucci F, Vordermark D, Pless M, Hofmann D, Bühler V, Rothschild SI (2018). Can concomitant diseases predict the compliance with cisplantin plus RT in patients with LA SCCHN? An exploratory endpoint Analysis of the COMPLY trial Annals of Oncology, 29, 393-394.
     
  328. Kortmann RD, Paulino AC (2018). Low-Grade Glioma In: Mahajan A, Paulino A, Radiation Oncology for Pediatric CNS Tumors (S. 190-212), Cham: Springer Verlag.
     
  329. Seidel C, Kortmann RD, Balabanov S, Meixensberger J (2018). B 32 ZNS-Tumoren In: HoneckerF, Preiß J, Claßen J, Dornoff W, Taschenbuch Onkologie - Interdisziplinäre Empfehlungen zur Therapie 2018/2019 (S. 230-236), München: W. Zuckschwerdt Verlag.
     
  330. Illerhaus G, Kortmann RD (2018). A 5 Lymphome des ZNS In: Honecker F, Preiß J, Claßen J, Dornoff W, Taschenbuch Onkologie - Interdisziplinäre Empfehlungen zur Therapie 2018/2019 (S. 40-42), München: W. Zuckschwerdt Verlag.
     
  331. Seidel C, Meixensberger J, Kortmann RD, (2018). Radiation Oncology In: Wenz F, Radiation Therapy in Craniopharyngioma (S. 1-8), Cham: Springer.
     
  332. Fleischhack G, Rutkowski S, Pfister M, Pietsch T, Tippelt S, Warmuth-Metz M, Bison B, van Velthoven-Wurster V, Messing-Jünger M, Kortmann RD, Timmermann B, Slavc I, Witt O, Gnekow A, Hernaiz-Driever P (2018). ZNS-Tumoren In: Niemeyer C, Eggert A, Pädiatrische Hämatologie und Onkologie (S. 359-419), Berlin, Heidelberg: Springer.
     
  333. Merchant T, Kortmann RD (2018). Introduction In: Merchant T, Kortmann RD, Pediatric Radiation Oncology (S. 1-2), Cham: Springer.
     
  334. Merchant T, Kortmann RD (2018). Future Directions In: Merchant T, Kortmann RD, Pediatric Radiation Oncology (S. 461-462), Cham: Springer.
     
  335. Seidel C, Meixensberger J, Kortmann RD (2018). Radiation Therapy in Craniopharyngioma In: Wenz F, Radiation Oncology (S. 1-8), Cham: Springer Verlag.
     
  336. Seidel C, Meixensberger J, Kortmann RD (2018). ZNS-Tumoren In: F. Honecker, J. Claßen, J. Preiß, W. Dornoff, Taschenbuch Onkologie, Interdisziplinäre Empfehlungen zur Therapie (S. 230-236), München: Zuckschwerdt Verlag .
     
  337. Seidel C, Meixensberger J, Kortmann RD (2018). Taschenbuch Onkologie, Interdisziplinäre Empfehlungen zur Therapie 2018/2019 In: Hocker F, Claßen J, Preiß J, Dornoff W., ZNS-Tumoren (S. 230-236), München: Zuckschwerdt Verlag .
     


    338. 2017


  338. Hambsch P, Istomin YP, Tzerkovsky DA, Patties I, Neuhaus J, Kortmann RD, Schastak S, Glasow A (2017). Efficient cell death induction in human glioblastoma cells by photodynamic treatment with Tetrahydroporphyrin-Tetratosylat (THPTS) and ionizing irradiation. Oncotarget, 8(42), 72411-72423.
     
  339. Seidel C, Kortmann RD (2017). [Corticosteroids compromise survival in glioblastoma patients after radio- and chemotherapy]. Strahlenther Onkol, 193(11), 982-983.
     
  340. Kuhnt T, Schreiber A, Pirnasch A, Hautmann MG, Hass P, Sieker FP, Engenhart-Cabillic R, Richter M, Dellas K, Dunst J (2017). Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck : Final 5year results of a phase II study. Strahlenther Onkol, 193(9), 733-741.
     
  341. Seidel C, Kortmann RD (2017). [No evidence for radiation-induced tumors after intracranial radiosurgery]. Strahlenther Onkol, 193(9), 765-766.
     
  342. Seidel C, Kortmann RD (2017). [Radiotherapy for glioblastoma : ASCO endorses the ASTRO guideline]. Strahlenther Onkol, 193(6), 513-514.
     
  343. Singer S, Danker H, Roick J, Einenkel J, Briest S, Spieker H, Dietz A, Hoffmann I, Papsdorf K, Meixensberger J, Mossner J, Schiefke F, Dietel A, Wirtz H, Niederwieser D, Berg T, Kersting A (2017). Effects of stepped psychooncological care on referral to psychosocial services and emotional well-being in cancer patients: A cluster-randomized phase III trial. Psychooncology, 26(10), 1675-1683.
     
  344. Steiniger B, Berger R, Eilzer S, Kornhuber C, Lorenz K, Peil T, Reiffenstuhl C, Schilz J, Schroder D, Schwedas M, Pensold S, Walke M, Weibert K, Wolf U, Wiezorek T (2017). Patient-related quality assurance with different combinations of treatment planning systems, techniques, and machines: A multi-institutional survey. Strahlenther Onkol, 193(1), 46-54.
     
  345. Gnekow AK, Walker DA, Kandels D, Picton S, Giorgio Perilongo, Grill J, Stokland T, Sandstrom PE, Warmuth-Metz M, Pietsch T, Giangaspero F, Schmidt R, Faldum A, Kilmartin D, De Paoli A, De Salvo GL (2017). A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (?16 years) low grade glioma - A final report. Eur J Cancer, 81, 206-225.
     
  346. Schweyen R, Stang A, Wienke A, Eckert A, Kuhnt T, Hey J (2017). The influence of dental treatment on the development of osteoradionecrosis after radiotherapy by modern irradiation techniques. Clin Oral Investig, 21(8), 2499-2508.
     
  347. Friedrich C, Shalaby T, Oehler C, Pruschy M, Seifert B, Picard D, Remke M, Warmuth-Metz M, Kortmann RD, Rutkowski S, Grotzer MA, von Bueren AO (2017). Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response. Childs Nerv Syst, 33(9), 1463-1471.
     
  348. Calaminus G, Frappaz D, Kortmann RD, Krefeld B, Saran F, Pietsch T, Vasiljevic A, Garre ML, Ricardi U, Mann JR, Gobel U, Alapetite C, Murray MJ, Nicholson JC (2017). Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial. Neuro Oncol, 19(12), 1661-1672.
     
  349. Stoppel G, Eich HT, Matuschek C, Kortmann RD, Meyer F, Martinsson U, Nilsson K, Kristensen I, Vordermark D, Willich N, Christiansen H, Koch R, Steinmann D (2017). Lung toxicity after radiation in childhood: Results of the International Project on Prospective Analysis of Radiotoxicity in Childhood and Adolescence. Radiother Oncol, 125(2), 286-292.
     
  350. Singer S, Bartels M, Briest S, Einenkel J, Niederwieser D, Papsdorf K, Stolzenburg JU, Kunstler S, Taubenheim S, Krauss O (2017). Socio-economic disparities in long-term cancer survival-10 year follow-up with individual patient data. Support Care Cancer, 25(5), 1391-1399.
     
  351. Greither T, Vorwerk F, Kappler M, Bache M, Taubert H, Kuhnt T, Hey J, Eckert AW (2017). Salivary miR-93 and miR-200a as post-radiotherapy biomarkers in head and neck squamous cell carcinoma. Oncol Rep, 38(2), 1268-1275.
     
  352. Inhestern J, Schmalenberg H, Dietz A, Rotter N, Maschmeyer G, Jungehulsing M, Grosse-Thie C, Kuhnt T, Gorner M, Sudhoff H, Wittekindt C, Guntinas-Lichius O (2017). A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1). Ann Oncol, 28(8), 1917-1922.
     
  353. Polgar C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgauer M, Lossl K, Polat B, Kovacs G, Fischedick AR, Fietkau R, Resch A, (2017). Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Lancet Oncol, 18(2), 259-268.
     
  354. Moustakis C, Blanck O, Ebrahimi F, Ka Heng Chan M, Ernst I, Krieger T, Duma MN, Oechsner M, Ganswindt U, Heinz C, Alheit H, Blank H, Nestle U, Wiehle R, Kornhuber C, Ostheimer C, Petersen C, Pollul G, (2017). Time for standardization of SBRT planning through large scale clinical data and guideline-based approaches. Strahlenther Onkol, 193(12), 1068-1069.
     
  355. Moustakis C, Blanck O, Ebrahimi Tazehmahalleh F, Ka Heng Chan M, Ernst I, Krieger T, Duma MN, Oechsner M, Ganswindt U, Heinz C, Alheit H, Blank H, Nestle U, Wiehle R, Kornhuber C, Ostheimer C, Peterse (2017). Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy. Strahlenther Onkol, 193(10), 780-790.
     
  356. Janssens GO, Gandola L, Bolle S, Mandeville H, Ramos-Albiac M, van Beek K, Benghiat H, Hoeben B, Morales La Madrid A, Kortmann RD, Hargrave D, Menten J, Pecori E, Biassoni V, von Bueren AO, van Vuurde (2017). Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group. Eur J Cancer, 73, 38-47.
     
  357. Kortmann RD, Paulino AC (2017). Low-Grade Glioma. In: Mahajan A, Paulino AC, Radiation Oncology for Pediatric CNS Tumors. (S. 189-213), Cham: Springer Verlag.
     
  358. O Neill BP, Allen J, Berger MS, Kortmann RD (2017). Astrocytic tumours: pilocytic astrocytoma, pleomorphic xanthoastrocytoma, and subependymal giant cell astrocytoma. In: Batchelor TT, Nishikawa R, Tarbell NJ, Weller M, Oxford Textbook of Neuro-Oncology. (S. 15-27), Oxford: Oxford University Press.
     


    359. 2016


  359. Berk BA, Nagel S, Hering K, Paschke S, Hoffmann KT, Kortmann RD, Gaudino C, Seidel C (2016). White matter lesions reduce number of brain metastases in different cancers: a high-resolution MRI study. J Neurooncol, 130(1), 203-209.
     
  360. Seidel C, Kortmann RD (2016). [Cigarette smoking before and after breast cancer diagnosis : Increasing the mortality of breast cancer]. Strahlenther Onkol, 192(10), 739-740.
     
  361. Hering K, Bresch A, Lobsien D, Mueller W, Kortmann RD, Seidel C (2016). Primary Intradural Extramedullary Spinal Melanoma in the Lower Thoracic Spine. Case Rep Oncol Med, 2016, 3815280.
     
  362. Seidel C, Kortmann RD (2016). [Survival benefit from the addition of bevacizumab to first-line radiochemotherapy for the treatment of proneural glioblastoma?]. Strahlenther Onkol, 192(1), 65-66.
     
  363. von Bueren AO, Kortmann RD, von Hoff K, Friedrich C, Mynarek M, Muller K, Goschzik T, Zur Muhlen A, Gerber N, Warmuth-Metz M, Soerensen N, Deinlein F, Benesch M, Zwiener I, Kwiecien R, Faldum A, Bode U, Fleischhack G, Hovestadt V, Kool M, Jones D, Northcott P, Kuehl J, Pfister S, Pietsch T, Rutkowski S (2016). Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters. J Clin Oncol, 34(34), 4151-4160.
     
  364. Indelicato DJ, Merchant T, Laperriere N, Lassen Y, Vennarini S, Wolden S, Hartsell W, Pankuch M, Brandal P, Law CC, Taylor R, Laskar S, Okcu MF, Bouffet E, Mandeville H, Bjork-Eriksson T, Nilsson K, Nystrom H, Constine LS, Story M, Timmermann B, Roberts K, Kortmann RD (2016). Consensus Report From the Stockholm Pediatric Proton Therapy Conference. Int J Radiat Oncol Biol Phys, 96(2), 387-392.
     
  365. Kortmann RD, Freeman C, Marcus K, Claude L, Dieckmann K, Halperin E, Esiashvili N, Paulino A, Mahajan A, Seiersen K, Ahern V, Ricardi U, Carrie C (2016). Paediatric radiation oncology in the care of childhood cancer: A position paper by the International Paediatric Radiation Oncology Society (PROS). Radiother Oncol, 119(2), 357-360.
     
  366. Beyer S, von Bueren AO, Klautke G, Guckenberger M, Kortmann RD, Pietschmann S, Muller K (2016). A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015. PLoS One, 11(2), 1-12.
     
  367. Prager I, Patties I, Himmelbach K, Kendzia E, Merz F, Muller K, Kortmann RD, Glasow A (2016). Dose-dependent short- and long-term effects of ionizing irradiation on neural stem cells in murine hippocampal tissue cultures: neuroprotective potential of resveratrol. Brain Behav, 6(10), e00548.
     
  368. Patties I, Kortmann RD, Menzel F, Glasow A (2016). Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs. J Exp Clin Cancer Res, 35(1), 94.
     
  369. Kuhnt T, Stang A, Wienke A, Vordermark D, Schweyen R, Hey J (2016). Potential risk factors for jaw osteoradionecrosis after radiotherapy for head and neck cancer. Radiat Oncol, 11, 101.
     
  370. von Bueren AO, Seidel C, Friedrich C (2016). Comment on: Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients? J Neurooncol, 129(1), 189-191.
     
  371. Sabel M, Fleischhack G, Tippelt S, Gustafsson G, Doz F, Kortmann R, Massimino M, Navajas A, von Hoff K, Rutkowski S, Warmuth-Metz M, Clifford SC, Pietsch T, Pizer B, Lannering B (2016). Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study. J Neurooncol, 129(3), 515-524.
     
  372. Bartelheim K, Nemes K, Seeringer A, Kerl K, Buechner J, Boos J, Graf N, Durken M, Gerss J, Hasselblatt M, Kortmann RD, Teichert von Luettichau I, Nagel I, Nygaard R, Oyen F, Quiroga E, Schlegel PG, Sc (2016). Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007. Cancer Med, 5(8), 1765-1775.
     
  373. Herrlinger U, Schafer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Friedrich F, Rohde V, Ringel F, Schlegel U, Sabel M, Ronellenfitsch MW, Uhl M, Maciaczyk J, Grau S, Schnell O, Hanel M, Krex (2016). Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. J Clin Oncol, 34(14), 1611-1619.
     
  374. Pixberg C, Koch R, Eich HT, Martinsson U, Kristensen I, Matuschek C, Kortmann RD, Pohl F, Elsayad K, Christiansen H, Willich N, Lindh J, Steinmann D (2016). Acute Toxicity Grade 3 and 4 After Irradiation in Children and Adolescents: Results From the IPPARCA Collaboration. Int J Radiat Oncol Biol Phys, 94(4), 792-799.
     
  375. Ott OJ, Strnad V, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgauer M, Lossl K, Polat B, Kovacs G, Fischedick AR, Wendt TG, Fietkau R, (2016). GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance. Radiother Oncol, 120(1), 119-123.
     
  376. Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Gutierrez Miguelez C, Slampa P, Allgauer M, Lossl K, Polat B, Kovacs G, Fischedick AR, Wendt TG, F (2016). 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet, 387(10015), 229-238.
     
  377. Singer S, Roick J, Briest S, Stark S, Gockel I, Boehm A, Papsdorf K, Meixensberger J, Muller T, Prietzel T, Schiefke F, Dietel A, Braunlich J, Danker H (2016). Impact of socio-economic position on cancer stage at presentation: Findings from a large hospital-based study in Germany. Int J Cancer, 139(8), 1696-1702.
     
  378. Mozet C, Kuhnt T, Sattler B, Remmele J, Thome U, Stepan H, Kluge R, Dietz A, Knoedler M (2016). [Head and Neck Cancer in Pregnancy - Recommendations for Diagnosis and Therapy With Case Report]. Laryngorhinootologie, 95(10), 674-683.
     
  379. Seidel C, Meixensberger J, Kortmann RD (2016). ZNS-Tumoren. In: Preiß J, Honecker F, Claßen J, Dornoff W, Taschenbuch Onkologie 2016/17 (S. 214-220), München: W. Zuckschwerdt Verlag.
     


    380. 2015


  380. Kortmann RD (2015). [Memory protection with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases?]. Strahlenther Onkol, 191(6), 534-535.
     
  381. Seidel C, Kuhnt T, Kortmann RD, Hering K (2015). Radiation-induced camptocormia and dropped head syndrome: Review and case report of radiation-induced movement disorders. Strahlenther Onkol, 191(10), 765-770.
     
  382. Muller K, Henke G, Pietschmann S, van Gool S, De Vleeschouwer S, von Bueren AO, Compter I, Friedrich C, Matuschek C, Klautke G, Kortmann RD, Hundsberger T, Baumert BG (2015). Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model. J Neurooncol, 124(2), 325-332.
     
  383. Seidel C, Hambsch P, Hering K, Bresch A, Rohde S, Kortmann RD, Gaudino C (2015). Analysis of frequency of deep white matter metastasis on cerebral MRI. J Neurooncol, 123(1), 135-139.
     
  384. Pietschmann S, von Bueren AO, Kerber MJ, Baumert BG, Kortmann RD, Muller K (2015). An individual patient data meta-analysis on characteristics, treatments and outcomes of glioblastoma/ gliosarcoma patients with metastases outside of the central nervous system. PLoS One, 10(4), e0121592.
     
  385. Seidel C, Kortmann RD (2015). [Brain metastases in pulmonary adenocarcinoma with EGFR mutation: how important is therapy with erlotinib compared to radiotherapy?]. Strahlenther Onkol, 191(2), 205-207.
     
  386. Muller K, Henke G, Compter I, von Bueren AO, Friedrich C, Janssens G, Kramm CM, Hundsberger T, Paulsen F, Kortmann RD, Zwiener I, Baumert BG (2015). External validation of a prognostic model estimating the survival of patients with recurrent high-grade gliomas after reirradiation. Pract Radiat Oncol, 5(3), e143-150.
     
  387. Schweyen R, Hey J, Seidel J, Wienke A, Paelecke-Habermann Y, Vordermark D, Kuhnt T (2015). Impact of parotid gland dose and patient-related factors on radiation damages to dental hard tissues. J DENT SCI, 10(3), 263-269.
     
  388. Patties I, Haagen J, Dorr W, Hildebrandt G, Glasow A (2015). Late inflammatory and thrombotic changes in irradiated hearts of C57BL/6 wild-type and atherosclerosis-prone ApoE-deficient mice. Strahlenther Onkol, 191(2), 172-179.
     
  389. Mathias D, Mitchel RE, Barclay M, Wyatt H, Bugden M, Priest ND, Whitman SC, Scholz M, Hildebrandt G, Kamprad M, Glasow A (2015). Low-dose irradiation affects expression of inflammatory markers in the heart of ApoE -/- mice. PLoS One, 10(3), e0119661.
     
  390. Szuecs M, Kuhnt T, Punke C, Witt G, Klautke G, Kramp B, Hildebrandt G (2015). Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer. J Radiat Res, 56(1), 159-168.
     
  391. Camara-Costa H, Resch A, Kieffer V, Lalande C, Poggi G, Kennedy C, Bull K, Calaminus G, Grill J, Doz F, Rutkowski S, Massimino M, Kortmann RD, Lannering B, Dellatolas G, Chevignard M (2015). Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy. Int J Radiat Oncol Biol Phys, 92(5), 978-985.
     
  392. Tallen G, Resch A, Calaminus G, Wiener A, Leiss U, Pletschko T, Friedrich C, Langer T, Grabow D, Driever PH, Kortmann RD, Timmermann B, Pietsch T, Warmuth-Metz M, Bison B, Thomale UW, Krauss J, Mynare (2015). Strategies to improve the quality of survival for childhood brain tumour survivors. Eur J Paediatr Neurol, 19(6), 619-639.
     
  393. Friedrich C, Warmuth-Metz M, von Bueren AO, Nowak J, Bison B, von Hoff K, Pietsch T, Kortmann RD, Rutkowski S (2015). Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare disease. J Neurosurg Pediatr, 15(3), 227-235.
     
  394. Rosler P, Christiansen H, Kortmann RD, Martini C, Matuschek C, Meyer F, Rube C, Langer T, Koch R, Eich HT, Willich N, Steinmann D (2015). Hepatotoxicity after liver irradiation in children and adolescents : results from the RiSK. Strahlenther Onkol, 191(5), 413-420.
     
  395. Boehm A, Lindner F, Wichmann G, Bauer U, Wittekind C, Knoedler M, Lordick F, Dietzsch S, Scholz M, Kortmann R, Dietz A (2015). Impact of indication-shift of primary and adjuvant chemo radiation in advanced laryngeal and hypopharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol, 272(8), 2017-2025.
     
  396. Bolling T, Weege J, Eich HT, Timmermann B, Meyer FM, Rube C, Kortmann RD, Fischedick K, Rodel C, Koch R, Willich N (2015). Acute and late side effects to salivary glands and oral mucosa after head and neck radiotherapy in children and adolescents. Results of the "Registry for the evaluation of side effects after radiotherapy in childhood and adolescence". Head Neck, 37(8), 1137-1141.
     
  397. Lewitzki V, Andratschke N, Kuhnt T, Hildebrandt G (2015). Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib. Radiat Oncol, 10, 29.
     
  398. Nowak J, Seidel C, Pietsch T, Alkonyi B, Fuss TL, Friedrich C, von Hoff K, Rutkowski S, Warmuth-Metz M (2015). Systematic comparison of MRI findings in pediatric ependymoblastoma with ependymoma and CNS primitive neuroectodermal tumor not otherwise specified. Neuro Oncol, 17(8), 1157-1165.
     
  399. von Bueren AO, Friedrich C, von Hoff K, Kwiecien R, Muller K, Pietsch T, Warmuth-Metz M, Hau P, Benesch M, Kuehl J, Kortmann RD, Rutkowski S (2015). Metastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000 protocol. Eur J Cancer, 51(16), 2434-2443.
     
  400. Wolf U (2015). Radiophysical Principles In: Panizzon RG, Seegenschmiedt MH, Radiation Treatment and Radiation Reactions in Dermatology (S. 13-31), Berlin Heidelberg: Springer Verlag.
     


    401. 2014


  401. Friedrich F, Meixensberger J (2014). Strahlentherapie multipler Hirnmetastasen. Der Onkologe, 20(8), 776-777.
     
  402. Kennedy C, Kortmann RD (2014). In reply to Genc et al. Comment. Int J Radiat Oncol Biol Phys, 89(4), 928-929.
     
  403. Gerber NU, von Hoff K, Resch A, Ottensmeier H, Kwiecien R, Faldum A, Matuschek C, Hornung D, Bremer M, Benesch M, Pietsch T, Warmuth-Metz M, Kuehl J, Rutkowski S, Kortmann RD (2014). Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy. Int J Radiat Oncol Biol Phys, 89(4), 863-871.
     
  404. Kortmann RD (2014). [The chemotherapy before or after radiation therapy does not influence survival of children with high-risk medulloblastomas: results of the multicenter and randomized study of the Pediatric Oncology Group (POG 9031)]. Strahlenther Onkol, 190(1), 106-108.
     
  405. Kortmann RD (2014). Current concepts and future strategies in the management of intracranial germinoma. Expert Rev Anticancer Ther, 14(1), 105-119.
     
  406. Pietschmann S, von Bueren AO, Henke G, Kerber MJ, Kortmann RD, Muller K (2014). An individual patient data meta-analysis on characteristics, treatments and outcomes of the glioblastoma/gliosarcoma patients with central nervous system metastases reported in literature until 2013. J Neurooncol, 120(3), 451-457.
     
  407. Muller K, Schlamann A, Guckenberger M, Warmuth-Metz M, Gluck A, Pietschmann S, Wawer A, Kortmann RD, Kramm C, von Bueren AO (2014). Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group. Strahlenther Onkol, 190(4), 377-381.
     
  408. Schlamann A, von Bueren AO, Hagel C, Zwiener I, Seidel C, Kortmann RD, Muller K (2014). An individual patient data meta-analysis on characteristics and outcome of patients with papillary glioneuronal tumor, rosette glioneuronal tumor with neuropil-like islands and rosette forming glioneuronal tumor of the fourth ventricle. PLoS One, 9(7), e101211.
     
  409. Patties I, Habelt B, Rosin B, Dorr W, Hildebrandt G, Glasow A (2014). Late effects of local irradiation on the expression of inflammatory markers in the Arteria saphena of C57BL/6 wild-type and ApoE-knockout mice. Radiat Environ Biophys, 53(1), 117-124.
     
  410. Muller K, Mynarek M, Zwiener I, Siegler N, Zimmermann M, Christiansen H, Budach W, Henke G, Warmuth-Metz M, Pietsch T, von Hoff K, von Bueren A, Bode U, Rutkowski S, Kortmann RD, Fleischhack G, Tippelt S (2014). Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studies. Int J Radiat Oncol Biol Phys, 88(5), 1019-1024.
     
  411. Friedrich F, Kortmann RD (2014). Stereotaktische Radiochirurgie bei Kleinhirnbrückenwinkel-Meningeomen. Neurosurg Scan, 4(2), 259-260.
     
  412. Bode U, Zimmermann M, Moser O, Rutkowski S, Warmuth-Metz M, Pietsch T, Kortmann RD, Faldum A, Fleischhack G (2014). Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trial. J Neurooncol, 120(3), 635-642.
     
  413. Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong YK, Aldape KD, Lhermitte B, Pietsch T, Grujicic D, Steinbach JP, Wick W, Tarnawski R, Nam DH, Hau P, Weyerbrock A, ... Kortmann RD ... et al. (2014). Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol, 15(10), 1100-1108.
     
  414. Valentini V, Abrahamsson PA, Aranda SK, Astier A, Audisio RA, Boniol M, Bonomo L, Brunelli A, Bultz B, Chiti A, De Lorenzo F, Eriksen JG, Goh V, Gospodarowicz MK, Grassi L, Kelly J, Kortmann RD, Kutlu (2014). Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014). Ann Oncol, 25(9), 1863-1865.
     
  415. Hoffmann A, Warmuth-Metz M, Gebhardt U, Pietsch T, Pohl F, Kortmann RD, Calaminus G, Muller HL (2014). Childhood craniopharyngioma - changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007. Klin Padiatr, 226(3), 161-168.
     
  416. Seeringer A, Bartelheim K, Kerl K, Hasselblatt M, Leuschner I, Rutkowski S, Timmermann B, Kortmann RD, Koscielniak E, Schneppenheim R, Warmuth-Metz M, Gerss J, Siebert R, Graf N, Boos J, Fruhwald MC (2014). Feasibility of intensive multimodal therapy in infants affected by rhabdoid tumors - experience of the EU-RHAB registry. Klin Padiatr, 226(3), 143-148.
     
  417. Friedrich C, Muller K, von Hoff K, Kwiecien R, Pietsch T, Warmuth-Metz M, Gerber NU, Hau P, Kuehl J, Kortmann RD, von Bueren AO, Rutkowski S (2014). Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocol. J Neurooncol, 116(3), 567-575.
     
  418. Kennedy C, Bull K, Chevignard M, Culliford D, Dorr HG, Doz F, Kortmann RD, Lannering B, Massimino M, Navajas Gutierrez A, Rutkowski S, Spoudeas HA, Calaminus G (2014). Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional radiation therapy for standard-risk medulloblastoma. Int J Radiat Oncol Biol Phys, 88(2), 292-300.
     
  419. Singer S, Danker H, Briest S, Dietrich A, Dietz A, Einenkel J, Papsdorf K, Lordick F, Meixensberger J, Mossner J, Niederwieser D, Prietzel T, Schiefke F, Stolzenburg JU, Wirtz H, Kersting A (2014). Effect of a structured psycho-oncological screening and treatment model on mental health in cancer patients (STEPPED CARE): study protocol for a cluster randomized controlled trial. Trials, 15, 482.
     
  420. Singer S, Meyer A, Wienholz S, Briest S, Brown A, Dietz A, Binder H, Jonas S, Papsdorf K, Stolzenburg JU, Kohler U, Rassler J, Zwerenz R, Schroter K, Mehnert A, Lobner M, Konig HH, Riedel-Heller SG (2014). Early retirement in cancer patients with or without comorbid mental health conditions: a prospective cohort study. Cancer, 120(14), 2199-2206.
     
  421. Knödler M, Kuhnt T, Lordick F (2014). Perioperative Therapie bei Adenokarzinomen des Ösophagus und ösophagogastralen Übergangs. Der Onkologe, 20(12), 1210-1216.
     
  422. Lordick F, Gockel I, Mössner J, Kuhnt T, Wittekind C (2014). Interdisziplinäre Therapie des Ösophaguskarzinoms 6. Best Practice Onkologie, 6, 11654.
     


    423. 2013


  423. Kortmann RD, Ochel HJ (2013). [Hyperfractionated vs. conventionally fractionated radiotherapy of nonmetastatic medulloblastoma]. Strahlenther Onkol, 189(3), 266-268.
     
  424. Patties I, Kortmann RD, Glasow A (2013). Inhibitory effects of epigenetic modulators and differentiation inducers on human medulloblastoma cell lines. J Exp Clin Cancer Res, 32, 27.
     
  425. Muller K, Gnekow A, Falkenstein F, Scheiderbauer J, Zwiener I, Pietsch T, Warmuth-Metz M, Voges J, Nikkhah G, Flentje M, Combs SE, Vordermark D, Kocher M, Kortmann RD (2013). Radiotherapy in pediatric pilocytic astrocytomas. A subgroup analysis within the prospective multicenter study HIT-LGG 1996 by the German Society of Pediatric Oncology and Hematology (GPOH). Strahlenther Onkol, 189(8), 647-655.
     
  426. Scholtyssek F, Zwiener I, Schlamann A, Seidel C, Meixensberger J, Bauer M, Hoffmann KT, Combs SE, von Bueren AO, Kortmann RD, Muller K (2013). Reirradiation in progressive high-grade gliomas: outcome, role of concurrent chemotherapy, prognostic factors and validation of a new prognostic score with an independent patient cohort. Radiat Oncol, 8(1), 161.
     
  427. Muller K, Schlamann A, Seidel C, Warmuth-Metz M, Christiansen H, Vordermark D, Kortmann RD, Kramm CM, von Bueren AO (2013). Craniospinal irradiation with concurrent temozolomide and nimotuzumab in a child with primary metastatic diffuse intrinsic pontine glioma. A compassionate use treatment. Strahlenther Onkol, 189(8), 693-696.
     
  428. Muller K, Diez B, Muggeri A, Pietsch T, Friedrich C, Rutkowski S, von Hoff K, von Bueren AO, Zwiener I, Bruns F (2013). What's in a name? Intracranial peripheral primitive neuroectodermal tumors and CNS primitive neuroectodermal tumors are not the same. Strahlenther Onkol, 189(5), 372-379.
     
  429. Seidel C, Hentschel B, Simon M, Schnell O, Heese O, Tatagiba M, Krex D, Reithmeier T, Kowoll A, Weller M, Wick W (2013). A comprehensive analysis of vascular complications in 3,889 glioma patients from the German Glioma Network. J Neurol, 260(3), 847-855.
     
  430. Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, Dill D, Dippel E, Eigentler T, Feyer P, Follmann M, Frerich B, Ganten MK, Gartner J, Gutzmer R, Hassel J, Hauschild A, Hohenberge (2013). Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma". J Dtsch Dermatol Ges, 11, 1-116.
     
  431. Karremann M, Rausche U, Roth D, Kuhn A, Pietsch T, Gielen GH, Warmuth-Metz M, Kortmann RD, Straeter R, Gnekow A, Wolff JE, Kramm CM (2013). Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma. Br J Cancer, 109(4), 844-851.
     
  432. Breuninger H, Eigentler T, Bootz F, Hauschild A, Kortmann RD, Wolff K, Stockfleth E, Szeimies RM, Rompel R, Garbe C, Grabbe S (2013). Brief S2k guidelines--Cutaneous squamous cell carcinoma. J Dtsch Dermatol Ges, 11(Suppl3), 37-45.
     
  433. Ugurel S, Kortmann RD, Mohr P, Mentzel T, Garbe C, Breuninger H (2013). Brief S2k guidelines--Dermatofibrosarcoma protuberans. J Dtsch Dermatol Ges, 11(Suppl3), 16-18.
     
  434. Hauschild A, Breuninger H, Kaufmann R, Kortmann RD, Klein M, Werner J, Reifenberger J, Dirschka T, Garbe C (2013). Brief S2k guidelines--Basal cell carcinoma of the skin. J Dtsch Dermatol Ges, 11(Suppl3), 10-15.
     
  435. Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, Dill D, Dippel E, Eigentler T, Feyer P, Follmann M, Frerich B, Ganten MK, Gartner J, Gutzmer R, Hassel J, Hauschild A, Hohenberge (2013). S3-guideline "diagnosis, therapy and follow-up of melanoma" - short version. J Dtsch Dermatol Ges, 11(6), 563-602.
     
  436. Walker DA, Liu J, Kieran M, Jabado N, Picton S, Packer R, St Rose C (2013). A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method. Neuro Oncol, 15(4), 462-468.
     
  437. Keller S, Muller K, Kortmann RD, Wolf U, Hildebrandt G, Liebmann A, Micke O, Flemming G, Baaske D (2013). Efficacy of low-dose radiotherapy in painful gonarthritis: experiences from a retrospective East German bicenter study. Radiat Oncol, 8, 29.
     
  438. Benesch M, von Bueren AO, Dantonello T, von Hoff K, Pietsch T, Leuschner I, Claviez A, Bierbach U, Kropshofer G, Korinthenberg R, Graf N, Suttorp M, Kortmann RD, Friedrich C, von der Weid N, Kaatsch P (2013). Primary intracranial soft tissue sarcoma in children and adolescents: a cooperative analysis of the European CWS and HIT study groups. J Neurooncol, 111(3), 337-345.
     
  439. Friedrich C, von Bueren AO, von Hoff K, Gerber NU, Ottensmeier H, Deinlein F, Benesch M, Kwiecien R, Pietsch T, Warmuth-Metz M, Faldum A, Kuehl J, Kortmann RD, Rutkowski S (2013). Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro Oncol, 15(2), 224-234.
     
  440. Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Colle (2013). A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol, 31(1), 65-72.
     
  441. Friedrich C, von Bueren AO, von Hoff K, Kwiecien R, Pietsch T, Warmuth-Metz M, Hau P, Deinlein F, Kuehl J, Kortmann RD, Rutkowski S (2013). Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study. Eur J Cancer, 49(4), 893-903.
     
  442. Calaminus G, Kortmann R, Worch J, Nicholson JC, Alapetite C, Garre ML, Patte C, Ricardi U, Saran F, Frappaz D (2013). SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol, 15(6), 788-796.
     
  443. Bartlett F, Kortmann R, Saran F (2013). Medulloblastoma. Clin Oncol (R Coll Radiol), 25(1), 36-45.
     
  444. Wiestler B, Claus R, Hartlieb SA, Schliesser MG, Weiss EK, Hielscher T, Platten M, Dittmann LM, Meisner C, Felsberg J, Happold C, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Grimm C, Weiche (2013). Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective. Neuro Oncol, 15(8), 1017-1026.
     


    445. 2012


  445. Singer S, Krauss O, Keszte J, Siegl G, Papsdorf K, Severi E, Hauss J, Briest S, Dietz A, Brahler E, Kortmann RD (2012). Predictors of emotional distress in patients with head and neck cancer. Head Neck, 34(2), 180-187.
     
  446. Lannering B, Rutkowski S, Doz F, Pizer B, Gustafsson G, Navajas A, Massimino M, Reddingius R, Benesch M, Carrie C, Taylor R, Gandola L, Bjork-Eriksson T, Giralt J, Oldenburger F, Pietsch T, Figarella- (2012). Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol, 30(26), 3187-3193.
     
  447. Muller HL, Gebhardt U, Warmuth-Metz M, Pietsch T, Sorensen N, Kortmann RD (2012). Meningioma as second malignant neoplasm after oncological treatment during childhood. Strahlenther Onkol, 188(5), 438-441.
     
  448. Patties I, Kortmann RD, Glasow A (2012). Combinatorial effects of Resveratrol, 5-aza-2'deoxycytidine, and irradiation on clonogenic survival and stem call population in human Medulloblastoma cell lines. Klin Pädiatrie, 6, 224.
     
  449. Hambsch P, Kortmann RD, Schastak S, Glasow A (2012). Photodynamic treatment with Tetrahydroporphyrin Tetratosylat induces programmed cell death in human glioblastoma cell lines. Klin Pädiatrie, 6, 224.
     
  450. Vester K, Treudler R, Paasch U, Becker C, Liebmann A, Simon JC, Wickenhauser C, Kunz M (2012). Specific bilateral ear infiltration as an early manifestation of chronic lymphocytic leukaemia. Eur J Dermatol, 22(2), 265-266.
     
  451. Zwerenz R, Beutel ME, Imruck BH, Wiltink J, Haselbacher A, Ruckes C, Schmidberger H, Hoffmann G, Schmidt M, Kohler U, Langanke D, Kortmann RD, Kuhnt S, Weissflog G, Barthel Y, Leuteritz K, Brahler E (2012). Efficacy of psychodynamic short-term psychotherapy for depressed breast cancer patients: study protocol for a randomized controlled trial. BMC Cancer, 12, 578.
     
  452. Gnekow AK, Falkenstein F, von Hornstein S, Zwiener I, Berkefeld S, Bison B, Warmuth-Metz M, Driever PH, Soerensen N, Kortmann RD, Pietsch T, Faldum A (2012). Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Neuro Oncol, 14(10), 1265-1284.
     
  453. Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Combs SE, Vesper J, Braun C, Meixensberger J, Ketter R, Mayer-Steinacker R, Reifenberger G (2012). Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol, 13(7), 707-715.
     
  454. Gerber NU, von Hoff K, von Bueren AO, Treulieb W, Deinlein F, Benesch M, Zwiener I, Soerensen N, Warmuth-Metz M, Pietsch T, Mittler U, Kuehl J, Kortmann RD, Grotzer MA, Rutkowski S (2012). A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma. Eur J Cancer, 48(13), 2028-2036.
     
  455. Wolff B, Ng A, Roth D, Parthey K, Warmuth-Metz M, Eyrich M, Kordes U, Kortmann R, Pietsch T, Kramm C, Wolff JE (2012). Pediatric high grade glioma of the spinal cord: results of the HIT-GBM database. J Neurooncol, 107(1), 139-146.
     
  456. Dietz A, Boehm A, Wichmann G, Niederwieser D, Dietzsch S, Fuchs M (2012). [Multimodal laryngeal preservation: current data-based opinion]. HNO, 60(1), 19-31.
     
  457. Hinz A, Einenkel J, Briest S, Stolzenburg JU, Papsdorf K, Singer S (2012). Is it useful to calculate sum scores of the quality of life questionnaire EORTC QLQ-C30? Eur J Cancer Care (Engl), 21(5), 677-683.
     
  458. Manda K, Glasow A, Paape D, Hildebrandt G (2012). Effects of ionizing radiation on the immune system with special emphasis on the interaction of dendritic and T cells. Front Oncol, 2, 102.
     
  459. Lindholm C, Acheva A, Koivistoinen A, Perala M, Heinavaara S, Jahns J, Salomaa S, Hildebrandt G (2012). Search for clastogenic factors in the plasma of locally irradiated individuals. Radiat Res, 177(3), 298-306.
     
  460. Scholbach J, Schulz A, Westphal F, Egger D, Wege AK, Patties I, Koberle M, Sack U, Lange F (2012). Comparison of hematopoietic stem cells derived from fresh and cryopreserved whole cord blood in the generation of humanized mice. PLoS One, 7(10), 46772.
     
  461. Schuhmann MU, Tatagiba MS, Witt O, Kortmann RD (2012). Tumoren des Zentralnervensystems. In: Fuchs J, Solide Tumoren im Kindesalter. (S. 141-149), Stuttgart: Schattauer.
     
  462. Kortmann RD (2012). Strahlentherapie. In: Fuchs J, Solide Tumoren im Kindesalter. (S. 22-31), Stuttgart: Schattauer.
     
  463. Kortmann RD (2012). Pineal parenchymal tumors, embryonal tumors, and germ cell tumors. In: Grisold W, Soffietty R, Handbook of Clinical Neurology. (S. 615-631), Amsterdam, Boston, London, New York, Oxford, Paris: Elsevier.
     


    464. 2011


  464. Patties I, Rosin B, Hildebrandt G, Glasow A (2011). Inflammatorische Veränderungen der Arteria saphena (A. saphena) nach Bestrahlung in Mäusen. Proceeding des 20 Symposiums Experimentelle Strahlentherapie und Klinische Strahlenbiologie, 2011, 163-165.
     
  465. Muller K, Zwiener I, Welker H, Maass E, Bongartz R, Berthold F, Pietsch T, Warmuth-Metz M, von Bueren A, Rutkowski S (2011). Curative treatment for central nervous system medulloepithelioma despite residual disease after resection : Report of two cases treated according to the GPHO protocol HIT 2000 and review of the literature. Strahlenther Onkol, 187(11), 757-762.
     
  466. Dietzsch S, Melzer R, Boehm A, Wolf U, Kortmann R, Fuchs M (2011). [Treatment related swallowing dysfunction and the potentialities of IMRT]. Laryngorhinootologie, 90(11), 657-662.
     
  467. Jahns J, Anderegg U, Saalbach A, Rosin B, Patties I, Glasow A, Kamprad M, Scholz M, Hildebrandt G (2011). Influence of low dose irradiation on differentiation, maturation and T-cell activation of human dendritic cells. Mutat Res, 709-710, 32-39.
     
  468. Sachse MM, Wagner G, Aydin H, Pohlmann S, Heinicke F, Liebmann A (2011). Treatment of extensive lentigo maligna melanoma of the scalp by brachytherapy moulage technique. Br J Dermatol, 164(1), 219-221.
     
  469. Friedrich F, Papsdorf K (2011). Strahlentherapeutische Optionen bei Schmerzem des muskuloskelettalen Systems. arthritis + rheuma, 2, 120-127.
     
  470. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Hassel MB, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller R (2011). Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol, 29(2), 134-141.
     
  471. Wolff JE, Driever PH, Wolff B, Kramm CM, Kortmann RD, Pietsch T, Rutkowski S, Gnekow A (2011). Pediatric neuro-oncology in small centers - quality control of network support: the HIT-GBM experience. Anticancer Res, 31(2), 661-664.
     
  472. von Hoff K, Hinkes B, Dannenmann-Stern E, von Bueren AO, Warmuth-Metz M, Soerensen N, Emser A, Zwiener I, Schlegel PG, Kuehl J, Fruhwald MC, Kortmann RD, Pietsch T, Rutkowski S (2011). Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatr Blood Cancer, 57(6), 978-985.
     
  473. Kramm CM, Butenhoff S, Rausche U, Warmuth-Metz M, Kortmann RD, Pietsch T, Gnekow A, Jorch N, Janssen G, Berthold F, Wolff JE (2011). Thalamic high-grade gliomas in children: a distinct clinical subset? Neuro Oncol, 13(6), 680-689.
     
  474. von Bueren AO, von Hoff K, Pietsch T, Gerber NU, Warmuth-Metz M, Deinlein F, Zwiener I, Faldum A, Fleischhack G, Benesch M, Krauss J, Kuehl J, Kortmann RD, Rutkowski S (2011). Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro Oncol, 13(6), 669-679.
     
  475. Wolff JE, Kortmann RD, Wolff B, Pietsch T, Peters O, Schmid HJ, Rutkowski S, Warmuth-Metz M, Kramm C (2011). High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D pilot study. J Neurooncol, 102(3), 433-442.
     
  476. von Bueren AO, Oehler C, Shalaby T, von Hoff K, Pruschy M, Seifert B, Gerber NU, Warmuth-Metz M, Stearns D, Eberhart CG, Kortmann RD, Rutkowski S, Grotzer MA (2011). c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients. BMC Cancer, 11, e74.
     
  477. von Hornstein S, Kortmann RD, Pietsch T, Emser A, Warmuth-Metz M, Soerensen N, Straeter R, Graf N, Thieme B, Gnekow AK (2011). Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: report from the HIT-LGG 1996 trial. Pediatr Blood Cancer, 56(7), 1046-1054.
     
  478. Benesch M, Sperl D, von Bueren AO, Schmid I, von Hoff K, Warmuth-Metz M, Ferrari R, Lassay L, Kortmann RD, Pietsch T, Rutkowski S (2011). Primary central nervous system primitive neuroectodermal tumors (CNS-PNETs) of the spinal cord in children: four cases from the German HIT database with a critical review of the literature. J Neurooncol, 104(1), 279-286.
     
  479. Bolling T, Geisenheiser A, Pape H, Martini C, Rube C, Timmermann B, Fischedick K, Kortmann RD, Gerss J, Koch R, Willich N (2011). Hypothyroidism after head-and-neck radiotherapy in children and adolescents: preliminary results of the "Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence" (RiSK). Int J Radiat Oncol Biol Phys, 81(5), e787-791.
     
  480. Warmuth-Metz M, Blashofer S, von Bueren AO, von Hoff K, Bison B, Pohl F, Kortmann RD, Pietsch T, Rutkowski S (2011). Recurrence in childhood medulloblastoma. J Neurooncol, 103(3), 705-711.
     
  481. Ott OJ, Hildebrandt G, Potter R, Hammer J, Hindemith M, Resch A, Spiegl K, Lotter M, Uter W, Kortmann RD, Schrauder M, Beckmann MW, Fietkau R, Strnad V (2011). Accelerated partial breast irradiation with interstitial implants: risk factors associated with increased local recurrence. Int J Radiat Oncol Biol Phys, 80(5), 1458-1463.
     
  482. Bolling T, Ernst I, Pape H, Martini C, Rube C, Timmermann B, Fischedick K, Kortmann RD, Willich N (2011). Dose-volume analysis of radiation nephropathy in children: preliminary report of the risk consortium. Int J Radiat Oncol Biol Phys, 80(3), 840-844.
     
  483. Strnad V, Hildebrandt G, Potter R, Hammer J, Hindemith M, Resch A, Spiegl K, Lotter M, Uter W, Bani M, Kortmann RD, Beckmann MW, Fietkau R, Ott OJ (2011). Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. Int J Radiat Oncol Biol Phys, 80(1), 17-24.
     
  484. Horn LC, Schierle K, Schmidt D, Ulrich U, Liebmann A, Wittekind C (2011). [Current TNM/FIGO classification for cervical and endometrial cancer as well as malignant mixed muellerian tumors. Facts and background]. Pathologe, 32(3), 239-243.
     
  485. Singer S, Kuhnt S, Zwerenz R, Eckert K, Hofmeister D, Dietz A, Giesinger J, Hauss J, Papsdorf K, Briest S, Brown A (2011). Age- and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients. Br J Cancer, 105(3), 445-451.
     
  486. Singer S, Brown A, Einenkel J, Hauss J, Hinz A, Klein A, Papsdorf K, Stolzenburg JU, Brahler E (2011). Identifying tumor patients' depression. Support Care Cancer, 19(11), 1697-1703.
     
  487. Fischer M, Horn IS, Bertolini J, Dietzsch S, Fuchs M, Dietz A (2011). [Laryngeal MALT lymphoma with known Sjögren syndrome]. HNO, 59(1), 111-114.
     
  488. Gessner K, Wichmann G, Boehm A, Reiche A, Bertolini J, Brus J, Sterker I, Dietzsch S, Dietz A (2011). Therapeutic options for treatment of Merkel cell carcinoma. Eur Arch Otorhinolaryngol, 268(3), 443-448.
     
  489. Gerber NU, von Hoff K, von Bueren AO, Treulieb W, Warmuth-Metz M, Pietsch T, Soerensen N, Faldum A, Emser A, Schlegel PG, Deinlein F, Kortmann RD, Rutkowski S (2011). Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006. J Neurooncol, 102(3), 459-469.
     
  490. Majorczyk S, Adam G, Adler G, Albers P, Bechstein O, Hauschild A, Hölscher AH, Hohenberger P, Hübner J, Iro H, Jürgens H, Klingebiel T, Kortmann RD, Krege S, Meyer HJ, Ortmann O, Pavel M, Schmutzler R (2011). Primäre Hirntumoren (Gliome/Meningeome). In: Hohenberger W, Penk A, Majorczyk S, Das Krebsbuch - Die Volkskrankheit verstehen, erkennen, behandeln, vermeiden. (S. 246-247), München: Verlag Zabert Sandmann GmbH .
     
  491. Adamietz IA, Albers P, Arnold D, Bahra M, Bamberg M, Beckmann M, Beckmann MW, Belka C, Bielack S, Bokemeyer C, Bölling T, Branscheid D, Büchler MW, Budach V, Budach W, Dieckmann R, Dienemann HC, Dirks (2011). Hirntumoren. In: Schlag PM, Bamberg M, Jäger D, Interdisziplinäre Entscheidungswege in der Onkologie. (S. 41-47), Köln: Deutscher Ärzteverlag.
     


    492. 2010


  492. Grosu AL, Kortmann RD (2010). [Radiotherapy of brain tumors. New techniques and treatment strategies for]. Nervenarzt, 81(8), 918-926.
     
  493. Wolff JE, Driever PH, Erdlenbruch B, Kortmann RD, Rutkowski S, Pietsch T, Parker C, Metz MW, Gnekow A, Kramm CM (2010). Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol. Cancer, 116(3), 705-712.
     
  494. Honig S, Trantakis C, Frerich B, Sterker I, Kortmann RD, Meixensberger J (2010). Meningiomas involving the sphenoid wing outcome after microsurgical treatment-a clinical review of 73 cases. Cen Eur Neurosurg, 71(4), 189-198.
     
  495. Benesch M, Weber-Mzell D, Gerber NU, von Hoff K, Deinlein F, Krauss J, Warmuth-Metz M, Kortmann RD, Pietsch T, Driever PH, Quehenberger F, Urban C, Rutkowski S (2010). Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database. J Neurosurg Pediatr, 6(2), 137-144.
     
  496. Selo N, Bolling T, Ernst I, Pape H, Martini C, Rube C, Timmermann B, Fischedick K, Kortmann RD, Gerss J, Koch R, Willich N (2010). Acute toxicity profile of radiotherapy in 690 children and adolescents: RiSK data. Radiother Oncol, 97(1), 119-126.
     
  497. Hernaiz Driever P, von Hornstein S, Pietsch T, Kortmann R, Warmuth-Metz M, Emser A, Gnekow AK (2010). Natural history and management of low-grade glioma in NF-1 children. J Neurooncol, 100(2), 199-207.
     
  498. Muller HL, Gebhardt U, Schroder S, Pohl F, Kortmann RD, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Calaminus G, Kolb R, Wiegand C, Sorensen N (2010). Analyses of treatment variables for patients with childhood craniopharyngioma--results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up. Horm Res Paediatr, 73(3), 175-180.
     
  499. Hinz A, Krauss O, Hauss JP, Hockel M, Kortmann RD, Stolzenburg JU, Schwarz R (2010). Anxiety and depression in cancer patients compared with the general population. Eur J Cancer Care (Engl), 19(4), 522-529.
     
  500. Dietz A, Boehm A, Horn IS, Kruber P, Bechmann I, Golusinski W, Niederwieser D, Dollner R, Remmerbach TW, Wittekind C, Dietzsch S, Hildebrandt G, Wichmann G (2010). Assay-based response evaluation in head and neck oncology: requirements for better decision making. Eur Arch Otorhinolaryngol, 267(4), 483-494.
     


    501. 2009


  501. Patties I, Jahns J, Hildebrandt G, Kortmann RD, Glasow A (2009). Additive effects of 5-aza-2\'-deoxycytidine and irradiation on clonogenic survival of human medulloblastoma cell lines. Strahlenther Onkol, 185(5), 331-338.
     
  502. Brandes AA, Franceschi E, Tosoni A, Reni M, Gatta G, Vecht C, Kortmann RD (2009). Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET). Crit Rev Oncol Hematol, 71(2), 165-179.
     
  503. Basara N, Schulze A, Wedding U, Mohren M, Gerhardt A, Junghanss C, Peter N, Dolken G, Becker C, Heyn S, Kliem C, Lange T, Krahl R, Ponisch W, Fricke HJ, Sayer HG, Al-Ali H, Kamprad F, Niederwieser D (2009). Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission. Leukemia, 23(4), 635-640.
     
  504. Little MP, Tawn EJ, Tzoulaki I, Wakeford R, Hildebrandt G, Tapio S, Elliott P (2009). Comments: The non-cancer mortality experience of male workers at British Nuclear Fuels plc, 1946-2005. Int J Epidemiol, 38(4), 1159-1164.
     
  505. Willich N, Ernst I, Pape H, Rube C, Timmermann B, Asadpour B, Kortmann RD, Bolling T (2009). Evaluation of side effects after radiotherapy in childhood and adolescence: from retrospective case reports to a prospective, multicentric and transnational approach. Strahlenther Onkol, 185, 3-4.
     
  506. Wrede B, Hasselblatt M, Peters O, Thall PF, Kutluk T, Moghrabi A, Mahajan A, Rutkowski S, Diez B, Wang X, Pietsch T, Kortmann RD, Paulus W, Jeibmann A, Wolff JE (2009). Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 study. J Neurooncol, 95(3), 383-392.
     
  507. Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenber (2009). NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol, 27(35), 5874-5880.
     
  508. Salminen E, Anacak Y, Laskar S, Kortmann RD, Raslawski E, Stevens G, Ribeiro RC (2009). Twinning partnerships through International Atomic Energy Agency (IAEA) to improve radiotherapy in common paediatric cancers in low- and mid-income countries. Radiother Oncol, 93(2), 368-371.
     
  509. Kuhnt S, Ernst J, Singer S, Ruffer JU, Kortmann RD, Stolzenburg JU, Schwarz R (2009). Fatigue in cancer survivors--prevalence and correlates. Onkologie, 32(6), 312-317.
     
  510. von Hoff K, Hinkes B, Gerber NU, Deinlein F, Mittler U, Urban C, Benesch M, Warmuth-Metz M, Soerensen N, Zwiener I, Goette H, Schlegel PG, Pietsch T, Kortmann RD, Kuehl J, Rutkowski S (2009). Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT\'91. Eur J Cancer, 45(7), 1209-1217.
     
  511. Henke G, Paulsen F, Steinbach JP, Ganswindt U, Isijanov H, Kortmann RD, Bamberg M, Belka C (2009). Hypofractionated reirradiation for recurrent malignant glioma. Strahlenther Onkol, 185(2), 113-119.
     
  512. Glas M, Happold C, Rieger J, Wiewrodt D, Bahr O, Steinbach JP, Wick W, Kortmann RD, Reifenberger G, Weller M, Herrlinger U (2009). Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide. J Clin Oncol, 27(8), 1257-1261.
     
  513. Rutkowski S, Gerber NU, von Hoff K, Gnekow A, Bode U, Graf N, Berthold F, Henze G, Wolff JE, Warmuth-Metz M, Soerensen N, Emser A, Ottensmeier H, Deinlein F, Schlegel PG, Kortmann RD, Pietsch T, Kuehl (2009). Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. Neuro Oncol, 11(2), 201-210.
     
  514. Bottcher P, Krastel D, Hierholzer J, Westphalen K, Florian S, Hildebrandt G, Vera G, Oechtering G (2009). Percutaneous cementoplasty in the palliative, multimodal treatment of primary bone tumors of the distal aspect of the radius in four dogs. Vet Surg, 38)(7), 888-901.
     
  515. Fricke S, Ackermann M, Stolzing A, Schimmelpfennig C, Hilger N, Jahns J, Hildebrandt G, Emmrich F, Ruschpler P, Posel C, Kamprad M, Sack U (2009). Allogeneic non-adherent bone marrow cells facilitate hematopoietic recovery but do not lead to allogeneic engraftment. PLoS One, 4(7), e6157.
     
  516. Sterker I, Tegetmeyer H, Papsdorf K, Fuhrer-Sakel D (2009). Effect of combined intravenous glucocorticoids and orbital radiotherapy in restoring driving competency in patients with Graves\' orbitopathy. Horm Metab Res, 41(5), 391-396.
     
  517. Singer S, Kuhnt S, Gotze H, Hauss J, Hinz A, Liebmann A, Krauss O, Lehmann A, Schwarz R (2009). Hospital anxiety and depression scale cutoff scores for cancer patients in acute care. Br J Cancer, 100(6), 908-912.
     
  518. Wilkowski R, Boeck S, Ostermaier S, Sauer R, Herbst M, Fietkau R, Flentje M, Miethe S, Boettcher HD, Scholten T, Bruns CJ, Rau HG, Hinke A, Heinemann V (2009). Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer--a multi-centre randomised phase II study. Br J Cancer, 101, 1853-1859.
     
  519. Hockel M, Horn LC, Manthey N, Braumann UD, Wolf U, Teichmann G, Frauenschlager K, Dornhofer N, Einenkel J (2009). Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol, 10(7), 683-692.
     
  520. Roa W, Xing JZ, Small C, Kortmann R, Miriamanoff R, Okunieff P, Shibamoto Y, Jeremic B (2009). Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme. Expert Rev Anticancer Ther, 9(11), 1643-1650.
     
  521. Singer S, Gotze H, Mobius C, Witzigmann H, Kortmann RD, Lehmann A, Hockel M, Schwarz R, Hauss J (2009). Quality of care and emotional support from the inpatient cancer patient\'s perspective. Langenbecks Arch Surg, 394(4), 723-731.
     
  522. Schlegel U, Korfel A, Thiel E, Wick W, Kortmann RD, Deckert M, Schackert G (2009). Primäre ZNS-Lymphome Onkologe, 15(3), 211-221.
     
  523. Kortmann RD, Bamberg M, Meixensberger J (2009). Zentralnervensystem. In: Bamberg M, Molls M, Sack H, Radioonkologie. Klinik (S. 798-899), München, Wien, New York : W. Zuckschwerdt Verlag .
     
  524. Kortmann RD, Schuck A, Rübe Ch, Willich N, Dunst, J (2009). Maligne Erkrankungen im Kindes- und Jugendalter In: Bamberg M, Molls M, Sack H, Radioonkologie. Band 2: Klinik (S. 982-1048), München Wien New York: W. Zuckschwerdt Verlag.
     


    525. 2008


  525. Glasow A, Barrett A, Petrie K, Gupta R, Boix-Chornet M, Zhou DC, Grimwade D, Gallagher R, von Lindern M, Waxman S, Enver T, Hildebrandt G, Zelent A (2008). DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia Blood, 111(4), 2374-2377.
     
  526. Kamprad F, Ranft D, Weber A, Hildebrandt G (2008). Functional changes of the gustatory organ caused by local radiation exposure during radiotherapy of the head-and-neck region. Strahlenther Onkol, 184(3), 157-162.
     
  527. Hildebrandt, G (2008). Radio(chemo)therapie des lokal fortgeschrittenen Nasopharynxkarzinoms. SKG Mitteilungsblatt - Wiss. Beiträge, 13(2), 11-15.
     
  528. Patties I, Glasow A, Jahns J, Kortmann RD, Hildebrandt, G (2008). Einfluss von 5'Aza-2'Deoxycytidine auf die Strahlensensivität von humanen Medulloblastomzelllinien. Exp Strahlenther Klin Strahlenbiol, 17, 138-142.
     
  529. Wolf U, Hofheinz F, Oehme L, van den Hoff J (2008). PET und Bestrahlungsplanung - technische Aspekte. Nuklearmediziner, 31(1), 12-16.
     
  530. Hildebrandt G, Wolf U (2008). Nachruf für Prof. em. Dr. med. habil. Friedrich Kamprad Ärzteblatt Sachsen, 19(9), 483.
     
  531. Sterker I, Hirsch W, Kortmann RD, Wittekind C, Bierbach U (2008). [Treatment strategies and results of orbital malignancies in childhood] Klin Monatsbl Augenheilkd, 225(10), 843-856.
     
  532. Hauschild A, Breuninger H, Kaufmann R, Kortmann RD, Schwipper V, Werner J, Reifenberger J, Dirschka T, Garbe C (2008). Short German guidelines: basal cell carcinoma. J Dtsch Dermatol Ges, 6 (Suppl 1), S2-S4.
     
  533. Breuninger H, Bootz F, Hauschild A, Kortmann RD, Wolff K, Stockfleth E, Szeimies M, Rompel R, Garbe C (2008). Short German guidelines: squamous cell carcinoma. J Dtsch Dermatol Ges, 6 (Suppl 1), S5-S8.
     
  534. Garbe C, Schadendorf D, Stolz W, Volkenandt M, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R, Hauschild A (2008). Short German guidelines: malignant melanoma. J Dtsch Dermatol Ges, 6 (Suppl 1), S9-S14.
     
  535. Ugurel S, Kortmann RD, Mohr P, Mentzel T, Garbe C, Breuninger H (2008). Short German guidelines: dermatofibrosarcoma protuberans. J Dtsch Dermatol Ges, 6 (Suppl 1), S17-S18.
     
  536. Becker J, Mauch C, Kortmann RD, Keilholz U, Bootz F, Garbe C, Hauschild A, Moll I (2008). Short German guidelines: Merkel cell carcinoma. J Dtsch Dermatol Ges, 6 (Suppl 1), S15-S16.
     
  537. Wolff JE, Kramm C, Kortmann RD, Pietsch T, Rutkowski S, Jorch N, Gnekow A, Driever PH (2008). Valproic acid was well tolerated in heavily pretreated pediatric patients with high-grade glioma. J Neurooncol, 90(3), 309-314.
     
  538. Baumert BG, Brada M, Bernier J, Kortmann RD, Dehing-Oberije C, Collette L, Davis JB (2008). EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm. Radiother Oncol, 88(2), 163-172.
     
  539. Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R (2008). Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting. Melanoma Res, 18(2), 152-160.
     
  540. Jager B, Schuhmann MU, Schober R, Kortmann RD, Meixensberger J (2008). Induction of gliosarcoma and atypical meningioma 13 years after radiotherapy of residual pilocytic astrocytoma in childhood. Pediatr Neurosurg, 44(2), 153-158.
     
  541. Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R (2008). Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Res, 18(1), 61-67.
     
  542. Wolff JE, Classen CF, Wagner S, Kortmann RD, Palla SL, Pietsch T, Kuhl J, Gnekow A, Kramm CM (2008). Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM database. J Neurooncol, 87(2), 155-164.
     
  543. Little MP, Tawn EJ, Tzoulaki I, Wakeford R, Hildebrandt G, Paris F, Tapio S, Elliott P (2008). A systematic review of epidemiological associations between low and moderate doses of ionizing radiation and late cardiovascular effects, and their possible mechanisms. Radiat Res., 169(1), 99-109.
     
  544. Semrau R, Hansemann K, Adam M, Andratschke N, Brunner T, Heinzelmann F, Hildebrandt G, Vordermark D, Zips D (2008). Quality of training in radiation oncology in Germany. Results of a 2006 survey. Strahlenther Onkol, 184(5), 239-244.
     
  545. Schiefke F, Hildebrandt G, Pohlmann S, Heinicke F, Hemprich A, Frerich B (2008). Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas. J Craniomaxillofac Surg, 36(5), 285-292.
     
  546. Hirsch E, Wolf U, Heinicke F, Silva MA (2008). Dosimetry of the cone beam computed tomography Veraviewepocs 3D compared with the 3D Accuitomo in different fields of view. Dentomaxillofac Radiol, 37(5), 268-273.
     
  547. Garcia Silva MA, Wolf U, Heinicke F, Grundler K, Visser H, Hirsch E (2008). Effective dosages for recording Veraviewepocs dental panoramic images: analog film, digital, and panoramic scout for CBCT. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 106(4), 571-577.
     
  548. Silva MA, Wolf U, Heinicke F, Bumann A, Visser H, Hirsch E (2008). Cone-beam computed tomography for routine orthodontic treatment planning: a radiation dose evaluation. Am J Orthod Dentofacial Orthop, 133(5), 640.e1-5.
     
  549. Bolling T, Schuck A, Pape H, Rube C, Pollinger B, Timmermann B, Kortmann RD, Dieckmann K, Willich N (2008). Study protocol of the German "Registry for the detection of late sequelae after radiotherapy in childhood and adolescence" (RiSK). Radiat Oncol, 3, 10.
     
  550. Warmuth-Metz M, Bison B, Dannemann-Stern E, Kortmann R, Rutkowski S, Pietsch T (2008). CT and MR imaging in atypical teratoid/rhabdoid tumors of the central nervous system. Neuroradiology, 50(5), 447-452.
     
  551. Rutkowski S, Fleischhack G, Gnekow A, Kramm C, Müller H, Calaminus G, Wrede B, Frühwald M, Krauss J, Faldum A, Kortmann RD, Pietsch T, Warmuth-Metz M (2008). Hirntumoren bei Kindern und Jugendlichen Leitsymptome und diagnostische Standards Monatsschr Kinderheilkd, 156(12), 1165-1172.
     
  552. Kramm C, Rausche U, Butenhoff S, Kühnöl C, Kunze C, Kortmann RD, Wolff J, van Gool S (2008). Hochmaligne Gliome im Kindes- und Jugendalter Monatsschr Kinderheilkd, 156(12), 1201-1207.
     
  553. Müller HL, Gebhardt U, Kortmann RD, Pohl F, Pietsch T, Warmuth-Metz M, Kaatsch P, Faldum A, Zwiener I, Calaminus G, Kolb R, Wiegand C, Sörensen N (2008). Kraniopharyngeom im Kindes- und Jugendalter Monatsschr Kinderheilkd, 156(12), 1194-1200.
     
  554. Hildebrandt G, Kamprad F (2008). Degenerative joint disease - Activated osteoarthrosis deformans: hip, knee, shoulder and other joints. In: Seegenschmiedt MH, Makoski HB, Trott KR, Brady LW, Radiotherapy for non-malignant disorders: Contemporary concepts and clinical results. (S. 317-332), Berlin-Heidelberg-New York: Springer Verlag.
     
  555. Trott KR, Kamprad F (2008). Chapter 2: Side effects and lang-term risks from radiotherapy of benign diseases. In: Seegenschmiedt MH, Makoski HB, Trott KR, Brady LW, Radiotherapy for non-malignant disorders: Contemporary concepts and clinical results. (S. 29-43), Berlin-Heidelberg-New York: Springer Verlag.
     
  556. Trott KR, Kamprad F, Hildebrandt G (2008). Chapter 1: Radiobiological principles. In: Seegenschmiedt MH, Makoski HB, Trott KR Brady LW (eds.), Radiotherapy for non-malignant disorders: Contemporary concepts and clinical results. (S. 3-27), Berlin-Heidelberg-New York: Springer Verlag.
     
  557. Wolf U, Wiezorek T (2008). Chapter 4: Radiophysical principles. In: Seegenschmiedt MH, Makoski HB, Trott KR and Brady LW, Radiotherapy for non-malignant disorders: Contemporary concepts and clinical results. (S. 59-87), Berlin-Heidelberg-New York: Springer Verlag.
     


    558. 2007


  558. Friedrich F, Papsdorf K, Liebmann A, Wolf U, Lamesch P, Hildebrandt G (2007). [Case report: primary hyperfractionated accelerated radiotherapy in a case of hepatocellular carcinoma (HCC)] Zentralbl Chir, 132(4), 316-321.
     
  559. Rodel F, Keilholz L, Herrmann M, Sauer R, Hildebrandt G (2007). Radiobiological mechanisms in inflammatory diseases of low-dose radiation therapy. Int J Radiat Biol, 83(6), 357-366.
     
  560. Liebmann A, Pohlmann S, Heinicke F, Hildebrandt G (2007). Helmet mold-based surface brachytherapy for homogeneous scalp treatment: a case report. Strahlenther Onkol, 183(4), 211-214.
     
  561. Kortmann RD, Bongartz R, Dieckmann K, Dunst J, Flentje M, Gademann G, Christiansen H, Kamprad FH, Karstens JH, Pape H, Ruhl U, Schmidt BF, Willich N, Schulz-Ertner D, Schwarz R, Timmermann B, Pohl F, (2007). [Requirements and performance profile of the Paediatric Radiation Oncology Working Group (APRO): evaluation of the present situation and description of future developments] Klin Padiatr, 219(3), 166-172.
     
  562. Jurgens H, Klingebiel T, Gobel U, Kortmann RD (2007). [Supporting research in pediatric oncology and hematology] Klin Padiatr, 219(3), 125-126.
     
  563. Kortmann RD (2007). Therapie bei Glioblastom und Medulloblastom im Kindesalter. Klinische Onkologie, 3, 36-41.
     
  564. Dietzsch S, Boicev A, Hildebrandt, G (2007). Fortschritte der multimodalen Therapie bei nicht-resektablen Kopf-Hals-Tumoren. Forum HNO, 9, 48-58.
     
  565. Ludwig S, Hauss JP, Hohlfeld S, Hildebrandt G, Horn LC, Leinung S (2007). [The Male Breast Carcinoma - A Center Experience.] Zentralbl Chir, 132(5), 386-390.
     
  566. Singer S, Bringmann H, Hauss J, Kortmann RD, Kohler U, Krauss O, Schwarz R (2007). [Prevalence of concomitant psychiatric disorders and the desire for psychosocial help in patients with malignant tumors in an acute hospital] Dtsch Med Wochenschr, 132(40), 2071-2076.
     
  567. Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R (2007). Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Melanoma Res, 17(6), 393-399.
     
  568. Ott OJ, Hildebrandt G, Potter R, Hammer J, Lotter M, Resch A, Sauer R, Strnad V (2007). Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiother Oncol, 82(3), 281-286.
     
  569. Grotzer MA, Hoff KV, Bueren AO, Shalaby T, Hartmann W, Warmuth-Metz M, Emser A, Kortmann RD, Kuehl J, Pietsch T, Rutkowski S (2007). [Welche klinischen und molekularbiologischen Tumormarker haben sich im Rahmen des HIT\'91-Protokolls als relevant erwiesen? - Implikationen fur zukunftige Strategien bei Medulloblastom.] Klin Padiatr, 219(6), 312-317.
     
  570. Timmermann B, Lomax AJ, Nobile L, Grotzer MA, Weiss M, Kortmann RD, Bolsi A, Goitein G (2007). Novel Technique of Craniospinal Axis Proton Therapy with the Spot-Scanning System : Avoidance of Patching Multiple Fields and Optimized Ventral Dose Distribution. Strahlenther Onkol, 183(12), 685-688.
     
  571. Bolling T, Schuck A, Pape H, Rube C, Meyer FM, Martini C, Timmermann B, Asadpour B, Kortmann RD, Beck JD, Langer T, Paulides M, Konemann S, Willich N (2007). [Register for the evaluation of side effects after radiation in childhood and adolescence--first results] Klin Padiatr, 219(3), 139-145.
     
  572. Rutkowski S, von Bueren A, von Hoff K, Hartmann W, Shalaby T, Deinlein F, Warmuth-Metz M, Soerensen N, Emser A, Bode U, Mittler U, Urban C, Benesch M, Kortmann RD, Schlegel PG, Kuehl J, Pietsch T, Gro (2007). Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT\'91. Clin Cancer Res, 13(9), 2651-2657.
     
  573. Hinkes BG, von Hoff K, Deinlein F, Warmuth-Metz M, Soerensen N, Timmermann B, Mittler U, Urban C, Bode U, Pietsch T, Schlegel PG, Kortmann RD, Kuehl J, Rutkowski S (2007). Childhood pineoblastoma: experiences from the prospective multicenter trials HIT-SKK87, HIT-SKK92 and HIT91. J Neurooncol, 81(2), 217-223.
     
  574. Ludwig S, Hauss JP, Hohlfeld S, Hildebrandt G, Horn LC, Leinung S (2007). Mammakarzinom des Mannes - Leipziger Daten im Literaturvergleich Senologie, 4(4), 266-269.
     
  575. Bolling T, Schuck A, Pape H, Rube C, Meyer FM, Martini C, Timmermann B, Asadpour B, Kortmann RD, Beck JD, Langer T, Paulides M, Willich N (2007). German register for detection of late sequelae after radiotherapy for children and adolescents (RiSK): present status and first results. Strahlenther Onkol, 183, 7-8.
     
  576. Wolf U, Wiezorek T (2007). Chapter 4: Radiophysical principles. In: Seegenschmiedt MH, Makoski HB, Trott KR, Brady LW, Radiotherapy for non-malignant disorders: Contemporary concepts and clinical results. (S. 59-87), Berlin-Heidelberg-New York: Springer Verlag.
     
  577. Hildebrandt G, Dietzsch S (2007). Kapitel 5.4.: Strahlenbiologische Besonderheiten. In: Dietz A, Flentje M, Keilholz U, Kopf-Hals-Tumoren - Therapie des Larynx-/ Hypopharynxkarzinoms unter besonderer Berücksichtigung des Larynxorganerhalts. (S. 40-41), Bremen-London-Boston: UNI-MED-Verlag AG.
     
  578. Dietzsch S, Hildebrandt G (2007). Kapitel 12.: Aktuelle postoperative adjuvante Therapieempfehlungen. In: Dietz A, Flentje M, Keilholz U, Kopf-Hals-Tumoren - Therapie des Larynx-/ Hypopharynxkarzinoms unter besonderer Berücksichtigung des Larynxorganerhalts. (S. 116-118), Bremen-London-Boston: UNI-MED-Verlag AG.
     
  579. Hildebrandt G, Dietzsch S (2007). Kapitel 13.1.: Prinzipielle Betrachtungen multimodaler Therapieansätze. In: Dietz A, Flentje M, Keilholz U, Kopf-Hals-Tumoren - Therapie des Larynx-/ Hypopharynxkarzinoms unter besonderer Berücksichtigung des Larynxorganerhalts. (S. 119-122), Bremen-London-Boston: UNI-MED-Verlag AG.
     


    580. 2006


  580. Kneissl GD, Burger W, Meixensberger J, Friedrich F, Kortmann RD (2006). Holiday heart syndrome possibly triggered after the start of radiochemotherapy for glioblastoma multiforme. Cardiology, 105(2), 86-88.
     
  581. Klüter S, Krastel D, Ludewig E, Reischauer A, Heinicke F, Pohlmann S, Wolf, U, Grevel V, Hildebrandt G (2006). High-dose-rate-brachytherapy for intranasal tumours in dogs: results of a pilot study. Veterinary Compar Oncol (VCO), 4(4), 218-231.
     
  582. Karlas T, Anderegg U, Jahns J, Hildebrandt G (2006). Expression von TGF-β1 in LPS/IFN-γ stimulierten murinen Makrophagen: Effekte einer Low-Dose Bestrahlung. Exp Strahlenther Klin Strahlenbiol, 15, 80-84.
     
  583. Schoppmeyer K, Miethe S, Wiedmann M, Liebmann A, Hauss J, Mossner J, Caca K, Witzigmann H, Hildebrandt G (2006). Radiochemotherapy followed by gemcitabine and capecitabine in extrahepatic bile duct cancer: a phase I/II trial. Am J Clin Oncol, 29(6), 576-582.
     
  584. Liebmann A, Wolf U, Hildebrandt G (2006). Primäre und adjuvante Radio-Chemo-Therapie des Zervixkarzinoms. J Turkish German Gynecol Assoc, 7(3), 239-249.
     
  585. Friedrich F, Jahns J, Hindemith M, Liebmann A, Hildebrandt G (2006). Histomorphologische Untersuchung der Effekte kleiner Strahlendosen verschiedener Fraktionierung auf die experimentelle Arthritis der Ratte. Exp Strahlenther Klin Strahlenbiol, 15, 70-74.
     
  586. Wolff JE, Wagner S, Reinert C, Gnekow A, Kortmann RD, Kuhl J, Van Gool SW (2006). Maintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade glioma. J Neurooncol, 79(3), 315-321.
     
  587. Bolling T, Schuck A, Rube C, Hesselmann S, Pape H, Dieckmann K, Pollinger B, Kortmann RD, Speiser-Held I, Meyer FM, Martini C, Asadpour B, Timmermann B, Beck JD, Langer T, Paulides M, Schmidt B, Willi (2006). [Therapy-associated late effects after irradiation of malignant diseases in childhood and adolescence. Feasibility analyses of a prospective multicenter register study] Strahlenther Onkol, 182(8), 443-449.
     
  588. Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, Reni M, Brandes AA, Curschmann J, Villa S, Cairncross G, Allgeier A, Lacombe D, Stupp R (2006). Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol, 24(16), 2563-2569.
     
  589. Breuninger H, Sebastian G, Kortmann RD, Schwipper V, Werner J, Garbe C (2006). [Brief guidelines: Basal cell carcinoma of the skin] J Dtsch Dermatol Ges, 4(5), 441-443.
     
  590. Herrlinger U, Rieger J, Koch D, Loeser S, Blaschke B, Kortmann RD, Steinbach JP, Hundsberger T, Wick W, Meyermann R, Tan TC, Sommer C, Bamberg M, Reifenberger G, Weller M (2006). Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03. J Clin Oncol, 24(27), 4412-4417.
     
  591. Leo C, Horn LC, Rauscher C, Hentschel B, Liebmann A, Hildebrandt G, Hockel M (2006). Expression of erythropoietin and erythropoietin receptor in cervical cancer and relationship to survival, hypoxia, and apoptosis. Clin Cancer Res, 12(23), 6894-6900.
     
  592. Wagner S, Benesch M, Berthold F, Gnekow AK, Rutkowski S, Strater R, Warmuth-Metz M, Kortmann RD, Pietsch T, Wolff JE (2006). Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas. Br J Cancer, 95(8), 991-997.
     
  593. Breuninger H, Sebastian G, Kortmann RD, Wolff K, Bootz F, Garbe C (2006). [Brief guidelines: squamous cell carcinoma of the skin, lip and eyelids] J Dtsch Dermatol Ges, 4(3), 260-262.
     
  594. Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R (2006). [Brief guidelines: malignant melanoma of the skin] J Dtsch Dermatol Ges, 4(4), 344-349.
     
  595. Wagner S, Warmuth-Metz M, Emser A, Gnekow AK, Strater R, Rutkowski S, Jorch N, Schmid HJ, Berthold F, Graf N, Kortmann RD, Pietsch T, Sorensen N, Peters O, Wolff JE (2006). Treatment options in childhood pontine gliomas. J Neurooncol, 79(3), 281-287.
     
  596. Timmermann B, Kortmann RD, Kuhl J, Rutkowski S, Meisner C, Pietsch T, Deinlein F, Urban C, Warmuth-Metz M, Bamberg M (2006). Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials. J Clin Oncol, 24(10), 1554-1560.
     
  597. Kortmann RD (2006). Kapitel 66.7, Strahlentherapie. In: Gadner H, Gaedicke G, Niemeyer C, Ritter J, Pädiatrische Hämatologie und Onkologie. (S. 787-789), Heidelberg: Springer Medizin Verlag.
     
  598. Kortmann RD (2006). Kapitel 66.19 Tumoren des Spinalkanals: ZNS-Tumoren. In: Gadner H, Gaedicke G, Niemeyer C, Ritter J, Pädiatrische Hämatologie und Onkologie. (S. 812-814), Heidelberg: Springer Medizin Verlag.
     
  599. Hildebrandt G (2006). CT-based implant technique after closed cavity surgery. In: Strnad V, Ott O, Partial breast irradiation using multicatheter brachytherapy. (S. 63-70), München-Wien-New York: Zuckerschwerdt Verlag.
     
  600. Kortmann RD, Hehr T, Claßen J, Paulsen F, Bamberg M (2006). Kapitel 23: Strahlentherapie des Melanoms. In: Garbe C, Management des Melanoms, Diagnosestellung, Therapie, Nachsorge. Onkologie aktuell. (S. 261-272), Heidelberg: Springer Medizin Verlag.
     
  601. Hildebrandt G, Rödel F (2006). Radiobiologische Aspekte der Bestrahlung inflammatorischer Prozesse. In: Seegenschmied MH, Micke O, 40. Symposium Radioonkologie/Strahlentherapie: Radiotherapie bei gutartigen Erkrankungen. (S. 241-252), Münster: Diplodocus-Verlag.
     
  602. Rödel F, Herrmann M, Hildebrand G (2006). Strahlenwirkung auf nicht getroffene Zellen am Beispiel der Molekularbiologie der antiinflammatorischen Strahlenwirkung. In: RADIZ Schlema, "Wirkungs-mechanismen niedriger Strahlendosen - Forschung für Radon-Balneotherapie und Strahlenschutz" 4. Biophysikalische Arbeitstagung 22.09.-24.09.2006. (S. 97-101), Bad Schlema: Radon-Dokumentations- und Informationszentrum .
     


    603. 2005


  603. Kortmann RD, Höffken K (2005). Editorial: Alter Wein in neuen Schläuchen? Onkologe, 12(11), 1247.
     
  604. Kortmann RD (2005). Qualitätssicherung in der Onkologie. Onkologe 2005, 12(11), 1248-1251.
     
  605. Hildebrandt G, Papsdorf K, Kortmann RD (2005). Strahlentherapie maligner Gliome. Journal Onkologie, 7, 12-20.
     
  606. Dietz A, Weber A, Dollner R, Hildebrandt G (2005). [Decision making in non resectable head and neck tumours] Laryngorhinootologie, 84(3), 200-206.
     
  607. Kortmann RD, Papsdorf K (2005). Fortschritte in der Primärtherapie maligner Gliome - was ist gesichert, wo liegen die Perspektiven? Onkologie Service aktuell, 1, 4-10.
     
  608. Herrlinger U, Steinbrecher A, Rieger J, Hau P, Kortmann RD, Meyermann R, Schabet M, Bamberg M, Dichgans J, Bogdahn U, Weller M (2005). Adult medulloblastoma Prognostic factors and response to therapy at diagnosis and at relapse. J Neurol, 252(3), 291-299.
     
  609. Calaminus G, Bamberg M, Harms D, Jurgens H, Kortmann RD, Sorensen N, Wiestler OD, Gobel U (2005). AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89. Neuropediatrics, 36(2), 71-77.
     
  610. Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolff JE, Kortmann RD, Kuehl J (2005). Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med, 352(10), 978-986.
     
  611. Rodel F, Franz S, Sheriff A, Gaipl U, Heyder P, Hildebrandt G, Schultze-Mosgau S, Voll RE, Herrmann M (2005). The CFSE distribution assay is a powerful technique for the analysis of radiation-induced cell death and survival on a single-cell level. Strahlenther Onkol, 181(7), 456-462.
     
  612. Ott OJ, Potter R, Hildebrandt G, Hammer J, Lotter M, Beckmann MW, Sauer R, Strnad V (2005). [Partial breast irradiation for early breast cancer with favorable prognostic factors: 3-year results of the German-Austrian phase II-trial] Rofo, 177(7), 962-967.
     
  613. Taphoorn MJ, Stupp R, Coens C, Osoba D, Kortmann R, van den Bent MJ, Mason W, Mirimanoff RO, Baumert BG, Eisenhauer E, Forsyth P, Bottomley A (2005). Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol, 6(12), 937-944.
     
  614. Schaue, D, Jahns J, Hildebrandt G, Trott KR (2005). Radiation treatment of acute inflammation in mice. Int J Radiat Biol, 81(9), 657-667.
     
  615. Timmermann B, Kortmann RD, Kuhl J, Rutkowski S, Dieckmann K, Meisner C, Bamberg M (2005). Role of radiotherapy in anaplastic ependymoma in children under age of 3 years: results of the prospective German brain tumor trials HIT-SKK 87 and 92. Radiother Oncol, 77(3), 278-285.
     
  616. Hildebrandt G, Trott KR (2005). Kapitel 27: Strahlenbiologische Grundlagen In: Falkenbach A, Morbus Bechterew - Beratung, Betreuung, Behandlung. (S. 477-490), Wien - New York: Springer Verlag.
     
  617. Hildebrandt G, Pohlmann S (2005). Kapitel 22: Hauttumore In: Strnad V, Pötter R, Kovacs G, Stand und Perspektiven der klinischen Brachytherapie. (S. 184-188), Bremen - London - Boston: Uni-Med-Verlag AG.
     
  618. Weller M, Krauseneck P, Kath R, Kortmann RD, Schmoll HJ (2005). Kapitel 74: Primäre Hirntumoren bei Erwachsenen. In: Schmoll HJ, Höffken K, Possinger K, Kompendium Internistische Onkologie. (S. 3219-3260), Heidelberg: Springer Medizin Verlag.
     
  619. Weller M, Kortmann RD, Schmoll JH (2005). Kapitel 75: Pinealistumoren bei Jugendlichen und Erwachsenen. In: Schmoll HJ, Höffken K, Possinger K, Kompendium Internistische Onkologie. (S. 3261-3272), Heidelberg: Springer Medizin Verlag.
     


    620. 2004


  620. Liebmann A, Hindemith M, Jahns J, Madaj-Sterba P, Weisheit S, Kamprad F, Hildebrandt G (2004). Low-dose X-irradiation of adjuvant-induced arthritis in rats. Efficacy of different fractionation schedules. Strahlenther Onkol, 180(3), 165-172.
     
  621. Kortmann RD, Timmermann B, Rutkowski S, Bamberg M (2004). Re: B. Beuthien-Baumann, et al. Differentiation between recurrent tumor and radiation necrosis in a child with anaplastic ependymoma after chemotherapy and radiation therapy. Strahlenther Onkol 2003;179:819-22. Strahlenther Onkol, 180(4), 245.
     
  622. Rodel F, Schaller U, Schultze-Mosgau S, Beuscher HU, Keilholz L, Herrmann M, Voll R, Sauer R, Hildebrandt G (2004). The induction of TGF-beta(1) and NF-kappaB parallels a biphasic time course of leukocyte/endothelial cell adhesion following low-dose X-irradiation. Strahlenther Onkol, 180(4), 194-200.
     
  623. Kortmann RD, Jeremic B, Weller M, Lutterbach J, Paulsen F, Bamberg M (2004). Immediate postoperative radiotherapy or "watch and wait" in the management of adult low-grade glioma? Strahlenther Onkol, 180(7), 408-418.
     
  624. Liebmann A, Wolf U, Hildebrandt G (2004). Adjuvante und primäre Strahlentherapie des Zervixkarzinoms gyn : praktische Gynäkologie, 9, 162-173.
     
  625. Kortmann RD, Hehr T, Classen J, Paulsen F, Garbe C, Bamberg M (2004). Strahlentherapie des Melanoms Onkologe, 10, 717-728.
     
  626. Dietz A, Kortmann RD (2004). Kehlkopfkrebs - Wandel der onkologischen Strategie in Richtung Organerhalt Ärzteblatt Sachsen, 15(11), 520-525.
     
  627. Hildebrandt G, Wolf U (2004). Prof. Dr. med. habil. Friedrich Kamprad zum 65. Geburtstag Ärzteblatt Sachsen, 15(3), 104.
     
  628. Rodel F, Hantschel M, Hildebrandt G, Schultze-Mosgau S, Rodel C, Herrmann M, Sauer R, Voll RE (2004). Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation. Int J Radiat Biol, 80(2), 115-123.
     
  629. Ott OJ, Potter R, Hammer J, Hildebrandt G, Lotter M, Resch A, Pohls U, Beckmann MW, Sauer R, Strnad V (2004). Accelerated Partial Breast Irradiation with Iridium-192 Multicatheter PDR/HDR BrachytherapyPreliminary Results of the German-Austrian Multicenter Trial. Strahlenther Onkol, 180(10), 642-649.
     
  630. Strnad V, Ott O, Potter R, Hildebrandt G, Hammer J, Resch A, Lotter M, Ackermann S, Beckmann MW, Sauer R (2004). Interstitial brachytherapy alone after breast conserving surgery: interim results of a German-Austrian multicenter phase II trial. Brachytherapy, 3(3), 115-119.
     
  631. Korholz D, Claviez A, Hasenclever D, Kluge R, Hirsch W, Kamprad F, Dorffel W, Wickmann L, Papsdorf K, Dieckmann K, Kahn T, Mauz-Korholz C, Dannenberg C, Potter R, Brosteanu O, Schellong G, Sabri O (2004). The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies. Klin Padiatr, 216(3), 150-156.
     
  632. Calaminus G, Bamberg M, Jurgens H, Kortmann RD, Sorensen N, Wiestler OD, Gobel U (2004). Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89. Klin Padiatr, 216(3), 141-149.
     
  633. Rohrbach JM, Krober SM, Teufel T, Kortmann RD, Zierhut M (2004). EBV-induced polymorphic lymphoproliferative disorder of the iris after heart transplantation. Graefes Arch Clin Exp Ophthalmol, 242(1), 44-50.
     
  634. Gnekow AK, Kortmann RD, Pietsch T, Emser A (2004). Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH). Klin Padiatr, 216(6), 331-342.
     
  635. Koerholz D, Kluge R, Kahn T, Kamprad F, Papsdorf K, Dörffel W, Wickmann L, Claviez A, Schellong G, Hasenclever D, Brosteanu O, Dieckmann K, Pötter R, Hirsch W, Sorge I, Dannenberg C, Mauz-Koerholz C, (2004). Behandlung des Morbus Hodgkin im Kindes- und Jugendalter. Journal Onkologie, 8, 4-9.
     
  636. Kamprad F, Sauer R (2004). Kapitel - Brustdrüse In: Bamberg M, Molls M, Sack H, Radioonkologie - Band 2 -Klinik (S. 818-853), München-Wien-New York: Zuckerschwerdt.
     
  637. Haase W, Kamprad F (2004). Kapitel - Haut In: Bamberg M, Molls M, Sack H, Radioonkologie - Band 2 - Klinik (S. 898-919), München - Wien - New York: Zuckerschwerdt.
     
  638. Kortmann RD, Bamberg M (2004). Kapitel - Zentralnervensystem In: Bamberg M, Molls M, Sack H, Radioonkologie - Band 2 - Klinik (S. 951-1917), München - Wien - New York: Zuckerschwerdt.
     
  639. Wolf U, Wilke W (2004). 35. Wissenschaftliche Tagung der Deutschen Gesellschaft für Medizinische Physik (22.-25.09.2004, Leipzig) In: Wolf U, Wilke W, Medizinische Physik 2004 (S. 1-356), Leipzig: Gärtner Druck.
     
  640. Kortmann RD, Freeman CR, Taylor RE (2004). Chapter 10: Radiotherapy techniques In: Walker DA, Perilongo G, Punt JAG, Taylor RE, Brain and spinal tumours of childhood (S. 188-212), London: Arnold Publisher.
     
  641. Gnekow AK, Packer RJ, Kortmann RD (2004). Astrocytic tumours, low grade: general considerations In: Walker DA, Perilongo G, Punt JAG, Taylor RE, Brain and spinal tumours of childhood (S. 245-258), London: Arnold Publisher.
     
  642. Gnekow AK, Packer RJ, Kortmann RD (2004). Astrocytic tumours, low grade: treatment considerations by primary site and tumour dissemination In: Walker DA, Perilongo G, Punt JAG, Taylor RE, Brain and spinal tumours of childhood (S. 259-276), London: Arnold Publisher.
     
  643. Rekate HL, Nadkarni TD, Gnekow AK, Packer RJ, Kortmann RD (2004). Chapter 21: Intradural spinal tumours In: Walker DA, Perilongo G, Punt JAG, Taylor RE, Brain and spinal tumours of childhood (S. 387-396), London: Arnold Publisher.